Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023323	s-fsh	iu/l (iu/l)	10248	13152	0.00%
3023323	s-fsh	u/l (iu/l)	9148	11400	0.58%
3023323	s-fsh	— (—)	4442	5485	100.00%	Distribution not available
3023323	p-follikkeliastimuloivahormoni	u/l (iu/l)	215	234	0.00%
3023323	follikkeliastimuloivahormoni	u/l (iu/l)	68	72	0.00%
3023323	s-follikkeliastimuloivahormoni	iu/l (iu/l)	31	31	0.00%
3023323	s-follikkeliastimuloivahormoni(ko)	u/l (iu/l)	25	27	0.00%
3023323	s-follikkeliastimuloivahormoni	u/l (iu/l)	15	16	0.00%	Distribution not available
3023323	p-follikkeliastimuloivahormoni(pi)	u/l (iu/l)	9	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Amenorrhoea

784

1835

5.31

307.65

1.8

1.3

12.64

22.06

iu/l

17.41

645

1580

Disorders of other endocrine glands

2513

8780

3.05

307.65

1.8

1.3

17.93

26.11

iu/l

30.69

2087

7528

Female infertility, cervigal, vaginal, other or unspecified origin

2705

5414

3.85

307.65

1.3

1.2

18.74

28.08

iu/l

38.12

2341

4711

Hypopituitarism

625

916

8.52

307.65

2.1

1.4

11.95

22.13

iu/l

12.69

497

725

Female infertility

3037

5493

3.94

307.65

1.3

1.2

17.80

27.84

iu/l

46.71

2638

4776

Recurrent or chronic depression

2415

7169

2.59

307.65

1.4

1.3

23.88

29.52

iu/l

12.80

2042

6296

Exclusions for E4_PCOS_BROAD

1352

3568

4.40

307.65

1.9

1.4

17.27

26.16

iu/l

20.36

1105

2987

Female infertility, associated with anovulation

977

2664

4.58

307.65

1.3

1.2

10.60

22.32

iu/l

35.40

843

2322

Irregular menses

3780

15269

2.18

307.65

1.5

1.3

23.07

29.41

iu/l

26.91

3236

13359

Noninflammatory disorders of female genital tract

2664

5889

2.42

302.25

1.4

1.3

21.52

26.90

iu/l

11.75

2254

5100

Other menopausal disorders

1830

4062

2.84

288.54

1.4

1.3

41.13

34.60

iu/l

9.15

1624

3600

Depression

4416

17075

1.84

274.68

1.4

1.3

23.52

27.26

iu/l

11.41

3630

14893

Testicular dysfunction

220

138

18.90

264.58

2.0

1.3

14.70

7.85

iu/l

4.27

172

106

Benign neoplasm: Pituitary gland, craniopharyngeal duct

457

795

7.19

263.29

1.9

1.3

19.50

24.79

iu/l

2.52

371

677

Mood disorders

4540

17115

1.80

259.22

1.4

1.3

23.92

27.26

iu/l

9.38

3736

14928

Mood [affective] disorders

4534

17118

1.80

258.89

1.4

1.3

23.92

27.26

iu/l

9.29

3730

14931

Testicular hypofunction

204

119

20.53

254.62

2.0

1.3

15.21

7.55

iu/l

4.64

158

Anxiety disorders, excluding more controls

3847

14178

1.86

245.71

1.4

1.3

24.58

27.96

iu/l

7.82

3192

12453

Male infertility

261

257

11.53

238.21

1.6

11.50

7.73

iu/l

3.47

185

210

Disorders of the thyroid gland

4280

16187

1.79

237.83

1.4

1.3

25.42

27.18

iu/l

2.67

3670

14014

Benign neoplasm: Pituitary gland, craniopharyngeal duct

457

878

6.49

237.28

1.9

1.4

19.50

26.59

iu/l

4.17

371

736

Anxiety disorders

4223

17425

1.78

234.02

1.4

1.3

23.58

27.28

iu/l

10.61

3503

15125

Neurotic, stress-related and somatoform disorders

4206

17430

1.78

232.25

1.4

1.3

23.45

27.31

iu/l

11.48

3489

15131

Procreative management

1840

6956

2.38

228.58

1.5

1.4

22.78

28.46

iu/l

10.00

1488

5858

Polycystic ovarian syndrome, consortium definition

4343

15490

1.77

225.01

1.4

1.3

22.67

29.53

iu/l

35.26

3718

13545

Hypothyroidism, other/unspecified

4136

15920

1.77

224.69

1.4

1.3

25.43

27.46

iu/l

3.32

3556

13808

Hypothyroidism (congenital or acquired)

1931

4920

2.40

223.78

1.4

1.2

20.76

25.59

iu/l

7.76

1634

4337

Hypothyroidism and >3 levothyroxin purchases

1925

4908

2.40

223.44

1.4

1.2

20.85

25.62

iu/l

7.54

1630

4331

Hypothyroidism, levothyroxine purchases

1925

4908

2.40

223.44

1.4

1.2

20.85

25.62

iu/l

7.54

1630

4331

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1640

7277

2.40

215.14

1.7

1.3

22.52

29.33

iu/l

13.54

1374

6252

Mood disorders, excluding more controls

4013

14206

1.77

214.74

1.4

1.3

24.37

27.96

iu/l

9.38

3307

12486

Hypothyreosis and Thyroxine purchase for inclusion criteria

4201

16507

1.74

211.58

1.4

1.3

25.55

27.63

iu/l

3.52

3611

14315

Polycystic ovarian syndrome, broad definition

1225

5010

2.90

206.65

1.3

10.59

22.43

iu/l

52.74

1056

4346

Excessive, frequent and irregular menstruation

2165

5789

2.19

203.76

1.3

23.08

27.23

iu/l

6.79

1858

5015

Endocrine, nutritional and metabolic diseases

4107

12381

1.74

198.09

1.5

1.3

21.39

27.46

iu/l

25.54

3463

10714

Genitourinary diseases

2084

4917

2.18

195.76

1.5

1.4

19.23

22.50

iu/l

4.59

1700

4089

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

151

20.73

186.49

3.2

1.5

15.86

6.79

iu/l

6.49

122

Pain and other conditions associated with female genital organs and menstrual cycle

1299

5375

2.51

182.40

1.4

1.3

20.97

26.51

iu/l

8.58

1105

4653

Malignant neoplasm of testis

141

22.31

178.72

3.3

1.5

15.93

8.95

iu/l

3.31

121

Other antidepressants

3917

12348

1.69

175.33

1.4

1.3

24.40

27.41

iu/l

6.13

3280

10739

Endometriosis

1854

5406

2.15

169.18

1.3

1.2

26.61

28.59

iu/l

1.56

1645

4714

Depression or dysthymia

2501

7580

1.89

165.12

1.4

1.3

24.74

28.97

iu/l

7.57

2125

6625

Benign neoplasm of other and unspecified endocrine glands

558

1625

3.73

162.98

1.8

1.3

22.48

30.48

iu/l

6.42

460

1416

Exclusions for E4_PCOS_CONSORTIUM

3991

15838

1.64

158.59

1.5

1.3

24.67

28.09

iu/l

8.41

3396

13735

Hypothyroidism, strict autoimmune

3330

13486

1.68

151.45

1.3

25.52

27.50

iu/l

2.75

2865

11709

Migraine, single triptan purchase ok & required. ICD-code if available is included

3700

15856

1.63

147.87

1.3

26.67

27.02

iu/l

0.24

3244

13580

Triptan medication for migraine, single purchase ok

3700

15856

1.63

147.87

1.3

26.67

27.02

iu/l

0.24

3244

13580

Ovarian dysfunction

778

3007

3.08

147.26

1.5

1.3

18.56

21.92

iu/l

2.00

673

2602

Medicines for HER+ breast cancer

1331

6156

2.21

145.67

1.5

1.3

37.83

37.26

iu/l

0.24

1155

5382

Ovarian cyst

1862

5571

2.02

145.22

1.3

26.95

28.01

iu/l

0.63

1614

4840

Medical treatment for female infertility

2052

11650

1.96

142.85

1.3

18.84

26.92

iu/l

29.08

1863

10157

Other diseases of hard tissues of teeth

2618

11446

1.76

142.46

1.5

1.3

26.13

27.12

iu/l

0.75

2185

9898

Benign neoplasm of other and unspecified endocrine glands

558

1770

3.42

142.36

1.8

1.3

22.48

30.89

iu/l

7.21

460

1526

Headache

2932

14971

1.69

139.84

1.4

1.3

24.75

27.06

iu/l

3.41

2514

12963

Neoplasms

3729

12725

1.61

137.62

1.5

1.3

22.68

23.04

iu/l

0.27

3141

10889

Dysplasia of cervi uteri

1389

5308

2.15

133.05

1.3

1.2

25.21

28.28

iu/l

2.82

1226

4624

Selective serotonin reuptake inhibitors

3699

12487

1.59

130.50

1.4

1.3

23.67

27.20

iu/l

8.21

3105

10843

L02BG Aromatase inhibitors

823

3345

2.57

129.54

1.5

1.3

44.08

39.01

iu/l

3.60

714

2888

Anxiety (asthma-related co-morbidities)

3044

15102

1.64

128.74

1.4

1.3

21.13

27.16

iu/l

21.05

2456

13234

Pain in joint

2234

8619

1.76

120.92

1.4

1.3

26.37

26.42

iu/l

0.02

1953

7380

Menorrhagia

1721

5090

1.95

120.58

1.3

26.47

29.87

iu/l

3.67

1486

4450

Polycystic ovarian syndrome

592

2217

3.23

119.94

1.4

1.3

9.51

20.36

iu/l

31.72

513

1909

Migraine

2757

14741

1.66

119.71

1.4

1.3

24.49

26.92

iu/l

3.47

2404

12747

Triptan medication for migraine, min. 3 purchases

3280

16974

1.59

117.72

1.3

26.23

27.41

iu/l

1.18

2902

14671

Persons encountering health services in circumstances related to reproduction

2091

8286

1.76

112.72

1.4

27.43

28.52

iu/l

0.71

1701

6937

Seminoma of testis, excluding all cancers (controls excluding all cancers)

28.13

109.60

3.6

1.5

16.65

7.07

iu/l

3.44

All anxiety disorders

3081

16282

1.57

108.68

1.4

1.3

20.96

26.46

iu/l

18.30

2484

14146

Malignant neoplasm of breast, HER-positive

1147

5669

2.08

108.56

1.5

1.3

41.19

38.86

iu/l

1.50

1000

4978

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4106

16039

1.49

108.49

1.4

1.3

24.96

27.13

iu/l

3.77

3483

13843

Cystitis

3711

15317

1.52

108.04

1.4

1.3

27.15

27.33

iu/l

0.12

3167

13300

Depression medications

1799

5078

1.85

105.49

1.4

1.3

20.62

25.08

iu/l

6.82

1502

4455

Seminoma of testis

22.32

99.41

3.6

1.5

16.65

8.78

iu/l

2.30

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

29.78

99.36

3.4

1.5

18.27

8.38

iu/l

2.14

Hyperfunction of pituitary gland

400

1348

3.46

95.90

1.9

1.3

16.55

26.42

iu/l

8.62

329

1140

General symptoms and signs

4319

15307

1.44

93.89

1.4

1.3

25.45

26.70

iu/l

1.55

3635

13212

Unspecified/other endometriosis

658

2858

2.54

93.54

1.3

1.2

22.23

24.64

iu/l

1.14

574

2505

Non-seminoma of testis

25.35

92.75

3.4

1.4

18.27

9.49

iu/l

1.92

Episodal and paroxysmal disorders

4314

15770

1.43

89.79

1.4

1.3

23.71

26.32

iu/l

5.55

3677

13498

Other soft tissue disorders, not elsewhere classified

3546

15227

1.47

88.65

1.4

1.3

26.77

25.48

iu/l

1.43

3018

12993

Endometriosis of pelvic peritoneum

925

4602

2.11

88.38

1.3

1.2

26.95

29.48

iu/l

1.38

830

4026

Other diseases of urinary system

3962

15786

1.44

87.90

1.4

1.3

26.64

26.82

iu/l

0.12

3385

13659

Used for control exclusion in common control thyroid runs

3984

14256

1.44

87.67

1.4

1.3

22.45

26.14

iu/l

9.85

3365

12212

Other endocrine disorders

294

848

3.70

82.51

2.3

1.5

11.78

19.32

iu/l

4.76

213

646

Oligomenorrhoea

262

754

3.99

80.14

1.6

1.3

14.39

23.73

iu/l

6.23

214

646

Acute upper respiratory infections

3768

16903

1.42

79.89

1.4

1.3

26.08

27.45

iu/l

1.69

3269

14508

Hypothyroidism, strict autoimmune, 3 medication purchases required

3369

16227

1.45

79.11

1.3

26.22

27.98

iu/l

2.32

2906

14085

Opioids

3968

15004

1.41

78.74

1.4

1.3

23.94

26.52

iu/l

5.29

3355

13003

Disorders of puberty

144

267

6.72

78.00

3.2

1.6

8.32

9.93

iu/l

0.40

118

195

Asthma, including avohilmo

4232

18007

1.39

77.28

1.4

24.86

26.48

iu/l

2.49

3612

15448

Persons encountering health services in other circumstances, wide

4235

16049

1.39

76.78

1.4

1.3

25.24

27.12

iu/l

2.93

3554

13849

Dermatitis and eczema

3856

18336

1.40

76.41

1.4

25.23

26.55

iu/l

1.67

3306

15719

Benign neoplasms

3289

13111

1.45

75.45

1.4

1.3

22.43

23.47

iu/l

1.07

2827

11283

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

195

435

4.32

73.43

1.3

31.30

33.77

iu/l

0.40

152

374

Asthma (mode)

3019

11545

1.46

73.17

1.4

1.3

24.90

27.72

iu/l

4.75

2567

9924

Codeine

3713

14785

1.40

71.82

1.4

1.3

24.78

26.79

iu/l

3.24

3172

12837

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1163

5420

1.80

70.08

1.5

1.3

41.36

37.90

iu/l

2.79

1010

4780

Other anxiety disorders

2250

13550

1.52

68.93

1.4

1.3

20.30

24.22

iu/l

7.61

1792

11765

Disorders of puberty, all

165

388

5.27

68.17

3.4

1.7

8.34

9.57

iu/l

0.35

137

279

Chronic diseases of tonsils and adenoids

3167

14362

1.42

67.61

1.3

1.4

25.35

26.80

iu/l

1.64

2739

12239

Any mental disorder

3887

14309

1.38

67.19

1.4

1.3

25.35

27.88

iu/l

4.55

3223

12537

Psychiatric diseases

3876

14265

1.38

67.19

1.4

1.3

25.30

27.89

iu/l

4.74

3213

12502

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3358

14347

1.41

67.14

1.6

1.3

33.96

28.97

iu/l

12.49

2801

12544

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3357

14347

1.41

66.97

1.6

1.3

33.95

28.97

iu/l

12.47

2802

12545

Malignant neoplasm, wide definition for exclusion

3357

14348

1.41

66.96

1.6

1.3

33.95

28.97

iu/l

12.47

2802

12545

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

728

3208

2.03

66.20

1.7

1.3

31.47

32.41

iu/l

0.29

605

2777

Endometriosis of ovary

815

4330

1.97

65.92

1.3

1.2

28.75

30.15

iu/l

0.55

715

3792

Behavioural syndromes associated with physiological disturbances and physical factors

1525

9659

1.64

65.79

1.5

1.3

20.49

22.88

iu/l

2.36

1245

8309

Dental caries 2

3206

18310

1.40

65.48

1.4

1.3

24.00

26.94

iu/l

5.46

2707

15784

Primary_lymphoid and hematopoietic malignant neoplasms

414

1673

2.53

65.47

2.0

1.4

22.65

27.37

iu/l

2.08

330

1419

Asthma

3018

11495

1.43

65.41

1.4

1.3

24.92

27.72

iu/l

4.69

2567

9881

Hyperprolactinaemia

304

1098

3.27

65.30

1.6

1.3

17.13

27.37

iu/l

7.04

251

952

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

100

147

7.07

65.10

1.3

1.2

30.75

32.27

iu/l

0.14

128

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2805

16346

1.44

65.04

1.3

26.41

28.76

iu/l

3.28

2432

14267

Any event in cancer register

3589

15692

1.38

63.67

1.6

1.3

31.90

27.42

iu/l

11.36

3049

13672

Neurological diseases

3589

13255

1.39

63.32

1.4

1.3

23.22

25.73

iu/l

4.49

3078

11275

Asthma, excluding more controls

3005

11436

1.43

63.17

1.4

1.3

24.77

27.70

iu/l

5.08

2556

9828

Diseases of male genital organs

632

1468

2.20

62.83

1.6

1.7

10.24

8.09

iu/l

3.41

474

1112

Examination and observation for other reasons

2087

8506

1.52

62.53

1.4

1.3

25.16

27.26

iu/l

2.05

1801

7213

Polyp of the female genital tract

1322

4646

1.71

62.38

1.3

30.52

31.78

iu/l

0.63

1169

4088

Non-small cell lung cancer

195

527

3.78

62.36

1.3

31.30

36.07

iu/l

1.01

152

448

Codeine or tramadol medication

4077

16993

1.35

61.94

1.4

1.3

25.49

26.99

iu/l

2.15

3494

14699

Delayed puberty

103

10.01

61.16

3.1

1.7

8.01

8.11

iu/l

0.01

Other disorders of adrenal gland

222

684

3.59

60.34

1.8

1.4

23.37

26.51

iu/l

0.65

181

556

Fenamates

599

1928

2.18

60.09

1.3

25.07

26.99

iu/l

0.68

527

1656

Follow-up examination after treatment for conditions other than malignant neoplasms

1832

7960

1.54

59.07

1.4

1.3

28.12

28.37

iu/l

0.11

1594

6819

Other headache syndromes

1758

11748

1.54

59.01

1.4

1.3

26.92

29.12

iu/l

1.99

1518

10241

Dental caries 2 and operation codes

3137

18364

1.38

58.99

1.4

1.3

23.84

26.91

iu/l

5.81

2650

15825

Anaemias

1148

4547

1.74

58.75

1.4

1.3

25.52

27.06

iu/l

0.74

956

4020

Disorders of conjunctiva

3067

18898

1.38

58.26

1.4

26.23

26.50

iu/l

0.17

2627

16219

Conjunctivitis

2942

18773

1.39

58.20

1.4

25.98

26.60

iu/l

0.45

2511

16116

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

395

1653

2.45

58.09

1.7

1.3

31.66

33.40

iu/l

0.45

334

1429

Short stature, not elsewhere classified

159

379

4.57

57.16

2.6

1.7

6.78

6.87

iu/l

0.02

114

247

L02BA Anti-estrogens

720

3871

1.96

56.91

1.5

1.3

31.75

37.35

iu/l

5.48

628

3398

Parasetamol

3185

11975

1.38

54.89

1.4

1.3

23.78

25.61

iu/l

2.47

2723

10317

Medical observation and evaluation for suspected diseases and conditions

2376

8526

1.45

54.80

1.5

1.3

23.22

27.23

iu/l

7.38

2040

7226

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

270

792

2.91

54.33

1.4

1.3

31.69

32.12

iu/l

0.06

216

669

Malignant neoplasm of respiratory system and intrathoracic organs

229

682

3.14

54.02

1.3

30.77

32.47

iu/l

0.28

181

579

Personality disorders, excluding more controls

1176

7351

1.66

53.66

1.4

1.3

21.77

24.93

iu/l

2.80

908

6474

First line medication for Crohn's disease

4046

16926

1.32

53.66

1.4

1.3

26.01

25.76

iu/l

0.18

3454

14484

Abdominal and pelvic pain

3339

12511

1.36

52.90

1.4

24.68

26.66

iu/l

2.76

2838

10698

Malignant neoplasm of bronchus and lung

187

508

3.50

52.73

1.3

30.93

35.25

iu/l

0.80

146

426

Lower back pain or/and sciatica

3464

18188

1.34

52.69

1.4

1.3

26.96

26.64

iu/l

0.23

2992

15684

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

219

583

3.18

51.54

1.3

32.01

33.95

iu/l

0.30

172

493

Dental caries 2, only avohilmo

3108

18436

1.35

51.07

1.4

24.00

26.82

iu/l

4.99

2646

15860

Primary_lymphoid and hematopoietic malignant neoplasms

414

1871

2.26

50.96

2.0

1.4

22.65

28.11

iu/l

2.69

330

1568

Asthma (only as main-diagnosis)

2621

11495

1.40

50.80

1.4

1.3

24.51

27.72

iu/l

5.45

2235

9881

Non-small cell lung cancer, adenocarcinoma

100

189

5.49

50.59

1.4

1.3

30.75

33.21

iu/l

0.26

158

Non-small cell lung cancer, adenocarcinoma, helper endpoint

100

189

5.49

50.59

1.3

30.75

33.21

iu/l

0.26

158

Other maternal disorders predominantly related to pregnancy

3068

14487

1.37

50.33

1.3

27.28

29.70

iu/l

3.53

2715

12575

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2743

16030

1.39

50.18

1.3

26.43

29.04

iu/l

3.89

2387

14019

Symptoms and signs involving the digestive system and abdomen

3325

12512

1.35

50.09

1.4

24.55

26.66

iu/l

3.04

2827

10698

Low back pain

2585

14586

1.39

49.80

1.4

1.3

26.08

26.38

iu/l

0.17

2228

12567

Adenomyosis (Endometriosis of uterus)

494

2441

2.12

49.46

1.4

1.3

26.69

32.41

iu/l

3.54

439

2136

Malignant neoplasm

3122

13890

1.35

49.46

1.6

1.3

34.38

29.98

iu/l

9.22

2599

12159

Symptoms and signs involving the circulatory and respiratory systems

4071

15814

1.31

49.37

1.4

1.3

23.65

26.32

iu/l

5.53

3450

13591

Asthma (only as main-diagnosis), excluding more controls

2621

11436

1.39

48.48

1.4

1.3

24.51

27.70

iu/l

5.36

2235

9828

Other specific joint derangements/joint disorders

2961

14880

1.36

48.42

1.4

1.3

26.40

25.18

iu/l

1.19

2604

12700

Lung cancer and mesothelioma

222

637

3.03

48.42

1.3

1.4

31.76

37.05

iu/l

1.20

175

544

Deposits [accretions] on teeth

271

1009

2.76

48.30

2.5

1.5

12.50

22.96

iu/l

9.19

206

796

Benign neoplasms

3588

15357

1.32

48.04

1.4

1.3

23.30

25.09

iu/l

2.68

3085

13141

Other nutritional deficiencies

2491

17962

1.38

47.95

1.4

1.3

20.36

27.79

iu/l

36.01

2081

15575

Dorsalgia

3633

15106

1.32

47.86

1.4

1.3

25.07

25.82

iu/l

0.68

3118

12948

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

175

5.71

47.79

2.9

1.7

11.62

14.45

iu/l

0.47

137

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

211

396

3.28

47.79

2.8

1.3

14.34

9.38

iu/l

3.67

170

319

Sleep disorders (combined)

3224

16056

1.33

47.37

1.4

1.3

25.88

29.12

iu/l

6.71

2691

13974

Any reimbursement code in KELA

2972

11136

1.36

46.98

1.4

1.3

23.42

24.21

iu/l

0.64

2500

9644

Nonorganic sleeping disorders, excluding more controls

780

4542

1.79

46.96

1.4

1.3

23.68

26.66

iu/l

1.74

639

3986

Endometriosis diagnosis and infertility diagnosis occurring together

783

4637

1.83

46.86

1.3

24.38

28.51

iu/l

3.01

705

4067

Pain (limb, back, neck, head abdominally)

2418

8743

1.40

46.86

1.4

24.72

26.13

iu/l

1.22

2047

7435

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

280

1113

2.59

46.28

1.7

1.3

28.51

28.01

iu/l

0.08

225

950

GASTRO-related operations

3358

12839

1.33

46.13

1.4

1.3

23.32

25.87

iu/l

4.63

2864

11000

Any gastric operation

3358

12839

1.33

46.13

1.4

1.3

23.32

25.87

iu/l

4.63

2864

11000

Adrenocortical insufficiency

166

508

3.60

45.70

1.7

1.3

26.06

27.91

iu/l

0.27

146

426

Use of cabergoline

105

240

5.33

44.86

1.8

1.3

14.77

22.59

iu/l

1.80

208

Other dorsopathies, not elsewhere classified

3704

15186

1.30

44.35

1.4

1.3

24.90

25.74

iu/l

0.80

3199

13004

Other noninflammatory disorders of vulva and perineum

391

1856

2.23

43.96

1.3

23.61

28.72

iu/l

2.52

341

1608

Diabetes, insulin treatment (Kela reimbursement)

1811

15546

0.70

43.76

1.4

24.54

30.55

iu/l

14.71

1522

13456

Fever of other and unknown origin

1601

10309

1.46

43.07

1.6

1.3

24.29

26.07

iu/l

1.43

1337

8917

Inflammatory diseases of female pelvic organs

2912

16787

1.34

42.98

1.3

27.19

28.39

iu/l

1.12

2493

14660

Antihypertensive medication - note that there are other indications

3182

13362

1.33

42.91

1.4

1.3

21.43

24.32

iu/l

5.82

2731

11413

Irritable bowel syndrome

1062

6877

1.59

41.56

1.4

1.3

23.71

28.37

iu/l

4.92

915

5962

Hypothyroidism, drug reimbursement

823

3546

1.73

41.51

1.3

1.2

32.00

31.87

iu/l

0.03

711

3207

Neurological diseases, wide definition

1590

5480

1.49

41.35

1.4

19.82

25.06

iu/l

8.95

1348

4598

Hodgkin lymphoma

129

357

3.97

41.33

1.8

1.4

22.37

18.66

iu/l

0.59

107

299

Disorders of adult personality and behaviour

1278

8639

1.53

41.17

1.4

1.3

20.55

24.43

iu/l

4.50

988

7495

Malaise and fatigue

1256

6976

1.52

40.97

1.5

1.3

25.90

27.74

iu/l

1.12

1077

6036

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2297

16880

1.37

40.92

1.4

1.3

26.71

27.31

iu/l

0.36

1989

14590

Oxycodone

615

3331

1.81

40.86

1.5

1.3

27.48

33.67

iu/l

4.88

510

2890

Contraceptive management

1497

7252

1.48

40.83

1.3

30.36

30.64

iu/l

0.11

1307

6151

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1800

15259

0.71

40.77

1.4

24.56

30.73

iu/l

15.30

1513

13219

Coxibs

807

2527

1.73

40.45

1.3

1.4

19.66

23.02

iu/l

2.24

699

2101

Sleep disorders

862

5364

1.66

40.29

1.4

1.3

23.67

25.72

iu/l

1.07

704

4620

Sleep apnoea, including avohilmo

2982

14921

1.31

39.40

1.4

1.3

27.19

30.81

iu/l

7.50

2521

13004

Molar incisor enamel hypoplasia, with caries

178

6.30

39.19

3.2

2.4

8.03

8.10

iu/l

0.01

103

Allergic conjunctivitis

2360

17544

1.35

39.19

1.4

1.3

26.83

27.14

iu/l

0.17

2043

15135

Rare circulating lymphoid malignancy

208

4.79

39.18

2.9

1.8

11.62

16.59

iu/l

1.13

162

Malignant melanoma, excluding all cancers (controls excluding all cancers)

317

1435

2.27

39.15

1.3

27.77

32.17

iu/l

1.56

260

1245

Diseases of oral cavity, salivary glands and jaws

2933

11525

1.32

38.85

1.4

1.3

27.59

27.10

iu/l

0.32

2474

9961

Gingivitis and periodontal diseases

2909

11495

1.32

38.84

1.4

1.3

27.01

27.11

iu/l

0.05

2461

9952

Use of hypnotics and sedatives

3545

16159

1.28

38.63

1.4

1.3

28.42

28.24

iu/l

0.11

3009

14027

Pain in limb

2636

14537

1.33

38.58

1.4

1.3

27.58

26.23

iu/l

1.27

2243

12451

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

112

7.62

38.54

2.9

1.8

8.39

13.57

iu/l

1.17

Acute lymphocytic leukaemia, helper endpoint

112

7.62

38.54

2.9

1.8

8.39

13.57

iu/l

1.17

Hodgkin lymphoma, hilmo

129

375

3.77

38.45

1.8

1.4

22.37

20.54

iu/l

0.24

107

313

Other reaction to severe stress, and adjustment disorders

1667

11988

1.43

38.34

1.4

1.3

24.34

25.99

iu/l

1.31

1386

10451

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

140

423

3.38

38.02

1.6

1.3

32.14

28.01

iu/l

0.60

102

360

Soft tissue disorders

3746

15434

1.27

38.00

1.4

23.73

25.28

iu/l

2.15

3231

13144

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

279

1217

2.36

37.72

1.3

27.64

32.04

iu/l

1.37

228

1052

Personal history of malignant neoplasm

162

549

3.21

37.59

2.3

1.4

19.22

30.53

iu/l

4.62

139

459

KRA_PSY_EATING, excluding more controls

550

3115

1.88

37.31

1.6

1.3

15.45

18.39

iu/l

1.79

448

2702

Obesity and other hyperalimentation

2336

17577

1.34

36.94

1.4

1.3

20.46

27.97

iu/l

35.49

1948

15265

Hypoplasia of dental enamel, including avohilmo

209

5.60

36.90

3.2

2.6

6.99

5.46

iu/l

0.60

127

Acetic acid derivatives and related substances

796

2490

1.69

36.85

1.4

1.3

19.69

23.25

iu/l

2.40

676

2070

Excessive attrition of teeth

1591

6090

1.45

36.83

1.4

1.3

25.16

25.19

iu/l

0.01

1318

5264

Insomnia

669

4004

1.74

36.72

1.5

1.3

24.02

25.91

iu/l

0.80

555

3451

Other abnormal products of conception

2285

11551

1.37

36.65

1.3

24.68

28.22

iu/l

5.74

2003

10132

Acute lymphocytic leukaemia

118

7.21

36.58

2.9

2.0

8.39

14.95

iu/l

1.64

Complications of procedures, not elsewhere classified

2535

16803

1.32

36.46

1.4

1.3

27.50

28.59

iu/l

0.91

2175

14589

Obesity related asthma

961

6260

1.57

36.32

1.4

1.3

23.84

31.55

iu/l

13.02

795

5418

Dentofacial anomalies [including malocclusion]

1143

7657

1.52

36.27

1.6

1.3

25.85

26.67

iu/l

0.35

981

6633

General examination and investigation of persons without complaint and reported diagnosis

2160

8526

1.37

36.11

1.4

1.3

24.37

27.23

iu/l

3.64

1897

7226

Supervision of high-risk pregnancy

1446

6161

1.48

36.04

1.3

27.88

31.88

iu/l

4.40

1297

5281

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1735

12601

1.39

35.88

1.4

1.3

27.79

29.35

iu/l

1.15

1480

10944

Habitual aborter

176

655

3.12

35.82

1.3

18.61

23.48

iu/l

1.17

143

565

Symptoms and signs involving the nervous and musculoskeletal systems

1616

11647

1.41

35.75

1.4

27.16

27.67

iu/l

0.24

1405

9984

Personality disorders

1176

8052

1.50

35.58

1.4

1.3

21.77

24.51

iu/l

2.24

908

6991

Obesity

2318

17533

1.33

35.51

1.4

1.3

20.37

27.96

iu/l

36.10

1930

15222

Chronic rhinitis, nasopharyngitis and pharyngitis

1121

7603

1.51

35.18

1.4

1.3

25.59

29.33

iu/l

3.50

947

6525

Hyperkinetic disorders, excluding more controls

528

2923

1.85

34.92

1.5

1.4

12.97

16.69

iu/l

3.25

411

2466

Non-selective monoamine reuptake inhibitors

905

5677

1.57

34.81

1.4

1.3

29.94

35.49

iu/l

5.31

764

5015

Lymphoid leukaemia

102

270

3.92

34.08

2.8

1.5

12.76

18.43

iu/l

1.49

217

Dental caries

696

4223

1.67

33.98

1.9

1.4

18.76

24.86

iu/l

6.04

537

3564

Nonorganic sleeping disorders

780

4946

1.63

33.91

1.4

23.68

25.19

iu/l

0.65

639

4258

Special screening examination for infectious and parasitic diseases

1291

6737

1.47

33.73

1.4

1.3

20.45

23.97

iu/l

3.61

1032

5722

Hypertrichosis

187

748

2.93

33.41

1.5

1.3

14.05

24.08

iu/l

5.89

163

636

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1548

5514

1.43

33.37

1.4

1.3

24.63

26.51

iu/l

1.31

1287

4755

Migraine without aura

1146

7942

1.50

33.28

1.4

1.3

24.35

25.71

iu/l

0.72

980

6881

Hirsutism in women

172

666

3.07

33.00

1.5

1.3

13.90

23.70

iu/l

5.35

148

568

Other medical care

830

5203

1.58

32.99

1.7

1.3

27.35

28.37

iu/l

0.39

701

4441

Complications associated with artificial fertilization

148

528

3.27

32.65

1.3

15.39

23.38

iu/l

2.75

131

462

Dental caries 2 and operation codes, only avohilmo

2640

12766

1.30

32.54

1.4

25.42

25.70

iu/l

0.16

2254

10935

Premenstrual syndrome

107

317

4.13

32.52

1.5

1.3

13.67

25.51

iu/l

4.76

279

Other special examinations and investigations of persons without complaint or reported diagnosis

2229

8526

1.34

32.50

1.5

1.3

23.82

27.23

iu/l

5.22

1931

7226

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1602

11715

1.39

32.50

1.4

1.3

27.77

29.39

iu/l

1.15

1372

10164

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

129

5.30

32.29

1.5

1.2

30.79

29.91

iu/l

0.06

109

Non-invasive ventilation

687

3998

1.65

32.02

1.5

1.3

28.69

31.57

iu/l

1.46

648

3520

Asthma (diagnoses ohter than nonallergic)

2811

19013

1.28

31.81

1.4

24.45

26.91

iu/l

3.89

2371

16362

Asthma-related infections

1708

12456

1.37

31.75

1.4

22.51

26.43

iu/l

6.06

1430

10675

Asthma, hospital admission 2, infections

1708

12456

1.37

31.75

1.4

22.51

26.43

iu/l

6.06

1430

10675

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

125

396

3.22

31.53

1.7

1.3

32.57

28.00

iu/l

0.61

336

Female infertility, tubal origin

293

1433

2.21

31.35

1.3

1.2

24.39

32.65

iu/l

4.29

257

1262

Chronic lower respiratory diseases

4095

18148

1.23

31.29

1.4

25.11

26.39

iu/l

1.68

3500

15568

Nausea and vomiting

700

4314

1.63

31.14

1.6

1.4

22.53

25.94

iu/l

1.93

588

3620

Other diseases of intestines

3781

17901

1.24

31.08

1.4

1.3

25.94

26.25

iu/l

0.23

3229

15360

Chronic sinusitis

1447

10502

1.40

31.03

1.4

1.3

27.00

29.57

iu/l

2.39

1270

9094

Specific personality disorders

1035

7114

1.50

30.87

1.4

1.3

21.03

24.90

iu/l

3.65

792

6178

Care involving use of rehabilitation procedures

1821

12991

1.35

30.76

1.5

1.3

27.70

29.95

iu/l

2.20

1573

11200

3786

16273

1.24

30.70

1.4

1.3

26.88

27.46

iu/l

0.49

3280

13981

531

3136

1.76

30.65

1.6

1.3

27.16

26.72

iu/l

0.11

429

2732

Other functional intestinal disorders

1151

7656

1.45

30.35

1.5

1.4

25.84

28.63

iu/l

2.09

970

6514

Cardiovascular diseases

3189

13951

1.26

30.10

1.4

1.3

23.21

24.24

iu/l

1.01

2722

11953

Dorsopathies

3689

15322

1.24

29.83

1.4

24.14

25.60

iu/l

1.88

3191

13099

Disorders of thyroid, IBD co-morbidities

881

4260

1.55

29.74

1.4

1.3

30.21

29.26

iu/l

0.34

753

3681

Malignant melanoma of skin

224

990

2.33

29.58

1.3

26.02

32.77

iu/l

2.35

180

851

Fibromyalgia

469

2722

1.83

29.56

1.4

1.3

29.35

32.48

iu/l

1.18

404

2370

Migraine without aura and triptan purchases

957

6574

1.52

29.49

1.4

1.3

24.51

25.56

iu/l

0.44

820

5655

Acute upper respiratory infections of multiple and unspecified sites

2724

16210

1.28

29.42

1.4

1.3

23.07

26.61

iu/l

7.21

2343

13912

Benzodiazepine use

3154

18097

1.25

29.39

1.4

1.3

25.00

27.43

iu/l

3.94

2603

15728

Bronchitis

3470

18523

1.24

29.24

1.4

1.3

23.61

27.02

iu/l

8.28

2973

15918

Pregnancy examination and test

1242

5542

1.47

29.24

1.3

23.54

29.21

iu/l

7.64

1099

4740

Migraine with aura

1179

8394

1.45

29.22

1.4

1.3

24.17

25.56

iu/l

0.77

1026

7279

Emotionally unstable personality disorder

660

4209

1.64

28.66

1.4

1.3

18.36

23.06

iu/l

4.02

489

3630

Autoimmune diseases

3767

15760

1.23

28.55

1.4

24.08

25.87

iu/l

2.60

3210

13467

1428

10408

1.38

28.42

1.5

1.4

22.06

25.64

iu/l

4.44

1190

8916

Malignant neoplasm of urinary organs

119

392

3.10

28.17

1.7

1.4

34.66

30.60

iu/l

0.50

326

Malignant melanoma

266

1289

2.11

27.84

1.3

26.26

33.20

iu/l

2.95

216

1111

Complications of medical and surgical care

2105

15543

1.30

27.74

1.4

1.3

27.73

29.18

iu/l

1.17

1801

13506

Temporomandibular joint disorders, including avohilmo

1897

14625

1.32

27.44

1.4

1.3

24.29

25.86

iu/l

1.32

1649

12632

Eating disorder

552

3417

1.71

27.41

1.6

1.4

15.45

18.32

iu/l

1.74

448

2890

Asthma, hospital admissions , main diagnosis only

2679

19224

1.26

27.36

1.4

24.23

26.85

iu/l

4.24

2275

16517

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

8.47

27.04

1.2

17.95

24.38

iu/l

0.49

Disorders of tooth development and eruption

243

1133

2.22

26.99

2.3

1.5

15.68

17.00

iu/l

0.31

190

900

COPD differential diagnosis

2879

11547

1.26

26.96

1.4

1.3

26.95

27.71

iu/l

0.57

2462

9925

ILD differential diagnosis

2878

11545

1.26

26.90

1.4

1.3

26.96

27.72

iu/l

0.56

2460

9924

Other pulmonary diagnosis

2891

11614

1.26

26.71

1.4

1.3

26.87

27.78

iu/l

0.73

2471

9983

Migraine with aura and triptan purchases

845

5781

1.52

26.55

1.4

1.3

23.96

25.22

iu/l

0.53

731

4971

Lymphoid leukaemia

102

320

3.30

26.42

2.8

1.6

12.76

20.06

iu/l

2.33

253

Excluding asthma or asthma-COPD overlap

2887

11614

1.26

26.36

1.4

1.3

26.91

27.78

iu/l

0.68

2467

9983

145

570

2.87

26.30

1.4

1.3

22.15

18.62

iu/l

0.68

135

484

malignant neoplasm of male genital organs

213

585

2.33

26.27

2.8

1.3

14.79

11.56

iu/l

1.87

179

457

Gastrointestinal diseases

2667

10664

1.27

25.95

1.4

1.3

23.18

25.53

iu/l

3.07

2272

9132

Malignant neoplasm of kidney, except renal pelvis

112

374

3.06

25.95

1.7

1.4

34.38

30.52

iu/l

0.44

309

Rheumatism, unspecified

443

2614

1.75

25.50

1.3

32.71

37.46

iu/l

2.14

384

2265

Complications of surgical and medical care, not elsewhere classified

2982

17413

1.24

25.50

1.4

1.3

27.44

27.89

iu/l

0.31

2555

15096

ILD medications: prednisolone, methylprednisolone, prednisone

3671

17192

1.22

25.32

1.4

1.3

26.68

26.34

iu/l

0.24

3186

14724

Acromegaly and pituitary gigantism

6.37

25.13

2.1

1.3

20.82

24.49

iu/l

0.28

Eating disorders

579

3698

1.64

24.99

1.6

1.4

15.81

18.91

iu/l

2.12

472

3137

Spontaneous abortion

2220

11970

1.29

24.87

1.3

26.42

28.51

iu/l

2.13

1911

10477

Endometriosis of rectovaginal septum and vagina

290

1522

1.99

24.87

1.3

24.11

27.48

iu/l

1.01

256

1331

Malignant neoplasm of breast

1586

8674

1.34

24.74

1.4

1.3

42.58

36.93

iu/l

8.32

1364

7644

Temporomandibular joint disorders

639

4167

1.58

24.58

1.4

1.3

27.57

29.30

iu/l

0.63

568

3602

Primary ovarian failure

154

652

2.73

24.47

2.1

1.3

50.72

28.05

iu/l

6.13

131

557

Obesity, other/unspecified

1344

10051

1.37

24.39

1.3

21.21

28.87

iu/l

20.67

1093

8771

Other symptoms and signs involving the nervous and musculoskeletal systems

1255

9283

1.37

24.06

1.4

1.3

27.42

27.88

iu/l

0.19

1118

7971

Secondary and unspecified malignant neoplasm of lymph nodes

161

676

2.45

24.03

1.6

1.4

23.74

26.87

iu/l

0.54

131

566

Endocrine disorders, other/unspecified

325

3.32

23.95

1.7

1.3

21.58

26.65

iu/l

0.72

282

Clear cell adenocarcinoma of kidney

166

4.11

23.76

1.5

1.4

30.79

31.24

iu/l

0.03

136

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

904

5788

1.46

23.71

1.5

1.4

12.86

15.38

iu/l

2.85

711

4812

Other general symptoms and signs

218

1043

2.19

23.71

1.5

1.4

21.29

24.30

iu/l

0.75

180

860

Outcome of delivery

1248

5730

1.41

23.63

1.3

26.87

30.66

iu/l

3.45

1035

4910

Other/unspecified dorsalgia

1121

8137

1.39

23.41

1.4

1.3

27.70

28.42

iu/l

0.29

944

7012

Malignant neoplasm of breast, HER2-negative

1483

8252

1.34

23.37

1.4

1.3

42.29

37.35

iu/l

6.36

1286

7263

ILD medications

3819

17566

1.20

23.34

1.4

1.3

25.71

25.95

iu/l

0.17

3296

15011

Mouth breathing

934

6600

1.43

23.33

1.4

22.82

29.50

iu/l

9.52

786

5609

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1458

11016

1.34

23.17

1.4

23.07

23.35

iu/l

0.12

1166

9528

Other diseases of blood and blood-forming organs, wide

506

3160

1.64

23.14

1.6

1.4

26.85

29.71

iu/l

1.13

429

2691

Symptoms and signs involving the skin and subcutaneous tissue

2066

16356

1.27

22.95

1.4

1.3

27.15

28.14

iu/l

0.69

1802

14114

Persons with potential health hazards related to communicable diseases

1699

13130

1.31

22.92

1.4

20.93

22.66

iu/l

1.61

1463

11196

Other diseases of upper respiratory tract

3359

14520

1.22

22.77

1.4

25.58

26.83

iu/l

1.37

2903

12363

Post-traumatic stress disorder

455

2828

1.69

22.28

1.4

1.3

16.80

21.90

iu/l

3.97

376

2436

Disorders of pituitary gland, other and/or unspecified

6.45

22.19

1.7

1.2

24.52

25.76

iu/l

0.07

Certain infectious and parasitic diseases

3578

14982

1.21

22.10

1.4

1.3

25.71

26.86

iu/l

1.20

3046

12954

Enlarged lymph nodes

432

2629

1.68

22.03

1.5

1.3

27.26

27.67

iu/l

0.09

365

2248

Asthma-related pneumonia

735

5017

1.48

22.01

1.4

23.69

28.18

iu/l

3.54

609

4278

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1453

10883

1.32

21.95

1.4

1.3

25.91

29.03

iu/l

3.17

1263

9353

Dentinal caries

561

3614

1.57

21.93

1.8

1.4

19.72

24.92

iu/l

3.80

438

3059

Hyperhidrosis

148

635

2.51

21.83

1.6

1.4

21.42

24.59

iu/l

0.64

134

545

Secondary uncertain malignant neoplasm

187

870

2.19

21.80

1.6

1.4

25.96

29.02

iu/l

0.56

153

734

Asthma, hospital admissions 3, pneumonia

736

5035

1.48

21.79

1.4

23.66

28.12

iu/l

3.50

610

4292

Asthma-related pneumonia or sepsis

736

5035

1.48

21.79

1.4

23.66

28.12

iu/l

3.50

610

4292

Generalized anxiety disorder

681

4635

1.52

21.66

1.4

1.3

20.23

22.17

iu/l

0.88

539

4008

Disorders of skin appendages

1599

12428

1.31

21.63

1.4

22.38

25.56

iu/l

4.13

1362

10685

Persistent mood disorders

568

3707

1.57

21.61

1.4

1.3

23.76

27.65

iu/l

2.17

446

3214

Inflammatory bowel disease treatment related agents

3775

18094

1.19

21.52

1.4

1.3

26.75

26.10

iu/l

0.58

3253

15500

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

10.74

21.48

2.5

1.6

24.55

7.49

iu/l

2.68

Anorexia (incl.atypical)

310

1757

1.86

21.24

1.7

1.4

13.24

18.82

iu/l

4.07

254

1479

Pain, not elsewhere classified

840

5944

1.44

21.21

1.4

1.3

25.99

27.30

iu/l

0.57

712

5163

Other joint disorders

3385

15079

1.21

21.19

1.4

24.20

25.00

iu/l

0.73

2960

12837

Postmenopausal bleeding

671

2447

1.53

21.18

1.4

1.3

44.03

43.97

iu/l

0.01

566

2166

Bipolar affective disorders

754

5253

1.47

21.08

1.3

21.41

25.24

iu/l

2.91

599

4586

Diseases of the skin and subcutaneous tissue

3464

14547

1.20

21.03

1.4

1.3

24.83

26.95

iu/l

3.25

2954

12493

Hyperkinetic disorders

530

3408

1.60

20.97

1.5

12.97

15.18

iu/l

1.48

411

2796

Oxicams

524

1875

1.61

20.87

1.3

24.31

27.72

iu/l

1.49

458

1599

Disturbance of activity and attention

503

3204

1.61

20.78

1.5

12.60

15.35

iu/l

2.03

395

2636

Disorders of puberty, other/unspecified

7.36

20.75

3.4

1.7

9.85

14.31

iu/l

0.42

Panic disorder

674

4632

1.50

20.46

1.4

1.3

19.10

22.95

iu/l

2.71

530

3996

Polyuria

392

2370

1.68

20.33

1.5

1.4

22.50

28.88

iu/l

3.67

328

2013

Cardiovascular diseases (excluding rheumatic etc)

3166

15315

1.21

20.13

1.4

1.3

24.74

25.37

iu/l

0.50

2695

13200

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

165

755

2.22

20.04

1.7

1.3

26.97

29.12

iu/l

0.33

137

644

Factors influencing health status and contact with health services

692

2335

1.50

19.84

1.5

1.3

22.97

29.50

iu/l

5.50

564

1974

Sleep apnoea

2517

14016

1.23

19.83

1.4

1.3

26.70

32.16

iu/l

14.02

2093

12252

Covid-19 confirmed case

777

5494

1.44

19.71

1.4

22.61

24.94

iu/l

1.23

641

4713

Sciatica+with lumbago

1525

11319

1.30

19.58

1.4

1.3

28.85

30.47

iu/l

1.10

1333

9864

Disturbances of skin sensation

1038

7728

1.37

19.55

1.4

1.3

25.49

27.01

iu/l

0.80

905

6708

L01XE Protein kinase inhibitors

115

457

2.61

19.49

1.6

1.3

26.04

33.63

iu/l

1.64

392

Hypertrophy of breast in women and men

829

5972

1.43

19.43

1.3

29.40

32.67

iu/l

2.08

723

5215

Visual disturbances and blindness

1254

9571

1.33

19.39

1.5

1.4

26.44

27.35

iu/l

0.44

1050

8214

Non-small cell lung cancer, squamous

5.82

19.33

1.2

1.3

17.95

25.55

iu/l

0.75

Non-small cell lung cancer, squamous, helper endpoint

5.82

19.33

1.2

1.3

17.95

25.55

iu/l

0.75

Hypoplasia of dental enamel , including avohilmo

156

718

2.34

19.23

2.6

1.9

10.26

11.58

iu/l

0.31

112

515

Molar incisor enamel hypoplasia

164

764

2.28

19.16

2.6

1.8

11.08

11.30

iu/l

0.04

115

550

Obesity due to excess calories

1599

12640

1.28

19.13

1.4

1.3

19.68

27.31

iu/l

26.16

1338

10963

Gender identity disorders

260

3.35

19.12

2.1

1.4

4.61

13.02

iu/l

7.16

204

729

5206

1.48

19.12

1.3

24.50

23.09

iu/l

0.54

572

4560

Female genital prolapse

948

3969

1.40

19.11

1.3

1.2

34.04

34.71

iu/l

0.23

822

3503

COPD/asthma/ILD related infections

3594

15262

1.19

18.99

1.4

1.3

26.35

27.53

iu/l

1.27

3095

13123

COPD/asthma related infections

3594

15262

1.19

18.99

1.4

1.3

26.35

27.53

iu/l

1.27

3095

13123

Visual disturbances

1192

9070

1.33

18.90

1.5

1.4

26.52

27.25

iu/l

0.32

1001

7789

Persons encountering health services in other circumstances

1110

8362

1.35

18.84

1.4

1.3

23.73

25.32

iu/l

0.85

891

7193

Dental caries 1 and operation codes

2359

9877

1.23

18.72

1.4

1.3

27.70

27.51

iu/l

0.09

1998

8530

Benign neoplasm of meninges

207

1064

2.00

18.69

1.6

1.3

31.75

33.84

iu/l

0.38

184

927

Diabetes medication

2418

17773

0.82

18.58

1.4

21.94

28.69

iu/l

26.54

2053

15376

Precocious puberty

5.50

18.51

3.3

1.7

7.02

9.36

iu/l

0.43

Monoamine oxidase A inhibitors

290

1663

1.79

18.51

1.4

1.3

26.46

33.77

iu/l

3.45

242

1456

Precocious central puberty

111

4.89

18.41

3.6

1.4

9.40

13.30

iu/l

0.62

Polyarthropathies

1443

12260

0.78

18.39

1.4

1.3

28.70

28.39

iu/l

0.13

1247

10549

Benign neoplasm: Cerebral meninges

191

961

2.05

18.36

1.5

1.3

31.69

33.60

iu/l

0.33

169

839

Ovarian dysfunction, other/unspecified

140

4.61

18.35

1.9

1.2

36.83

24.32

iu/l

1.39

118

Non-follicular lymphoma, hilmo, excluding all cancers

112

451

2.53

18.28

1.7

1.3

28.88

28.67

iu/l

0.02

387

Asthma and allergy

638

4381

1.48

18.23

1.4

21.29

24.30

iu/l

1.66

547

3738

Dental caries 3 and operation codes

2566

10871

1.22

18.20

1.4

1.3

27.82

27.11

iu/l

0.46

2176

9362

False labour

2096

10789

1.25

18.05

1.3

25.61

28.94

iu/l

4.73

1886

9285

Abnormalities of heart beat

943

6920

1.37

18.02

1.4

1.3

25.09

28.20

iu/l

2.15

816

5987

Asthma and allergy, excluding more controls

638

4393

1.48

17.97

1.4

21.29

24.33

iu/l

1.69

547

3749

Erosion of teeth, including avohilmo

773

5376

1.42

17.95

1.4

1.3

23.32

24.05

iu/l

0.25

637

4644

Symptoms and signs concerning food and fluid intake

232

1254

1.89

17.93

1.6

1.4

20.27

24.66

iu/l

1.29

201

1020

Diseases of the eye and adnexa

3339

14174

1.19

17.91

1.4

1.3

25.44

25.17

iu/l

0.17

2821

12177

Myalgia

786

5684

1.41

17.74

1.4

1.3

27.12

28.69

iu/l

0.67

672

4898

Allergic asthma (mode), excluding more controls

1000

7370

1.36

17.70

1.4

1.3

22.24

25.25

iu/l

2.37

860

6300

Allergic asthma (mode)

1000

7373

1.36

17.67

1.4

1.3

22.24

25.27

iu/l

2.40

860

6307

Congenital malformations, deformations and chromosomal abnormalities

2234

17680

1.23

17.66

1.5

1.3

24.79

25.15

iu/l

0.20

1888

15162

Other extrapyramidal and movement disorders in other diseases

439

2830

1.58

17.62

1.4

1.3

27.34

30.64

iu/l

1.24

376

2430

Abnormalities of breathing

3134

15768

1.19

17.47

1.4

1.3

24.83

26.36

iu/l

1.83

2691

13559

Constitutional tall stature

5.39

17.45

2.7

1.6

6.16

8.14

iu/l

0.34

Intestinal infectious diseases

2838

18605

1.20

17.43

1.5

1.3

22.52

25.89

iu/l

6.90

2392

15934

Sequelae with surgical and medical care as external cause

384

2406

1.63

17.43

1.4

1.3

27.02

30.10

iu/l

1.09

325

2069

Drug-induced adrenocortical insufficiency

257

3.19

17.41

1.7

1.4

31.18

29.80

iu/l

0.12

219

Sleep disorders, other/unspecified

157

760

2.21

17.41

1.5

1.4

25.02

23.18

iu/l

0.27

118

631

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1132

8693

1.33

17.18

1.4

1.3

22.27

25.41

iu/l

2.87

926

7665

Cushing syndrome

167

3.81

17.17

2.1

1.3

21.27

26.11

iu/l

0.49

139

Diaphragmatic hernia

602

4159

1.46

17.16

1.3

30.63

34.90

iu/l

2.33

507

3586

Disorders of lacrimal system

1068

8120

1.33

17.13

1.5

1.3

29.26

30.65

iu/l

0.65

912

7062

Other eating disorders

285

1687

1.79

17.07

1.6

1.4

13.73

17.25

iu/l

1.68

235

1398

Voice disturbances

731

5257

1.42

16.98

1.4

1.3

30.72

31.91

iu/l

0.43

633

4568

Sequelae of external causes of morbidity and mortality

507

3400

1.51

16.95

1.4

1.3

26.43

29.45

iu/l

1.28

425

2908

Nerve, nerve root and plexus disorders

3152

16832

1.19

16.88

1.4

1.3

29.26

27.94

iu/l

1.36

2771

14552

Diseases of the respiratory system

2270

9355

1.23

16.82

1.4

1.3

27.06

27.78

iu/l

0.45

1927

8004

Diseases of the musculoskeletal system and connective tissue

2281

9429

1.23

16.71

1.4

22.07

24.06

iu/l

2.18

1936

7956

Other obstetric conditions, not elsewhere classified

2474

13506

1.22

16.68

1.3

20.21

25.16

iu/l

13.37

2164

11763

Diabetes insipidus

123

4.30

16.68

2.2

1.3

16.29

23.82

iu/l

0.72

101

Contact with and exposure to communicable diseases

1481

11775

1.28

16.67

1.4

21.16

22.09

iu/l

0.59

1301

10056

Endometriosis ASRM stages 1,2

938

7103

1.36

16.36

1.3

26.98

28.29

iu/l

0.56

840

6201

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1633

8561

1.27

16.35

1.4

1.3

42.25

36.15

iu/l

9.76

1398

7566

Any operation in hilmo

138

305

2.35

16.33

1.5

1.2

16.49

25.25

iu/l

2.33

117

251

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2425

13239

1.22

16.24

1.3

19.85

24.78

iu/l

13.26

2124

11533

Tonsillectomy and adenotomy

2829

16727

1.19

16.20

1.4

20.26

25.44

iu/l

16.84

2440

14344

Mixed and other personality disorders

328

2031

1.68

16.20

1.5

1.3

20.61

26.05

iu/l

2.65

251

1757

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1630

8555

1.26

16.17

1.4

1.3

42.30

36.15

iu/l

9.87

1395

7561

Cough

1048

7682

1.32

16.12

1.4

25.78

29.84

iu/l

3.58

888

6591

Other abnormal uterine and vaginal bleeding

577

2836

1.47

16.07

1.4

1.3

28.42

31.92

iu/l

1.53

481

2462

Undescended testicle

135

3.99

16.00

2.9

2.1

10.98

5.49

iu/l

1.41

Other sleep disorders

275

1623

1.74

15.95

1.5

1.3

22.68

28.43

iu/l

2.09

230

1380

Other disorders of lacrimal gland

875

6548

1.36

15.77

1.5

1.3

29.20

30.67

iu/l

0.62

739

5706

Other metabolic disorders

471

3180

1.52

15.70

1.8

1.3

30.19

30.06

iu/l

0.03

387

2767

Postprocedural endocrine and metabolic disorders, not elsewhere classified

448

2999

1.54

15.61

1.8

1.3

30.76

30.21

iu/l

0.12

368

2621

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2336

11506

1.22

15.60

1.3

29.61

29.84

iu/l

0.11

2076

9884

Diarrhoea and gastroenteritis of presumed infectious origin

2156

16316

1.21

15.44

1.5

1.3

22.40

24.50

iu/l

2.43

1823

13970

Restless leg syndrome

292

1769

1.69

15.41

1.4

1.3

28.01

30.63

iu/l

0.62

246

1526

Dysphagia

428

2826

1.53

15.39

1.4

1.3

26.56

33.10

iu/l

3.92

372

2432

Persons encountering health services for specific procedures, not carried out

234

1338

1.81

15.38

1.3

1.4

25.93

23.61

iu/l

0.40

153

1122

Symptoms and signs involving speech and voice

815

6065

1.36

15.25

1.4

1.3

30.26

31.18

iu/l

0.33

703

5264

Atopic dermatitis

2370

17030

1.20

15.19

1.4

1.3

23.03

26.18

iu/l

5.19

2014

14636

Impotence

142

3.59

15.19

1.6

1.4

8.50

8.93

iu/l

0.08

114

Inflammatory disease of uterus

716

5265

1.41

15.19

1.4

1.3

23.92

27.04

iu/l

1.83

604

4610

Extrapyramidal and movement disorders

593

4196

1.43

14.92

1.4

1.3

27.44

30.95

iu/l

1.74

508

3591

Oter anti-inflammatory and antirheumatic agents, non-steroids

392

1387

1.58

14.81

1.4

1.3

30.14

33.69

iu/l

1.21

346

1215

Functional dyspepsia

733

5402

1.38

14.69

1.4

1.3

26.23

30.48

iu/l

3.11

642

4678

Propionic acid derivatives

793

2915

1.38

14.67

1.4

1.5

19.22

21.03

iu/l

0.89

651

2390

Deviated nasal septum

612

4367

1.42

14.64

1.4

1.3

26.47

29.12

iu/l

1.28

529

3725

Hypertrophy of breast

781

5852

1.37

14.57

1.3

30.50

33.09

iu/l

1.37

686

5119

Personal history of other diseases and conditions

553

3915

1.46

14.33

1.6

1.4

22.86

23.57

iu/l

0.21

434

3310

Dental operations

1532

6310

1.25

14.33

1.3

28.49

28.98

iu/l

0.21

1304

5436

Routine general health check-up of defined subpopulation

129

630

2.22

14.25

1.9

1.3

24.44

33.61

iu/l

2.19

107

547

Ovarian hyperstimulation (induction)

139

709

2.22

14.23

1.3

12.95

24.48

iu/l

6.31

123

604

Benign neoplasm of meninges

207

1166

1.82

14.19

1.6

1.3

31.75

35.10

iu/l

0.72

184

1013

Drug-induced polyneuropathy

5.02

14.15

3.0

2.3

14.10

19.54

iu/l

0.50

Other adrenocortical overactivity

111

4.31

14.13

2.0

1.5

15.60

15.72

iu/l

0.01

Persons encountering health services for examination and investigation

2052

8526

1.22

14.12

1.4

1.3

25.16

27.23

iu/l

1.98

1741

7226

Somatoform disorder

545

3859

1.44

14.10

1.5

1.3

25.26

29.34

iu/l

2.23

463

3370

Antenatal screening

1408

6380

1.27

14.04

1.3

32.29

31.37

iu/l

0.43

1236

5462

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

206

2.98

13.90

1.4

1.2

32.71

23.86

iu/l

1.12

171

Endometriosis ASRM stages 3,4

988

7699

1.31

13.78

1.3

27.65

28.16

iu/l

0.19

875

6733

Oedema, not elsewhere classified

623

4488

1.40

13.77

1.4

1.3

27.47

30.16

iu/l

1.27

536

3894

Diabetes, varying definitions

2529

17718

0.85

13.77

1.4

22.30

28.60

iu/l

23.33

2133

15340

Other specified and unspecified personality disorders

343

2232

1.59

13.73

1.3

23.19

25.17

iu/l

0.50

246

1920

Other congenital malformations

350

2292

1.58

13.66

1.7

1.5

20.55

23.90

iu/l

1.12

277

1878

Arthropathies

3425

15137

1.16

13.63

1.4

23.66

24.96

iu/l

1.53

2975

12865

Supervision of normal pregnancy

1369

6305

1.27

13.57

1.3

32.34

31.48

iu/l

0.38

1207

5400

Endometriosis of intestine

108

505

2.37

13.56

1.3

17.61

23.36

iu/l

1.23

442

Benign neoplasm: Cerebral meninges

191

1066

1.84

13.55

1.5

1.3

31.69

35.15

iu/l

0.74

169

917

Exposure to unspecified factor

2902

19415

1.17

13.52

1.4

24.88

26.43

iu/l

1.74

2401

16711

Agranulocytosis

259

1577

1.68

13.46

1.6

1.4

30.85

30.24

iu/l

0.10

223

1340

Artificial joint operation, meniscal resection

1230

10240

0.79

13.36

1.3

30.37

34.03

iu/l

3.66

1075

8820

Undetermined asthma

335

2171

1.57

13.34

1.5

1.4

26.25

29.32

iu/l

1.04

292

1873

Other disorders starting during childhood or adolecense, excluding more controls

191

1037

1.85

13.34

1.7

1.5

9.31

11.39

iu/l

0.83

145

816

Disorders of breast

1957

15225

1.21

13.33

1.3

30.10

30.70

iu/l

0.33

1717

13328

Melanocytic naevi

867

6651

1.32

13.31

1.4

1.3

24.62

26.46

iu/l

0.94

762

5768

Chromosomal abnormalities, not elsewhere classified

112

531

2.29

13.30

2.4

1.7

17.53

18.38

iu/l

0.14

409

Brain meningioma, excluding all cancers (controls excluding all cancers)

109

504

2.23

13.28

1.6

1.3

30.67

33.78

iu/l

0.41

439

Direct fill therapy

366

2425

1.54

13.27

1.9

1.5

22.21

25.66

iu/l

1.36

297

1993

Faecal incontinence

174

949

1.88

13.26

1.4

1.3

31.87

35.69

iu/l

0.71

144

828

Other (not insulin) diabetes medications

2056

14730

0.84

13.18

1.4

1.3

22.12

31.46

iu/l

44.09

1756

12858

Undetermined asthma, excluding more controls

335

2181

1.57

13.08

1.5

1.4

26.25

29.44

iu/l

1.09

292

1878

Erosion of teeth

338

2.61

13.01

2.0

1.5

10.82

24.97

iu/l

7.29

285

Dental operations, only avohilmo

1605

6707

1.23

12.98

1.3

28.68

28.82

iu/l

0.05

1366

5768

Diabetes mellitus

2570

17873

0.85

12.97

1.4

22.27

28.45

iu/l

22.95

2171

15470

Non-follicular lymphoma

112

526

2.17

12.96

1.7

1.4

28.88

30.09

iu/l

0.13

442

Maternal care for known or suspected abnormality of pelvic organs

1702

9774

1.23

12.93

1.3

25.57

28.99

iu/l

4.08

1505

8463

Melanocytic naevi of trunk

331

2165

1.57

12.82

1.5

1.3

24.91

26.45

iu/l

0.38

291

1859

Other disorders of eye and adnexa

431

2977

1.48

12.82

1.4

32.35

27.25

iu/l

1.60

342

2546

Cervicalgia

514

3660

1.43

12.74

1.3

28.54

31.29

iu/l

1.06

440

3164

Biguanides

1893

13918

0.83

12.73

1.4

1.3

21.66

31.72

iu/l

47.75

1618

12117

Oral corticosteroids

3262

17204

1.15

12.66

1.4

1.3

27.59

26.96

iu/l

0.50

2833

14819

Lack of expected normal physiological development

102

408

2.31

12.62

2.6

1.9

6.56

7.70

iu/l

0.44

294

Other disorders of ear

1655

13296

0.82

12.61

1.4

29.89

30.60

iu/l

0.37

1422

11417

Asthma, unspecified (mode)

1563

10195

1.23

12.61

1.4

1.3

26.47

29.48

iu/l

3.11

1309

8838

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

135

690

2.00

12.54

2.1

1.4

22.80

25.63

iu/l

0.49

115

582

Thyroiditis, ILD-related definition

413

2849

1.49

12.48

1.5

1.3

25.94

28.12

iu/l

0.62

345

2445

Anti-inflammatory and antirheumatic products, non-steroids

775

2917

1.35

12.42

1.4

1.5

18.87

21.03

iu/l

1.13

632

2390

Other and unspecified mood [affective] disorders

293

1889

1.61

12.34

1.4

17.35

21.20

iu/l

1.70

231

1617

Urticaria and erythema

1238

10021

1.25

12.27

1.4

25.85

27.04

iu/l

0.65

1072

8617

Thyrotoxicosis, other and/or unspecified

600

4425

1.38

12.18

1.4

1.3

30.76

30.21

iu/l

0.15

514

3851

Bulimia nervosa (incl. atypical)

209

1256

1.78

12.16

1.4

1.3

19.07

19.30

iu/l

0.04

163

1058

Autoimmune diseases related-to ILD

2495

18894

1.17

12.12

1.4

1.3

27.21

26.84

iu/l

0.22

2151

16270

Brachial plexus disorders

394

2716

1.50

12.11

1.4

1.3

29.82

30.62

iu/l

0.17

341

2350

Fissure and fistula of anal and rectal regions

576

4215

1.39

12.11

1.4

1.3

27.38

30.22

iu/l

1.25

502

3620

Type 2 diabetes, strict (exclude DM1)

2073

14585

0.84

12.08

1.4

1.3

22.33

31.78

iu/l

44.61

1758

12760

Disorders of vestibular function (Vertigo)

910

7056

1.29

12.04

1.3

29.73

32.68

iu/l

1.88

774

6124

Type 2 diabetes

2316

16056

0.85

12.01

1.3

22.61

30.31

iu/l

31.81

1960

14009

Granulosa cell carcinoma of ovary

5.94

11.94

3.0

1.4

30.57

22.80

iu/l

0.61

Dental caries 3

2229

9670

1.19

11.90

1.4

1.3

27.48

27.27

iu/l

0.10

1880

8366

Abnormalities of gait and mobility

162

893

1.84

11.90

1.6

1.5

25.67

27.22

iu/l

0.22

124

719

Certain disorders involving the immune mechanism

461

3266

1.44

11.84

1.8

1.4

25.11

29.42

iu/l

2.03

387

2795

Disorders of lens

608

5174

0.74

11.82

1.4

1.3

35.66

35.84

iu/l

0.04

490

4444

Type 2 diabetes, definitions combined

2078

14577

0.84

11.75

1.4

1.3

22.40

31.74

iu/l

43.60

1762

12754

Other noninflammatory disorders of vagina

236

1459

1.66

11.72

1.4

1.3

26.77

30.56

iu/l

0.97

205

1270

Dental caries 3, only avohilmo

2255

9812

1.18

11.70

1.3

1.4

27.64

27.15

iu/l

0.27

1899

8474

Other inflammation of vagina/vulva

199

1194

1.77

11.63

1.3

27.92

23.46

iu/l

0.96

155

1032

Asthma, unspecified (mode), excluding more controls

1560

10164

1.22

11.60

1.4

1.3

26.46

29.43

iu/l

3.04

1306

8804

Other inflammation of eyelid

304

1995

1.56

11.57

1.4

29.37

30.10

iu/l

0.13

248

1695

Injuries to the head

2622

19680

0.86

11.54

1.4

23.94

26.52

iu/l

3.96

2177

16937

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1081

8013

1.26

11.51

1.4

1.3

30.66

31.20

iu/l

0.20

933

6880

Varicose veins

924

8846

0.78

11.49

1.3

36.00

37.19

iu/l

0.48

818

7756

Postprocedural disorders of nervous system

348

2373

1.53

11.47

1.5

1.3

26.87

25.96

iu/l

0.19

310

2047

Speech and linguistic disorders, excluding more controls

258

1540

1.62

11.46

2.1

1.5

9.40

13.58

iu/l

2.68

185

1223

Cervical disc disorders

769

5919

1.31

11.41

1.4

1.3

31.64

33.79

iu/l

0.99

676

5142

Congenital malformations and deformations of the musculoskeletal system

341

2299

1.52

11.38

1.7

1.5

20.57

20.95

iu/l

0.08

275

1855

Uterine polyps

281

1824

1.58

11.35

1.3

34.08

35.84

iu/l

0.35

250

1596

Benign lipomatous neoplasm

564

4158

1.37

11.30

1.3

32.65

31.94

iu/l

0.19

498

3623

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

104

504

2.12

11.29

2.2

1.4

20.07

23.22

iu/l

0.49

424

Appendectomy

2200

18209

1.17

11.23

1.3

26.23

27.30

iu/l

0.85

1907

15760

Convulsions, not elsewhere classified

554

4026

1.38

11.23

1.5

1.4

22.62

22.41

iu/l

0.05

431

3409

Hard cardiovascular diseases

747

6235

0.76

11.21

1.3

31.32

33.95

iu/l

1.22

624

5369

Anankastic personality disorder

164

938

1.84

11.18

1.3

24.00

25.09

iu/l

0.16

142

798

Benign paroxysmal vertigo

558

4120

1.37

11.11

1.3

29.48

33.17

iu/l

1.81

481

3563

Diseases of the ear and mastoid process

3963

17832

1.13

11.08

1.4

1.3

25.88

26.52

iu/l

0.57

3398

15316

Abnormal involuntary movements

292

1918

1.55

11.07

1.4

25.90

27.54

iu/l

0.37

248

1617

Viral hepatitis, IBD co-morbidity

179

1045

1.76

11.06

1.3

24.65

27.31

iu/l

0.48

129

883

Viral Sepsis

319

2131

1.52

11.04

1.5

1.4

21.63

25.19

iu/l

1.25

263

1772

Paracetamol of NSAID medication

564

2065

1.39

11.03

1.5

18.20

19.20

iu/l

0.32

452

1657

Other disorders of urethra and urinary system

2227

14349

1.17

10.92

1.4

1.3

29.00

28.53

iu/l

0.27

1928

12521

Parodontitis or/and operation codes

1627

11512

0.83

10.88

1.4

1.3

32.19

27.94

iu/l

5.39

1371

10009

Implicit viral Sepsis

317

2122

1.51

10.87

1.5

1.4

21.68

25.14

iu/l

1.19

261

1763

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

489

3413

1.40

10.77

1.4

1.3

45.32

36.58

iu/l

5.46

406

2999

Other intervertebral disc disorders

2458

13014

1.16

10.76

1.4

1.3

30.55

28.50

iu/l

2.22

2152

11295

Dental caries, including avohilmo

1977

8568

1.19

10.75

1.4

1.3

28.05

27.80

iu/l

0.12

1660

7447

Pain in thoracic spine

445

3193

1.42

10.75

1.4

1.3

29.48

30.75

iu/l

0.33

382

2751

Infections of the skin and subcutaneous tissue

1541

12848

1.20

10.73

1.5

1.4

22.39

25.06

iu/l

2.82

1300

10964

Dental caries 1

1977

8573

1.19

10.66

1.4

1.3

28.04

27.79

iu/l

0.11

1661

7451

Disorders of ocular muscles, binocular movement, accommodation and refraction

1535

12763

1.21

10.66

1.5

1.4

25.77

25.57

iu/l

0.08

1271

10948

Follow-up examination after treatment for malignant neoplasms

153

859

1.81

10.63

1.5

1.3

39.96

36.96

iu/l

0.46

140

733

Other disorders of male genital organs

167

2.94

10.61

2.2

1.6

12.98

8.01

iu/l

1.39

132

Cluster headache, wide,, including avohilmo

194

1179

1.71

10.54

1.5

1.3

25.43

26.30

iu/l

0.14

172

1006

Diseases of salivary glands

464

3361

1.40

10.50

1.4

1.3

26.57

30.12

iu/l

1.56

401

2925

Other complications of surgical and medical care, not elsewhere classified

263

1713

1.57

10.49

1.4

1.3

25.65

29.50

iu/l

1.23

222

1468

Motor disorders, excluding more controls

281

2.51

10.45

2.9

2.0

5.99

6.29

iu/l

0.13

188

Disorders of psychological development

392

2560

1.45

10.44

2.0

1.6

10.34

13.40

iu/l

2.24

294

2015

Other and unspecified effects of external causes

920

7347

1.27

10.43

1.4

22.73

24.92

iu/l

1.34

769

6282

Type 2 diabetes, definitions combined, including avohilmo

2166

14877

0.86

10.42

1.4

1.3

22.53

31.52

iu/l

41.73

1839

13016

Gonarthrosis,primary

1279

9760

0.82

10.41

1.3

34.21

37.34

iu/l

2.82

1120

8510

Cervicocranial syndrome

297

1990

1.53

10.36

1.5

1.3

26.42

31.50

iu/l

1.83

261

1720

Drug-induced neutropenia

157

902

1.79

10.27

1.6

1.4

34.10

31.68

iu/l

0.36

134

774

Crossbite

246

1472

1.60

10.24

1.9

1.8

15.94

18.13

iu/l

0.61

189

1145

Brain meningioma

107

546

2.02

10.16

1.6

1.3

30.61

34.80

iu/l

0.61

465

Urticaria

1053

8567

1.25

10.12

1.4

25.89

26.43

iu/l

0.21

915

7359

Need for other prophylactic measures

136

753

1.86

10.11

1.6

1.5

20.31

26.97

iu/l

1.48

622

Other external causes of accidental injury

2987

13150

1.14

10.11

1.4

1.3

25.71

26.75

iu/l

0.94

2561

11363

Diseases of inner ear

1040

8247

1.24

10.10

1.4

1.3

30.60

32.38

iu/l

0.94

893

7149

Gastro-oesophageal reflux disease

1676

12575

1.19

10.08

1.4

1.3

27.85

30.94

iu/l

3.42

1431

10862

Cluster headache, strict, including avohilmo

188

1150

1.70

10.01

1.4

24.97

25.62

iu/l

0.10

167

980

Tramadol

2250

12509

1.16

9.98

1.4

1.3

26.85

29.97

iu/l

4.47

1896

10965

Noninfective enteritis and colitis

1247

10305

1.22

9.95

1.4

25.66

26.17

iu/l

0.22

1088

8786

Other female pelvic inflammatory diseases

546

4107

1.36

9.93

1.3

29.16

31.41

iu/l

0.83

474

3592

Adverse effects, not elsewhere classified

672

5201

1.32

9.92

1.4

23.69

26.05

iu/l

1.12

562

4443

Thyrotoxicosis

719

5613

1.30

9.84

1.4

1.3

31.55

30.38

iu/l

0.41

620

4860

Non-allergic asthma (mode), excluding more controls

442

3180

1.39

9.82

1.5

1.4

23.09

28.73

iu/l

3.58

363

2693

Abnormal weight loss

154

890

1.77

9.81

1.5

21.63

26.41

iu/l

1.09

133

737

Dermatographic urticaria

263

1749

1.56

9.79

1.4

1.3

23.46

27.34

iu/l

1.25

218

1495

Non-allergic asthma (mode)

442

3183

1.39

9.77

1.5

1.4

23.09

28.77

iu/l

3.63

363

2699

Falls/tendency to fall

3839

17195

1.12

9.76

1.4

1.3

25.05

26.07

iu/l

1.10

3238

14811

Colonic or urogenital fistula

600

4571

1.33

9.76

1.4

1.3

27.19

29.87

iu/l

1.21

524

3924

Accidents

2980

13150

1.14

9.75

1.4

1.3

25.54

26.75

iu/l

1.18

2560

11363

Subjective visual disturbances

605

4621

1.33

9.72

1.4

27.73

27.90

iu/l

0.04

513

3989

Other bacterial intestinal infections

322

2216

1.47

9.69

1.4

27.58

27.93

iu/l

0.06

260

1904

Pain associated with micturition

267

1774

1.53

9.68

1.4

27.78

27.18

iu/l

0.10

228

1495

Pruritus

311

2136

1.49

9.66

1.5

1.3

22.90

28.09

iu/l

2.31

262

1820

Deforming dorsopathies

688

5349

1.30

9.62

1.5

1.4

26.88

28.67

iu/l

0.75

593

4560

Dental caries 1, only avohilmo

2001

8768

1.17

9.62

1.4

1.3

28.11

27.58

iu/l

0.28

1687

7597

Other CVD

185

1125

1.66

9.61

1.4

28.67

30.41

iu/l

0.28

161

955

Cerebral cysts

176

1068

1.70

9.57

1.6

1.4

18.16

23.44

iu/l

1.75

152

898

Neuralgia and neuritis, unspecified

144

827

1.80

9.54

1.5

1.3

24.06

28.82

iu/l

1.09

122

704

Thyrotoxicosis with diffuse goitre

483

3594

1.37

9.48

1.4

1.3

30.57

31.25

iu/l

0.17

423

3150

Wilms' tumor, excluding all cancers (controls excluding all cancers)

6.93

9.48

3.1

1.8

26.46

12.39

iu/l

—

Weight loss

182

1113

1.67

9.43

1.6

1.4

20.84

25.80

iu/l

1.36

158

914

Leiomyoma of uterus

2213

10833

1.17

9.42

1.3

31.36

31.43

iu/l

0.03

1951

9600

Type 2 diabetes, wide definition

1064

8474

0.81

9.40

1.4

1.3

25.72

34.18

iu/l

15.67

874

7371

Bacterial infection, other or unspecified

784

5584

1.27

9.40

1.6

1.3

27.70

29.67

iu/l

0.90

630

4780

Emotional disorders starting during childhood or adolecense, excluding more controls

180

1081

1.69

9.39

1.7

1.5

8.15

10.49

iu/l

1.73

145

871

Lumbar disc prolapse

1785

12148

1.18

9.35

1.4

1.3

30.37

29.74

iu/l

0.33

1565

10572

Other disorders of bladder

155

908

1.73

9.35

1.3

1.4

22.46

27.85

iu/l

1.41

127

773

Vasomotor and allergic rhinitis

1381

11450

1.20

9.33

1.4

22.79

26.14

iu/l

3.75

1200

9759

Preparation and fitting of bite rail to mouth

452

3341

1.38

9.28

1.4

1.3

31.24

29.24

iu/l

0.51

406

2872

Cluster headache, wide

136

778

1.82

9.24

1.6

1.3

27.21

28.36

iu/l

0.16

121

669

Carbimazole or st.post thyroidectomy, condition for graves disease

660

5149

1.30

9.19

1.4

1.3

30.44

iu/l

0.00

570

4468

Radiculopathy

284

1929

1.49

9.16

1.4

1.3

31.41

32.86

iu/l

0.28

239

1664

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

108

578

1.96

9.16

1.4

1.3

32.96

28.97

iu/l

0.50

509

External causes of morbidity and mortality

2483

10880

1.15

9.12

1.4

1.3

25.39

26.77

iu/l

1.26

2134

9409

Benign neoplasm: Colon, unspecified

218

1391

1.57

9.11

1.4

1.3

28.43

34.13

iu/l

1.69

184

1197

Phobic anxiety disorders

528

4006

1.35

9.10

1.5

1.4

21.19

21.88

iu/l

0.20

415

3420

Postmenopausal atrophic vaginitis

597

2738

1.33

9.06

1.3

48.98

42.05

iu/l

4.54

547

2424

Recurring oral aphthae

113

613

1.90

9.03

1.5

22.53

26.27

iu/l

0.64

507

Other disorders of breast

462

3448

1.37

9.00

1.4

1.3

27.02

30.04

iu/l

1.12

405

2997

Asthma/COPD (KELA code 203)

2892

18081

1.13

8.96

1.4

25.99

26.46

iu/l

0.33

2488

15520

Melanocytic naevi of trunk

331

2335

1.45

8.95

1.5

1.3

24.91

27.29

iu/l

0.68

291

1994

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

179

1102

1.64

8.92

1.5

1.3

37.65

33.81

iu/l

0.74

150

944

Dental pulpitis 1, only avohilmo

3387

15797

1.13

8.91

1.4

25.23

25.64

iu/l

0.29

2837

13652

TMD related operations

554

4246

1.33

8.88

1.4

1.3

29.30

28.75

iu/l

0.13

500

3670

Hernia

1888

14807

0.86

8.86

1.4

25.19

29.36

iu/l

7.11

1608

12770

Short Achilles tendon (acquired)

464

2.05

8.86

1.4

1.3

26.66

34.73

iu/l

1.63

400

Deep endometriosis

389

2838

1.41

8.85

1.3

22.42

25.51

iu/l

1.23

346

2483

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

173

2.71

8.85

1.6

1.3

28.54

27.01

iu/l

0.10

149

Diffuse large B-cell lymphoma, helper endpoint

173

2.71

8.85

1.6

1.3

28.54

27.01

iu/l

0.10

149

Other shoulder lesions

266

1804

1.51

8.85

1.4

25.49

29.75

iu/l

1.37

227

1548

Salpingitis and oophoritis

562

4320

1.32

8.79

1.3

34.95

35.77

iu/l

0.22

475

3789

Malignant neoplasm of bladder

113

3.12

8.79

1.3

39.73

22.85

iu/l

1.69

Other diseases of liver

393

2859

1.40

8.78

1.4

1.3

30.13

32.09

iu/l

0.58

338

2463

Other noninfective gastroenteritis and colitis

585

4509

1.31

8.75

1.5

1.4

24.43

26.06

iu/l

0.62

509

3776

Anomalies of dental arch relationship, including avohilmo

659

4639

1.30

8.75

1.6

1.4

21.60

23.72

iu/l

0.98

537

3884

Cervicobrachial syndrome

631

4925

1.30

8.69

1.3

27.51

32.55

iu/l

3.72

556

4288

Bacterial intestinal infections, IBD co-morbidities

320

2249

1.44

8.67

1.4

27.48

28.66

iu/l

0.23

261

1912

Ectopic pregnancy

738

5895

1.28

8.65

1.3

27.94

31.19

iu/l

2.04

652

5158

Tinnitus

458

3418

1.36

8.64

1.4

1.3

31.41

31.68

iu/l

0.05

398

2951

Other specified and unspecified disorders of eye and adnexa

107

580

1.91

8.63

1.5

1.3

33.56

29.58

iu/l

0.47

494

Cluster headache, strict

130

750

1.81

8.63

1.5

1.4

26.63

27.80

iu/l

0.16

116

645

Disorders of refraction and accommodation

870

7037

1.25

8.59

1.5

1.4

23.80

25.94

iu/l

1.15

714

5982

Gingival hyperplasia

379

2.13

8.58

1.9

1.6

17.25

22.19

iu/l

0.87

304

Acute sinusitis

1810

14601

1.17

8.58

1.4

1.3

24.66

26.48

iu/l

1.69

1558

12575

Immunodeficiencies

146

870

1.74

8.58

1.8

1.5

18.58

27.82

iu/l

3.77

128

727

Other problems related to primary support group, including family circumstances

500

3712

1.35

8.52

1.6

1.4

21.39

22.95

iu/l

0.53

404

3104

Benign leiomyoma with endometriosis

383

2792

1.39

8.51

1.3

33.51

34.72

iu/l

0.28

334

2461

Other disorders of eyelid

580

4322

1.30

8.51

1.4

1.3

35.43

36.59

iu/l

0.35

507

3750

Other disorders of fluid, electrolyte and acid-base balance

369

2568

1.40

8.46

1.6

1.4

28.20

32.29

iu/l

1.39

307

2215

Psychotic depression

164

1008

1.67

8.44

1.4

1.3

25.02

27.62

iu/l

0.46

132

886

Paralytic ileus and intestinal obstruction

350

2507

1.41

8.43

1.5

1.3

30.39

32.96

iu/l

0.67

301

2154

Delayed milestone in childhood

372

2.13

8.42

2.8

2.4

6.47

5.87

iu/l

0.18

233

Specific developmental disorder of motor function

319

2.27

8.42

2.9

2.2

5.99

6.40

iu/l

0.19

205

Dental pulpitis 4, only avohilmo

3370

15768

1.12

8.40

1.4

25.09

25.64

iu/l

0.42

2820

13627

Visual field defects

160

977

1.67

8.40

1.7

1.4

26.52

28.92

iu/l

0.36

126

828

Other and unspecified nerve root and plexus disorders, also in other diseases

454

3405

1.35

8.37

1.4

1.3

30.83

31.73

iu/l

0.22

413

2953

Other diseases of blood and blood-forming organs

123

701

1.79

8.31

1.6

1.4

19.35

28.75

iu/l

3.66

107

600

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

205

1334

1.57

8.28

1.5

1.3

28.11

28.55

iu/l

0.06

168

1135

Chronic gastritis

357

2576

1.40

8.26

1.3

28.36

34.98

iu/l

3.84

292

2213

Dental pulpitis 4

3341

15562

1.12

8.24

1.4

24.87

25.62

iu/l

0.64

2798

13452

Ulcer of vagina/vulva

478

2.00

8.24

1.3

25.02

23.60

iu/l

0.13

413

All influenza

479

3625

1.33

8.21

1.6

1.4

21.86

24.51

iu/l

1.19

403

3038

Maternal care for other conditions predominantly related to pregnancy

1249

10451

1.20

8.21

1.3

25.27

27.26

iu/l

1.35

1090

9083

Unspecified privation

235

1577

1.52

8.20

1.3

1.4

21.80

26.01

iu/l

1.32

182

1335

Dental pulpitis 1

3340

15565

1.12

8.20

1.4

24.88

25.61

iu/l

0.63

2797

13455

Other enthesopathies

819

6637

1.25

8.17

1.3

30.93

33.75

iu/l

1.65

730

5748

Other and/or unspecified nontoxic goitre

182

1158

1.61

8.13

1.3

34.44

35.99

iu/l

0.20

161

1015

Cholera

287

2.24

8.08

1.4

1.3

47.32

42.54

iu/l

0.48

241

Diseases of pulp and periapical tissues, including avohilmo

3336

15557

1.12

8.08

1.4

24.87

25.61

iu/l

0.64

2793

13449

Spondylosis

1026

7281

1.22

8.06

1.4

1.3

32.49

35.75

iu/l

2.23

892

6332

Blepharochalasis

358

2598

1.39

8.03

1.4

1.3

37.90

40.62

iu/l

0.77

315

2248

Persons encountering health services for specific procedures and health care

3294

18340

1.12

8.03

1.5

1.3

27.91

26.48

iu/l

1.59

2796

15788

Exclusion endpoint for clefts

463

2.02

8.00

2.0

1.8

17.34

17.76

iu/l

0.04

365

Atrophic disorders of skin

339

2449

1.41

7.99

1.4

1.3

28.42

32.02

iu/l

1.15

283

2118

Abnormal findings on examination of blood, without diagnosis

657

4859

1.27

7.95

1.4

23.38

27.01

iu/l

2.30

560

4119

Mental disorders, not otherwise specified

310

2216

1.44

7.95

1.5

1.3

23.14

24.17

iu/l

0.23

256

1902

Sacrococcygeal disorders, not elsewhere classified

120

695

1.81

7.94

1.4

1.3

26.50

30.89

iu/l

0.76

107

608

Trochanteric bursitis

312

2224

1.43

7.94

1.3

31.00

36.50

iu/l

2.24

269

1922

Obsessive-compulsive disorder

265

1844

1.48

7.92

1.5

1.4

15.68

18.31

iu/l

0.99

220

1539

Vulvovaginal ulceration/inflammation in other diseases

289

2052

1.46

7.91

1.3

25.10

23.83

iu/l

0.24

243

1772

Syncope and collapse

773

5517

1.25

7.90

1.4

1.3

25.43

26.59

iu/l

0.42

633

4752

Melanocytic naevi

867

7105

1.24

7.86

1.4

1.3

24.62

27.23

iu/l

1.61

762

6124

Diabetic nephropathy, excluding more controls

1374

0.54

7.85

1.3

1.4

24.06

19.41

iu/l

0.53

1171

Benign neoplasm of other and ill-defined parts of digestive system

273

1900

1.45

7.85

1.4

1.3

33.01

32.79

iu/l

0.04

231

1665

Plantar fascial fibromatosis

284

2000

1.45

7.83

1.3

31.91

35.66

iu/l

1.13

249

1725

Benign neoplasm of eye and adnexa

163

1018

1.63

7.82

1.4

1.3

29.64

30.70

iu/l

0.15

141

891

Hypotension

127

741

1.73

7.79

1.4

1.3

27.02

28.36

iu/l

0.16

113

625

Medical abortion

2585

12483

1.14

7.79

1.3

27.66

27.90

iu/l

0.13

2203

10895

Nontoxic goitre/thyroid nodule

614

4841

1.28

7.78

1.4

1.3

32.88

34.69

iu/l

0.59

537

4230

Diabetes mellitus in pregnancy

2297

13210

1.15

7.78

1.3

21.33

28.09

iu/l

22.91

2028

11482

Disorders of mineral metabolism

151

928

1.66

7.76

1.5

1.4

25.35

29.98

iu/l

0.88

128

789

Myeloid leukaemia

145

2.76

7.76

2.4

1.3

19.31

22.50

iu/l

0.31

125

Torsion of ovary, ovarian pedicle and fallopian tube

540

1.91

7.72

1.3

26.39

25.33

iu/l

0.12

472

Disorders of synovium and tendon

1559

12109

1.17

7.71

1.4

1.3

28.66

29.13

iu/l

0.23

1386

10487

Other symptoms and signs involving the urinary system

157

975

1.63

7.69

1.4

22.70

26.56

iu/l

0.81

130

822

Scar conditions and fibrosis of skin

137

829

1.72

7.69

1.4

24.64

28.54

iu/l

0.76

116

700

Acne vulgaris

323

2340

1.42

7.68

1.4

1.5

15.14

15.52

iu/l

0.10

265

1961

Abnormal findings on diagnostic imaging of other body structures

267

1863

1.46

7.67

1.4

1.3

34.31

31.93

iu/l

0.48

230

1602

Other benign neoplasms of skin

682

5345

1.26

7.66

1.3

29.17

30.38

iu/l

0.43

590

4659

Candidiasis

349

2556

1.39

7.62

1.5

1.3

27.72

25.91

iu/l

0.41

279

2191

Recurring oral aphthae, including avohilmo

308

2208

1.42

7.61

1.5

1.4

28.48

25.48

iu/l

0.76

253

1855

Soft tissue disorders related to use, overuse and pressure

510

3940

1.31

7.58

1.3

29.55

33.54

iu/l

2.01

447

3371

Other septicaemia

467

3492

1.32

7.57

1.8

1.4

21.12

28.16

iu/l

5.27

373

2934

In situ neoplasms

748

5770

1.25

7.55

1.3

28.60

28.10

iu/l

0.16

663

5043

Acne

401

3011

1.36

7.53

1.4

1.5

15.78

16.34

iu/l

0.17

327

2532

Diabetic retinopathy, excluding more controls

251

2036

0.69

7.53

1.2

1.4

25.83

22.10

iu/l

0.89

206

1731

Gonarthrosis [arthrosis of knee](FG)

1436

9857

0.85

7.52

1.3

33.74

35.65

iu/l

1.34

1255

8609

Hypo-osmolality and hyponatraemia

177

1134

1.57

7.45

1.6

1.4

29.53

32.88

iu/l

0.60

149

967

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

206

1377

1.53

7.43

1.5

1.4

29.62

28.50

iu/l

0.19

175

1204

Postviral fatigue syndrome

281

2.37

7.42

1.6

1.4

22.22

22.04

iu/l

0.01

243

Polyneuropathies and other disorders of the peripheral nervous system

263

1837

1.44

7.40

1.6

1.4

30.16

29.85

iu/l

0.05

213

1572

Disorders of endocrine glands in diseases classified elsewhere

8.09

7.40

2.8

1.9

17.18

13.93

iu/l

—

Disorders of choroid and retina

957

8374

0.83

7.31

1.4

1.3

30.55

30.45

iu/l

0.03

811

7173

Haemangioma and lymphangioma, any site

221

1504

1.50

7.31

1.4

1.3

30.27

28.57

iu/l

0.27

191

1302

Hernia of abdominal wall, postoperative

330

2406

1.39

7.30

1.4

1.3

22.97

32.28

iu/l

7.28

272

2063

Muscle strain

540

1.86

7.29

1.4

25.17

24.32

iu/l

0.09

462

Hypermobility syndrome

274

1960

1.45

7.27

1.3

24.29

26.17

iu/l

0.42

239

1671

Haemangioma, any site

206

1384

1.52

7.27

1.4

1.3

30.34

29.01

iu/l

0.19

178

1200

Atypical facial pain

155

981

1.63

7.25

1.5

1.3

27.86

31.40

iu/l

0.65

130

844

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1132

9595

1.19

7.25

1.4

1.3

22.27

24.52

iu/l

1.69

926

8325

Venous thromboembolism

864

6911

1.22

7.23

1.4

1.3

30.88

31.69

iu/l

0.29

728

5981

Intestinal stricture

407

3068

1.34

7.19

1.4

1.3

30.06

31.69

iu/l

0.40

353

2635

Ischemic heart diseases

730

5642

0.81

7.18

1.4

1.3

30.54

35.53

iu/l

3.52

614

4829

Other disorders of gingiva or/and edentulous alveolar ridge

106

607

1.79

7.15

1.8

1.5

21.91

23.28

iu/l

0.18

494

Noninfectious colitis NAS

328

2403

1.39

7.15

1.4

23.25

26.54

iu/l

1.13

288

2036

Sexual dysfunction

189

2.50

7.14

1.7

1.3

15.17

20.69

iu/l

0.63

158

Atopic dermatitis, strict definition with reimbursement

1281

10647

1.18

7.13

1.5

1.4

22.25

23.51

iu/l

0.77

1095

9116

Abnormal findings on diagnostic imaging of lung

519

3937

1.29

7.13

1.4

1.3

32.36

33.54

iu/l

0.34

441

3371

Symptoms and signs involving emotional state

100

567

1.84

7.12

1.5

22.09

23.85

iu/l

0.24

480

Haemorrhage from respiratory passages

431

3039

1.32

7.11

1.4

24.99

30.07

iu/l

2.76

350

2566

Abrasion of teeth

859

5210

1.23

7.08

1.4

1.3

31.43

27.71

iu/l

2.28

733

4589

Nontoxic multinodular goitre

365

2719

1.36

7.08

1.4

1.3

33.29

35.61

iu/l

0.54

319

2374

Ehlers-Danlos syndrome

355

2.17

7.07

1.8

1.4

21.75

23.47

iu/l

0.16

306

Benign neoplasm of brain and other parts of central nervous system

128

775

1.69

7.05

1.8

1.4

29.41

27.59

iu/l

0.23

110

653

Wilms' tumor

5.13

7.04

3.1

2.1

26.46

18.28

iu/l

—

Family history of malignant neoplasm

405

3083

1.34

7.03

1.5

1.3

30.47

29.82

iu/l

0.15

365

2695

Unspecified lump in breast

472

3662

1.31

7.01

1.3

30.98

33.55

iu/l

0.89

411

3200

Diseases of liver

614

4904

1.26

6.99

1.4

1.3

29.24

31.46

iu/l

0.94

518

4206

Dental pulpitis 2, only avohilmo

1742

7757

1.15

6.99

1.4

1.3

27.22

27.43

iu/l

0.09

1451

6742

DVT of lower extremities and pulmonary embolism

568

4476

1.27

6.99

1.4

1.3

31.41

32.26

iu/l

0.23

471

3868

Rash and other nonspecific skin eruption

236

1643

1.46

6.95

1.4

32.40

29.18

iu/l

0.67

204

1397

Diabetic retinopathy

264

2339

0.71

6.91

1.2

1.4

25.02

22.18

iu/l

0.65

219

1973

Carcinoma in situ of breast, intraductal

173

1133

1.56

6.88

1.3

41.73

38.16

iu/l

0.69

152

997

Other symptoms and signs involving cognitive functions and awareness

601

4491

1.26

6.88

1.4

1.3

29.90

31.19

iu/l

0.42

510

3854

Striae atrophicae

253

2.31

6.86

1.4

1.3

28.12

25.65

iu/l

0.18

212

Motor disorders

352

2.07

6.85

2.9

2.1

5.99

6.38

iu/l

0.17

221

Other systemic involvement of connective tissue (FG)

621

4952

1.26

6.83

1.3

30.61

30.96

iu/l

0.09

542

4279

Cramp and spasm

120

723

1.71

6.82

1.4

26.30

26.93

iu/l

0.07

109

615

Gestational diabetes (for exclusion)

2415

15332

1.13

6.82

1.3

20.59

27.57

iu/l

27.35

2101

13384

Ocular pain

245

1728

1.45

6.82

1.4

28.75

26.56

iu/l

0.44

204

1469

Collagenous colitis

189

1264

1.52

6.82

1.5

1.4

30.11

29.62

iu/l

0.07

163

1076

Renal tubulo-interstitial diseases

1809

15755

0.88

6.80

1.4

1.3

27.43

26.81

iu/l

0.31

1520

13581

Speech and linguistic disorders

270

1856

1.42

6.79

2.1

1.6

9.21

12.72

iu/l

2.16

191

1434

Other systemic involvement of connective tissue

628

5057

1.25

6.73

1.4

1.3

30.44

30.57

iu/l

0.03

548

4378

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

110

2.86

6.71

2.4

1.3

21.40

23.92

iu/l

0.18

Conductive and sensorineural hearing loss

1021

8373

0.84

6.63

1.4

30.89

32.39

iu/l

0.73

880

7168

Orchitis and epididymitis

317

2.04

6.62

1.6

9.65

9.29

iu/l

0.09

257

Nonalcoholic fatty liver disease

217

1502

1.47

6.62

1.4

1.3

27.14

31.38

iu/l

1.25

180

1288

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

3.43

6.61

2.9

2.1

21.25

16.60

iu/l

0.28

Anosmia

230

2.25

6.61

1.5

1.3

35.10

37.41

iu/l

0.16

208

Viral infections characterized by skin and mucous membrane lesions

997

8408

1.19

6.61

1.5

1.4

24.19

26.00

iu/l

1.04

847

7147

Fibroblastic disorders

366

2755

1.34

6.60

1.3

29.81

35.22

iu/l

2.53

325

2362

Unspecified fall

983

8214

1.19

6.60

1.5

1.4

25.72

26.22

iu/l

0.18

824

6947

Benign neoplasm of ovary

360

2709

1.35

6.59

1.2

1.3

37.66

35.10

iu/l

0.69

318

2357

Congenital malformations of the musculoskeletal system, not elsewhere classified

447

1.96

6.59

1.8

1.5

21.44

23.15

iu/l

0.18

380

Abnormal serum enzyme levels

263

1853

1.41

6.56

1.4

20.81

24.55

iu/l

1.33

223

1549

Other disorders of optic [2nd] nerve and visual pathways

145

924

1.61

6.56

1.9

1.4

23.75

24.67

iu/l

0.12

119

770

Diffuse large B-cell lymphoma

201

2.33

6.56

1.6

1.3

28.54

28.40

iu/l

0.01

167

Invasive ventilation

117

705

1.69

6.56

1.6

1.4

26.44

26.94

iu/l

0.05

577

Disorders of muscles

226

1578

1.46

6.55

1.4

1.3

27.16

28.39

iu/l

0.21

196

1349

Ischaemic heart disease, wide definition

686

5277

0.81

6.54

1.4

1.3

30.94

35.68

iu/l

3.02

571

4521

Mental and behavioural disorders due to sedatives or hypnotics

181

1213

1.53

6.53

1.4

19.20

24.43

iu/l

1.73

129

1024

Dental pulpitis 2

1713

7663

1.15

6.53

1.4

1.3

27.01

27.40

iu/l

0.18

1424

6660

Haemorrhage in early pregnancy

1373

11652

1.17

6.49

1.3

26.46

28.92

iu/l

2.00

1199

10150

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2248

17663

0.89

6.48

1.5

1.4

24.59

27.16

iu/l

3.51

1876

15190

Pneumonias (Asthma/COPD co-morbidities)

2363

18251

0.89

6.45

1.4

24.61

26.90

iu/l

2.98

1972

15696

Enterocolitis due to Clostridium difficile

147

940

1.58

6.44

1.5

1.4

31.03

27.77

iu/l

0.42

116

793

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2122

16585

1.13

6.44

1.3

27.00

29.12

iu/l

2.35

1899

14456

Inguinal hernia

665

5512

0.81

6.43

1.4

20.27

24.05

iu/l

2.80

560

4616

Substance use, excluding alcohol

495

3904

1.28

6.40

1.4

19.59

24.64

iu/l

3.42

368

3333

Redundant prepuce, phimosis and paraphimosis

156

1005

1.55

6.40

1.6

1.7

7.70

7.69

iu/l

0.00

121

771

Other disorders involving the immune mechanism, not elsewhere classified

402

1.93

6.37

3.1

1.5

17.56

22.20

iu/l

0.79

329

Intussusception

312

2.07

6.37

1.5

1.3

29.32

31.92

iu/l

0.23

265

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

450

1.85

6.34

1.8

1.3

34.17

29.67

iu/l

0.45

385

Complications predominantly related to the puerperium

1168

10059

1.18

6.32

1.3

25.77

26.44

iu/l

0.29

1007

8771

Schizophrenia or delusion, excluding more controls

781

6425

1.22

6.31

1.4

1.3

20.92

26.68

iu/l

6.09

590

5610

Excessive vomiting in pregnancy

415

3230

1.32

6.31

1.3

23.41

26.56

iu/l

1.21

367

2782

Enthesopathies of lower limb, excluding foot

563

4516

1.26

6.31

1.3

27.86

31.51

iu/l

1.98

503

3891

Unspecified mental disorder

1173

10076

1.17

6.30

1.4

1.3

21.99

25.81

iu/l

4.20

927

8695

Other diseases of anus and rectum

497

3920

1.28

6.28

1.4

26.39

30.65

iu/l

2.28

429

3359

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

709

5852

1.23

6.27

1.4

1.3

21.04

25.09

iu/l

3.27

613

5092

Malignant neoplasm of other connective and soft tissue

144

2.57

6.27

1.5

1.4

26.98

26.81

iu/l

0.01

118

Pulmonary heart disease

357

2697

1.33

6.27

1.5

1.3

28.71

31.92

iu/l

1.11

293

2324

Other specified/unspecified dorsopathies

513

1.81

6.27

1.3

1.4

32.66

31.44

iu/l

0.10

443

Single delivery by caesarean section

1088

5373

1.19

6.24

1.3

25.97

24.98

iu/l

0.45

971

4449

6-mercaptopurine

103

613

1.74

6.23

2.0

1.4

19.97

20.24

iu/l

0.03

508

Pulmonary embolism

357

2700

1.33

6.22

1.5

1.3

28.71

31.95

iu/l

1.13

293

2327

Other diseases of intestine

167

1109

1.52

6.18

1.5

1.4

30.91

32.46

iu/l

0.26

135

944

Other heart diseases, wide

2556

17569

0.90

6.18

1.4

27.38

27.87

iu/l

0.30

2187

15157

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

223

1557

1.45

6.17

1.7

12.98

15.11

iu/l

0.63

166

1227

Other disorders starting during childhood or adolescence

193

1320

1.49

6.15

1.7

9.31

10.61

iu/l

0.45

145

996

Asthma mixed form (mode), excluding more controls

126

788

1.63

6.15

1.4

21.94

26.78

iu/l

1.07

110

659

Osteoporosis

234

1580

1.42

6.13

1.5

1.4

35.08

36.90

iu/l

0.29

197

1342

Asthma mixed form (mode)

126

789

1.63

6.12

1.4

21.94

26.95

iu/l

1.12

110

660

In situ neoplasms

748

6197

1.22

6.11

1.3

28.60

29.34

iu/l

0.25

663

5377

Poisoning by drugs, medicaments and biological substances

788

6574

1.21

6.10

1.4

22.33

25.38

iu/l

2.01

608

5656

Injuries to the neck

649

5311

1.24

6.09

1.3

1.4

22.15

24.25

iu/l

1.08

563

4545

Disorders of parathyroid gland

253

1798

1.40

6.09

1.4

1.3

32.52

36.89

iu/l

1.07

212

1556

Complications of other internal prosthetic devices, implants and grafts

379

1.92

6.07

1.9

1.3

22.10

30.24

iu/l

1.46

325

Viral and other specified intestinal infections

632

5035

1.24

6.07

1.6

1.4

15.51

16.19

iu/l

0.27

536

4152

Trigeminal neuralgia

151

991

1.56

6.05

1.4

1.3

34.15

31.97

iu/l

0.32

129

854

Use of pramipexole

319

2387

1.35

6.05

1.4

1.3

26.93

33.56

iu/l

2.84

273

2059

Other specified congenital malformation syndromes affecting multiple systems

399

1.94

6.03

1.9

1.8

18.38

17.36

iu/l

0.08

309

Other and unspecified erythematous conditions

388

1.91

6.03

1.4

24.93

28.36

iu/l

0.36

328

All pneumoniae

2402

18391

0.90

6.02

1.4

24.65

26.89

iu/l

2.88

2004

15819

Other disorders of kidney and ureter

174

1173

1.50

6.01

1.4

31.79

31.04

iu/l

0.10

141

983

Diseases of appendix

2254

18453

1.12

6.00

1.4

1.3

26.43

27.41

iu/l

0.75

1961

15938

Iron deficiency

101

609

1.75

6.00

1.4

13.60

19.97

iu/l

1.55

520

Mycoses

556

4478

1.25

6.00

1.5

1.3

26.06

26.63

iu/l

0.15

448

3823

Localized swelling, mass and lump of skin and subcutaneous tissue

679

5585

1.23

5.99

1.5

1.4

27.86

29.21

iu/l

0.51

594

4787

Other erythematous conditions

447

1.84

5.97

1.4

25.92

29.01

iu/l

0.36

379

Urolithiasis

448

3518

1.28

5.93

1.4

28.48

28.30

iu/l

0.03

375

3012

Benign lipomatous neoplasm

564

4556

1.25

5.91

1.3

32.65

32.69

iu/l

0.01

498

3949

Septicaemia

526

4046

1.26

5.90

1.8

1.4

21.63

28.28

iu/l

5.34

422

3399

Atopic dermatitis, strict definition

1239

10552

1.16

5.88

1.4

22.30

23.24

iu/l

0.50

1056

9012

Overexertion and strenuous or repetitive movements

234

1681

1.42

5.85

1.4

1.3

24.01

26.20

iu/l

0.41

189

1422

Parodontitis

1794

14881

0.88

5.85

1.4

1.3

32.08

30.58

iu/l

1.07

1500

12964

Pregnancy with abortive outcome

2656

12569

1.11

5.85

1.3

27.42

27.76

iu/l

0.19

2322

10965

Appendicitis, broad definition

2242

18444

1.12

5.83

1.3

26.34

27.40

iu/l

0.84

1950

15932

Parodontitis or operation codes

1797

14888

0.88

5.82

1.4

1.3

32.10

30.56

iu/l

1.11

1503

12970

Other follicular disorders

221

1579

1.43

5.80

1.3

23.21

25.73

iu/l

0.63

190

1349

Calculus of kidney and ureter

429

3362

1.28

5.80

1.4

1.3

28.21

28.33

iu/l

0.02

357

2882

Chronic periodontitis, including avohilmo

1785

14855

0.88

5.78

1.4

1.3

32.01

30.61

iu/l

0.97

1493

12941

Melanocytic naevi of lower limb, including hip

121

765

1.63

5.78

1.3

23.05

26.50

iu/l

0.61

102

654

Inflammatory diseases of prostate (prostatitis)

362

1.89

5.76

1.5

13.08

9.38

iu/l

0.83

294

Maternal care for known or suspected fetal abnormality and damage

996

7611

1.19

5.75

1.3

24.56

25.90

iu/l

0.65

850

6539

Open bite

213

1520

1.45

5.74

1.6

1.5

17.25

19.46

iu/l

0.55

171

1224

Other and unspecified visual disturbances

195

1362

1.46

5.71

1.5

1.4

23.23

28.00

iu/l

1.41

171

1164

Emotional disorders and disorders of social functioning with onset specific to childhood

198

1375

1.46

5.68

1.7

7.89

9.43

iu/l

1.11

158

1076

Benign neoplasm of bone and articular cartilage

214

1524

1.43

5.67

1.5

1.3

25.30

26.18

iu/l

0.15

189

1313

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

382

1.89

5.67

3.3

1.5

17.30

21.89

iu/l

0.75

313

Allergic rhinitis

1193

10266

1.16

5.66

1.4

21.94

24.62

iu/l

2.32

1030

8762

Cyst of kidney

416

1.83

5.65

1.3

30.71

31.03

iu/l

0.03

349

Other disorders of teeth and supporting structures

381

2954

1.30

5.65

1.5

1.3

26.97

28.51

iu/l

0.40

315

2557

Other puerperal infections

451

3606

1.29

5.65

1.4

1.3

20.09

20.57

iu/l

0.13

382

3116

Other and unspecified anaemias

503

3896

1.26

5.63

1.5

1.4

29.50

30.50

iu/l

0.25

403

3325

Immunodeficiency with predominantly antibody defects

495

1.79

5.63

1.9

1.5

21.07

25.95

iu/l

0.77

417

Artificial opening status

432

1.81

5.62

1.6

1.4

25.94

28.02

iu/l

0.23

353

Otitis media, unspecified

352

2494

1.32

5.59

1.7

1.5

13.27

17.65

iu/l

3.53

296

2013

Coxarthrosis

504

4254

0.80

5.55

1.4

1.3

35.98

38.34

iu/l

0.80

441

3639

Melanoma in situ

197

2.22

5.55

1.1

1.2

28.42

30.31

iu/l

0.15

175

Other specified/unspecified inflammatory spondylopathies

172

1186

1.49

5.54

1.3

24.99

27.75

iu/l

0.51

143

1022

Poisoning by medicine

718

5998

1.21

5.54

1.4

22.61

25.15

iu/l

1.38

553

5150

Perineal laceration during delivery

702

7453

0.82

5.53

1.2

1.3

19.34

20.81

iu/l

0.71

630

6350

Osteopathies and chondropathies

1102

9023

1.16

5.52

1.5

1.4

27.24

29.29

iu/l

1.22

952

7728

Cerebral palsy and other paralytic syndromes

254

1869

1.38

5.50

1.6

1.4

24.62

27.33

iu/l

0.67

205

1567

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.80

5.49

1.4

1.2

57.94

29.37

iu/l

2.45

Pneumocystosis

2.90

5.48

1.8

1.6

43.19

23.53

iu/l

1.14

Systemic connective tissue disorders

775

6514

1.20

5.48

1.4

1.3

30.57

30.38

iu/l

0.05

672

5628

Other disorders of bone

545

4435

1.24

5.45

1.5

1.4

25.08

27.50

iu/l

1.09

478

3790

Benign mammary dysplasia

310

2355

1.33

5.43

1.3

35.72

34.70

iu/l

0.20

276

2040

Acute bronchitis

831

6886

1.19

5.42

1.4

23.88

26.23

iu/l

1.39

685

5823

Senile cataract

428

3360

0.79

5.42

1.3

38.77

37.98

iu/l

0.16

335

2861

Androgenic alopecia

177

2.39

5.42

1.4

1.3

17.60

25.46

iu/l

1.23

155

Fentanyl

601

1.66

5.40

1.4

25.10

33.39

iu/l

1.79

507

Other noninflammatory disorders of uterus, except cervix

401

2135

1.29

5.40

1.3

31.65

38.69

iu/l

3.65

353

1873

Myeloid leukaemia

174

2.30

5.39

2.4

1.4

19.31

24.66

iu/l

0.61

146

Somnolence, stupor and coma

453

1.78

5.39

1.4

20.82

24.02

iu/l

0.40

385

Dissociative [conversion] disorders

145

973

1.54

5.39

1.5

1.4

23.39

22.37

iu/l

0.14

117

819

Other benign neoplasms of connective and other soft tissue

208

1487

1.42

5.38

1.4

1.3

25.91

29.65

iu/l

0.96

191

1291

Pulmonary heart disease, diseases of pulmonary circulation

372

2891

1.29

5.37

1.5

1.3

28.94

31.71

iu/l

0.92

304

2487

Pervasive developmental disorders excl. Autism + Asperger

249

2.12

5.37

2.0

1.9

14.11

11.50

iu/l

0.27

171

Wide developmental disorders, excluding more controls

100

609

1.68

5.37

1.9

1.6

11.30

13.73

iu/l

0.54

483

Stomatitis and related lesions

206

1472

1.42

5.36

1.4

24.79

25.73

iu/l

0.16

162

1274

Internal derangement of knee

954

8155

1.17

5.35

1.3

25.95

29.31

iu/l

2.68

822

6966

Artrosis, including avohilmo

2651

13221

1.11

5.32

1.4

1.3

28.74

30.18

iu/l

1.38

2326

11519

Abscess of anal and rectal regions

179

1248

1.46

5.32

1.4

25.03

25.30

iu/l

0.04

146

1056

Dislocation, sprain and strain of joints and ligaments at neck level

508

4122

1.25

5.31

1.4

22.78

23.82

iu/l

0.34

440

3523

Influenza and pneumonia

2667

19220

0.91

5.26

1.5

1.3

24.16

26.67

iu/l

3.90

2230

16533

Other facial nerve disorders

414

1.82

5.26

1.4

1.3

23.31

28.15

iu/l

0.65

356

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

204

1461

1.42

5.25

1.5

1.3

28.47

28.14

iu/l

0.04

175

1254

Specific development disorders of scholastic skills

158

1072

1.50

5.23

2.2

1.7

10.01

13.29

iu/l

1.28

112

828

Other disorders of white blood cells

111

703

1.61

5.23

1.5

1.4

24.43

27.25

iu/l

0.41

588

Meniscus derangement

1000

7947

0.86

5.23

1.3

29.74

33.55

iu/l

3.26

881

6849

Other acute lower respiratory infections

1162

9655

1.15

5.21

1.5

1.4

21.88

24.37

iu/l

2.10

954

8190

Disorders of adrenal gland, other and/or unspecified

3.23

5.19

1.7

1.3

24.38

26.77

iu/l

0.10

Fistulae involving female genital tract

225

2.13

5.17

1.4

1.3

26.27

32.09

iu/l

0.77

197

Cutaneous abscess, furuncle and carbuncle

616

5102

1.22

5.17

1.4

22.46

25.93

iu/l

2.02

515

4361

Diseases of pulp and periapical tissues

741

6237

1.20

5.17

1.5

1.3

25.58

27.51

iu/l

0.88

585

5422

Haemorrhoids and perianal venous thrombosis

384

3012

1.28

5.16

1.3

27.44

30.59

iu/l

1.12

333

2594

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

285

1.96

5.16

1.5

1.3

31.01

26.12

iu/l

0.39

246

Insulin medication

847

8494

0.85

5.14

1.4

21.20

26.51

iu/l

5.79

695

7206

Hyperparathyroidism

204

1444

1.41

5.13

1.4

1.3

33.07

37.85

iu/l

1.05

175

1255

Bicipital tendinitis

559

1.68

5.12

1.2

1.3

36.84

31.69

iu/l

0.71

472

Benign neoplasm: Stomach

128

840

1.54

5.11

1.3

36.11

33.65

iu/l

0.35

110

735

Ganglion

666

5569

1.21

5.11

1.3

29.19

29.97

iu/l

0.24

599

4810

Abnormal results of function studies

182

1284

1.44

5.10

1.5

1.4

26.48

27.46

iu/l

0.16

160

1078

Other viral diseases

964

8294

1.17

5.07

1.5

1.4

21.96

24.33

iu/l

1.56

816

7052

Heart failure, not strict

801

6511

0.84

5.06

1.5

1.4

28.11

33.26

iu/l

4.19

658

5572

Epilepsy

665

5539

1.21

5.06

1.5

1.4

27.36

26.91

iu/l

0.12

544

4692

Abnormal findings on diagnostic imaging of central nervous system

128

847

1.55

5.06

1.5

1.4

21.65

26.96

iu/l

1.23

115

708

Other anaemias

506

3964

1.24

5.04

1.5

1.4

29.61

30.45

iu/l

0.20

406

3379

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

582

4806

1.22

5.01

1.3

1.4

25.66

27.32

iu/l

0.65

500

4102

Sequelae of injuries of upper limb

204

1475

1.40

4.97

1.4

30.02

28.24

iu/l

0.32

180

1253

Benign neoplasm of mouth and pharynx

171

1197

1.45

4.97

1.4

1.3

32.04

29.89

iu/l

0.37

149

1041

Dermatitis

1482

13164

1.13

4.96

1.4

1.3

27.03

28.67

iu/l

1.19

1278

11356

Benign neoplasm: Rectum, anus and anal canal

184

1303

1.42

4.96

1.5

1.3

34.70

33.71

iu/l

0.14

158

1130

Benign leiomyoma with endometriosis

383

3032

1.28

4.95

1.3

33.51

35.82

iu/l

0.66

334

2652

Varicella [chickenpox]

109

698

1.60

4.94

1.7

1.5

13.88

19.37

iu/l

1.36

557

Carcinoma in situ, bladder

3.70

4.93

1.1

1.2

25.06

18.10

iu/l

—

Other and unspecified diseases of blood and blood-forming organs

249

2.02

4.93

1.6

1.4

21.22

27.48

iu/l

0.90

214

Viral hepatitis

196

1413

1.41

4.92

1.3

1.4

26.40

22.91

iu/l

0.70

142

1186

Malignant neoplasm of mesothelium and soft tissue

269

1.97

4.91

1.8

1.4

30.29

28.67

iu/l

0.12

225

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

263

1982

1.34

4.91

1.3

30.25

31.36

iu/l

0.22

229

1736

Other and unspecified polyneuropathies, also in other diseases

198

1424

1.40

4.89

1.4

32.30

30.56

iu/l

0.29

164

1215

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

491

3998

1.24

4.89

1.4

1.3

21.92

34.66

iu/l

22.68

426

3474

Other degenerative diseases of the nervous system

278

2766

0.76

4.89

1.3

32.74

29.76

iu/l

0.66

251

2396

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

149

1021

1.48

4.89

1.3

35.99

31.57

iu/l

0.80

134

882

Benign neoplasm of breast

306

2361

1.32

4.88

1.4

1.3

30.37

30.63

iu/l

0.04

258

2064

All influenza (not pneumonia)

291

2225

1.32

4.87

1.6

1.4

19.54

23.21

iu/l

1.50

249

1836

Hemiplegia

113

732

1.57

4.86

1.6

1.4

21.96

28.84

iu/l

1.52

618

Diverticular disease of intestine

899

6951

0.86

4.84

1.4

1.3

34.06

37.40

iu/l

2.24

790

6041

Congenital malformations of breast

609

1.68

4.84

1.4

20.74

24.62

iu/l

0.64

521

Hidradenitis suppurativa

139

949

1.52

4.82

1.3

24.64

24.93

iu/l

0.04

118

808

Infections, IBD-co-morbidities

397

2293

1.27

4.81

1.5

1.3

26.38

32.12

iu/l

2.45

325

1955

Diplopia

239

1782

1.36

4.79

1.5

1.4

29.40

28.12

iu/l

0.22

198

1528

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

3.36

4.79

2.1

1.2

25.15

26.76

iu/l

0.07

Benign neoplasm of brain and other parts of central nervous system

128

855

1.52

4.79

1.8

1.4

29.41

29.08

iu/l

0.04

110

715

Other diseases of arteries and capillaries

142

967

1.49

4.79

1.4

33.36

30.72

iu/l

0.39

124

825

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

329

1.86

4.78

1.4

1.3

30.49

28.10

iu/l

0.21

279

Thyroiditis

207

1515

1.40

4.78

1.4

1.3

29.48

29.46

iu/l

0.00

170

1303

Other disorders of patella

610

5098

1.21

4.77

1.4

1.3

27.17

29.63

iu/l

1.07

536

4388

Congenital malformations of genital organs

438

3532

1.26

4.77

1.5

1.4

22.52

24.20

iu/l

0.51

364

2989

Graves disease, strict definition

355

2807

1.29

4.77

1.4

1.3

28.97

29.14

iu/l

0.03

310

2432

Spondylolisthesis/Spondylolysis

352

2769

1.28

4.76

1.4

1.3

32.41

34.60

iu/l

0.57

308

2383

Coxarthrosis [arthrosis of hip](FG)

509

4493

0.82

4.75

1.4

1.3

36.26

37.85

iu/l

0.48

446

3863

Heartburn

221

1632

1.37

4.74

1.4

22.53

28.97

iu/l

2.66

190

1401

Cellulitis

407

3258

1.26

4.74

1.4

22.16

26.62

iu/l

2.27

350

2749

Bacterial, viral and other infectious agents

202

1472

1.39

4.74

1.4

22.34

23.33

iu/l

0.18

159

1237

Social phobias

298

2305

1.32

4.73

1.6

1.4

18.46

20.44

iu/l

0.61

232

1937

Sensorineural hearing loss

863

7036

0.86

4.72

1.4

30.62

33.18

iu/l

1.43

750

6028

Benign neoplasm of eye and adnexa

163

1144

1.44

4.71

1.4

29.64

32.16

iu/l

0.44

141

988

Diseases of tongue

110

713

1.57

4.71

1.3

1.4

26.95

29.25

iu/l

0.32

616

Disturbances of smell and taste

542

1.66

4.71

1.4

33.32

31.81

iu/l

0.14

466

Complications of labour and delivery

2512

12799

1.10

4.70

1.3

29.21

28.48

iu/l

0.48

2246

10986

Complications of the puerperium, not elsewhere classified

235

1775

1.38

4.69

1.3

27.24

26.95

iu/l

0.05

200

1538

Other heart diseases

1448

10743

0.88

4.69

1.4

27.96

29.96

iu/l

1.40

1220

9307

Benign neoplasm of other and ill-defined parts of digestive system

273

2082

1.32

4.67

1.4

1.3

33.01

34.33

iu/l

0.27

231

1808

Acute myeloid leukaemia and myelodysplastic syndromes

2.96

4.64

2.8

1.4

10.93

25.77

iu/l

2.23

Other strabismus

684

5772

1.19

4.64

1.5

1.4

26.49

25.50

iu/l

0.33

560

4901

Malignant neoplasm of endocrine gland

172

1226

1.43

4.63

1.4

30.90

29.85

iu/l

0.15

145

1053

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

480

1.68

4.62

1.4

1.3

28.66

28.82

iu/l

0.01

417

Acute bronchiolitis

170

1085

1.44

4.62

2.2

1.9

8.02

8.77

iu/l

0.25

122

796

Correction of physiology of bite - very demanding therapy visit

109

715

1.58

4.61

1.5

1.3

23.65

27.40

iu/l

0.72

103

613

Rosacea

311

2427

1.30

4.59

1.4

1.3

26.36

31.09

iu/l

1.75

271

2102

Other symptoms and signs involving the digestive system and abdomen

392

3141

1.26

4.58

1.4

31.43

33.22

iu/l

0.45

343

2710

Haemangioma, any site

206

1516

1.38

4.58

1.4

30.34

29.70

iu/l

0.08

178

1295

Other bacterial diseases

1756

13479

0.90

4.57

1.6

1.3

26.30

29.43

iu/l

3.75

1441

11561

Injury, poisoning and certain other consequences of external causes

2040

9246

1.11

4.56

1.4

1.3

25.24

26.94

iu/l

1.47

1738

7968

Ptosis of eyelid

128

862

1.50

4.56

1.5

1.3

34.51

33.90

iu/l

0.07

105

736

Other and unspecified drugs and medicaments

182

1313

1.41

4.55

1.5

1.4

28.43

28.18

iu/l

0.03

156

1113

Hypermetropia

166

1179

1.43

4.55

1.9

1.6

23.94

21.92

iu/l

0.30

129

931

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

188

1366

1.40

4.55

1.5

1.4

24.25

22.63

iu/l

0.28

147

1137

Poisoning by narcotics and psychodysleptics [hallucinogens]

265

1.96

4.55

1.4

1.5

22.00

14.90

iu/l

0.83

221

Other specified/unspecified soft tissue disorders

601

1.61

4.54

1.4

1.3

32.19

31.01

iu/l

0.11

513

Injuries to the abdomen, lower back, lumbar spine and pelvis

740

6259

1.18

4.54

1.4

24.25

25.20

iu/l

0.34

604

5331

Haemangioma and lymphangioma, any site

221

1647

1.36

4.53

1.4

30.27

29.35

iu/l

0.13

191

1405

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

833

7174

1.17

4.53

1.4

24.67

26.15

iu/l

0.70

709

6137

Major coronary heart disease event

430

3546

0.81

4.52

1.3

30.08

34.17

iu/l

1.61

369

3001

Injury of muscle and tendon at shoulder and upper arm level

416

3354

1.25

4.51

1.3

28.37

32.17

iu/l

1.59

367

2849

Strabismus

750

6399

1.18

4.49

1.5

1.4

26.25

26.02

iu/l

0.07

618

5425

Follicular cysts of skin and subcutaneous tissue

367

2925

1.27

4.49

1.4

26.62

28.81

iu/l

0.70

304

2511

TMD related pain

136

940

1.50

4.48

1.4

1.3

28.07

27.23

iu/l

0.10

125

802

Carcinoma in situ of other and unspecified sites

3.30

4.48

1.1

1.2

24.03

21.18

iu/l

0.16

Panniculitis affecting regions of neck and back

605

1.61

4.47

1.5

1.4

26.49

30.02

iu/l

0.49

519

Other and unspecified urticaria

617

5196

1.20

4.46

1.4

24.97

27.03

iu/l

0.90

552

4432

Subacute thyroiditis

101

654

1.59

4.46

1.3

26.19

30.62

iu/l

0.65

563

Diabetic nephropathy

1387

0.63

4.45

1.3

24.06

19.28

iu/l

0.55

1173

Fracture of skull and facial bones

410

3311

1.25

4.44

1.4

25.12

25.30

iu/l

0.04

332

2782

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

190

1388

1.39

4.44

1.4

17.57

19.52

iu/l

0.44

127

1152

STROKE

814

6570

0.86

4.43

1.4

1.3

33.71

33.92

iu/l

0.06

679

5704

Benign neoplasm: Colon, unspecified

218

1621

1.35

4.41

1.4

1.3

28.43

33.82

iu/l

1.58

184

1384

Explicit Sepsis

705

5744

1.18

4.41

1.7

1.4

21.74

26.84

iu/l

4.31

589

4888

Other diseases of jaws

158

1119

1.44

4.41

1.4

1.3

24.61

26.79

iu/l

0.41

130

970

Other and unspecified disorders of white blood cells

513

1.65

4.40

1.4

23.27

28.39

iu/l

0.83

434

Hypertensive diseases (excluding secondary)

2188

11585

1.10

4.40

1.4

1.3

28.84

30.23

iu/l

1.13

1855

10161

Achilles tendinitis

203

1498

1.37

4.40

1.3

28.14

33.81

iu/l

1.75

185

1295

Benign neoplasm: Parotid gland

116

773

1.52

4.39

1.2

1.3

34.32

30.12

iu/l

0.58

678

Inflammatory bowel disease

834

7200

1.17

4.38

1.4

25.83

26.23

iu/l

0.13

734

6168

Aplastic and other anaemias

555

4380

1.21

4.37

1.5

1.4

29.08

30.33

iu/l

0.35

446

3725

Tooth eruption problems

522

4297

1.22

4.37

1.6

1.5

15.46

14.98

iu/l

0.13

438

3554

Congenital iodine-deficiency syndrome/hypothyroidism

438

1.71

4.37

1.3

1.4

32.25

29.39

iu/l

0.28

378

TMD muscular pain linked with fibromyalgia

258

2.01

4.37

1.5

1.3

25.32

29.93

iu/l

0.45

220

Helminthiases

233

2.00

4.37

1.2

1.5

25.50

24.55

iu/l

0.06

193

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

154

1089

1.44

4.36

1.4

1.3

31.44

29.16

iu/l

0.38

136

947

Oral lichen ruber planus wide, hypothyreosis or thyroxin

529

1.64

4.36

1.5

1.3

28.09

36.12

iu/l

1.51

453

Personal history of allergy to drugs, medicaments and biological substances

221

2.06

4.35

1.3

18.61

25.30

iu/l

0.99

188

Other peripheral vertigo

156

1104

1.43

4.35

1.4

1.3

28.06

32.21

iu/l

0.87

125

945

Benign neoplasm: Skin of eyelid, including canthus

213

1585

1.36

4.34

1.3

33.91

32.56

iu/l

0.23

180

1380

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.93

4.34

1.8

2.6

18.25

23.47

iu/l

—

Abnormal blood-pressure reading, without diagnosis

101

657

1.57

4.33

1.4

26.71

30.17

iu/l

0.47

561

Unspecified haematuria

459

3212

1.23

4.33

1.5

1.4

31.53

28.35

iu/l

1.08

389

2703

Pure hyperglyceridaemia

145

2.26

4.33

1.3

1.4

18.54

25.72

iu/l

0.67

126

526

1.65

4.32

1.4

26.14

32.06

iu/l

0.89

443

Congenital malformations of the nervous system

559

1.64

4.32

1.6

1.7

20.42

20.49

iu/l

0.01

453

Hernia of abdominal wall

801

6898

1.17

4.30

1.4

1.3

23.90

28.82

iu/l

5.02

687

5939

Benign neoplasm: Choroid

461

1.67

4.30

1.4

1.3

30.11

31.66

iu/l

0.17

399

Other and unspecified local infections of skin and subcutaneous tissue

184

1343

1.39

4.29

1.6

1.4

26.30

26.23

iu/l

0.01

147

1128

Benign neoplasm: Brain, supratentorial

221

2.02

4.28

2.4

1.3

26.45

24.12

iu/l

0.15

185

Agoraphobia

130

899

1.49

4.28

1.5

1.4

22.79

22.28

iu/l

0.06

757

Other diseases of lip and oral mucosa

269

2076

1.31

4.26

1.5

1.3

31.94

30.49

iu/l

0.28

223

1814

Other and unspecified iron deficiency

678

5769

1.18

4.25

1.4

24.91

28.57

iu/l

1.92

559

4957

Presbycusis

164

2.13

4.24

1.4

37.56

33.09

iu/l

0.32

136

Other CVD (FINNGEN)

125

665

1.49

4.24

1.4

26.77

30.50

iu/l

0.57

111

571

HSIL lesion of the cervix uteri

1000

8807

1.15

4.23

1.3

24.87

25.95

iu/l

0.51

874

7734

Disorders of gallbladder, biliary tract and pancreas

2299

16170

0.91

4.23

1.4

1.3

29.60

29.67

iu/l

0.03

1995

14066

Cerebrovascular diseases

723

6058

0.85

4.23

1.4

1.3

30.97

32.88

iu/l

0.77

599

5220

Other local infections of skin and subcutaneous tissue

194

1432

1.37

4.22

1.6

1.4

26.78

26.91

iu/l

0.02

155

1205

Speech therapy

490

4054

1.22

4.22

1.4

1.3

33.44

31.94

iu/l

0.45

437

3461

Total colectomy

590

1.59

4.21

1.5

1.4

23.28

26.13

iu/l

0.33

501

Total colectomy operation

590

1.59

4.21

1.5

1.4

23.28

26.13

iu/l

0.33

501

Viral pneumonia

217

1629

1.35

4.20

1.5

1.4

24.64

24.82

iu/l

0.03

176

1350

Cholelithiasis, broad definition with cholecystitis

2040

15328

0.91

4.19

1.4

1.3

29.89

30.66

iu/l

0.49

1779

13384

Benign neoplasm of middle ear and respiratory system

644

1.55

4.19

1.4

1.3

29.45

28.40

iu/l

0.11

551

D07AA Corticosteroids, weak (group I)

492

4082

1.22

4.17

1.4

22.62

23.44

iu/l

0.24

415

3421

Melanocytic naevi of lower limb, including hip

121

827

1.50

4.17

1.3

1.4

23.05

27.26

iu/l

0.81

102

703

Coagulation defects, purpura and other haemorrhagic conditions

437

3586

1.23

4.14

1.4

24.84

26.00

iu/l

0.32

364

3050

Metatarsalgia

231

1758

1.33

4.13

1.4

1.3

31.56

32.61

iu/l

0.18

205

1502

Early onset COPD, excluding more controls

230

1742

1.33

4.13

1.4

1.3

29.10

33.78

iu/l

1.50

192

1487

Bell's palsy

237

1810

1.32

4.11

1.4

1.3

22.09

28.51

iu/l

2.40

190

1547

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

357

1.78

4.10

2.2

1.7

15.16

18.78

iu/l

0.47

274

Diseases of the digestive system

734

6287

1.17

4.10

1.4

25.67

27.67

iu/l

0.88

626

5331

Other and unspecified rosacea

220

1667

1.34

4.09

1.4

1.3

25.61

31.82

iu/l

1.97

192

1454

Other or unspecified ileus, impaction or obstruction

198

1470

1.35

4.08

1.5

1.3

29.37

32.12

iu/l

0.52

173

1256

Antepartum haemorrhage, not elsewhere classified

539

4553

1.21

4.08

1.3

26.63

26.66

iu/l

0.01

477

3954

Oral lichen ruber planus, including avohilmo

111

747

1.51

4.07

1.4

1.3

32.08

35.39

iu/l

0.48

102

644

Benign neoplasm: Adrenal gland

633

1.55

4.07

1.4

1.3

33.05

33.39

iu/l

0.03

551

Acute myeloid leukaemia

3.03

4.07

3.2

1.4

10.47

26.99

iu/l

2.12

Benign neoplasm: Sigmoid colon

155

1107

1.41

4.06

1.3

34.77

34.16

iu/l

0.07

128

962

Other and unspecified dermatitis

1242

11067

1.13

4.06

1.4

1.3

27.44

28.80

iu/l

0.80

1068

9548

Other benign neoplasms of skin

682

5832

1.18

4.05

1.3

29.17

31.31

iu/l

0.94

590

5055

Other congenital malformations of nervous system

272

1.92

4.03

1.4

1.7

21.22

19.64

iu/l

0.11

226

Benign intracranial hypertension

280

1.91

4.02

1.4

11.98

18.24

iu/l

1.27

237

Intestinal adhesions without obstruction

105

699

1.52

4.01

1.6

1.4

30.57

32.57

iu/l

0.20

595

Acute laryngitis and tracheitis

410

3306

1.24

4.01

1.5

1.4

15.51

19.01

iu/l

2.04

334

2725

Suicide or other Intentional self-harm

741

6393

1.17

4.01

1.3

23.26

26.86

iu/l

2.43

584

5499

Heterophoria

238

1831

1.32

4.00

1.4

23.74

24.14

iu/l

0.07

194

1525

Thrombocytopenia, unspecified

110

741

1.51

4.00

1.4

30.73

26.88

iu/l

0.46

621

Transplanted organ and tissue status

161

1164

1.40

3.99

2.1

1.5

21.28

26.01

iu/l

0.80

128

950

Myopia

441

3646

1.23

3.98

1.5

1.4

21.54

24.39

iu/l

1.18

376

3115

Postprocedural disorders of digestive system, not elsewhere classified

365

1.74

3.98

1.5

1.4

26.68

28.06

iu/l

0.10

306

Radial styloid tenosynovitis [de Quervain]

177

1306

1.38

3.98

1.3

28.66

30.54

iu/l

0.32

158

1124

Papilloedema, unspecified

382

1.73

3.98

1.7

1.4

19.35

22.06

iu/l

0.29

318

All dysplastic lesions of the cervix uteri

1419

12779

1.12

3.96

1.3

25.27

26.20

iu/l

0.53

1251

11167

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

547

1.61

3.95

1.2

1.3

49.86

26.47

iu/l

4.18

474

Other specified/unspecified necrotizing vasculopathies

119

2.34

3.95

1.4

1.3

30.55

26.73

iu/l

0.25

102

Pregnancy hypertension

1991

16438

1.10

3.93

1.3

26.78

28.89

iu/l

2.23

1785

14328

Benign neoplasm: Pancreas

138

2.22

3.93

1.4

1.2

37.88

28.71

iu/l

0.61

123

Autoimmune hyperthyroidism

202

1525

1.35

3.92

1.5

1.3

25.68

31.08

iu/l

1.88

174

1338

Other and unspecified injuries of ankle and foot

126

880

1.47

3.91

1.3

1.5

19.13

23.76

iu/l

1.04

115

720

Coronary atherosclerosis

442

3457

0.82

3.91

1.4

1.3

27.86

35.05

iu/l

4.26

373

2920

Benign neoplasm: Rectum

153

1099

1.40

3.90

1.5

1.3

35.98

33.71

iu/l

0.35

131

954

Mixed specific developmental disorders

451

1.65

3.89

2.5

2.1

6.70

7.49

iu/l

0.33

302

Carcinoma in situ of breast, intraductal

173

1274

1.38

3.89

1.3

41.73

39.33

iu/l

0.41

152

1111

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

170

1249

1.38

3.88

1.4

1.3

31.18

29.27

iu/l

0.32

149

1094

Implicit bacterial Sepsis

365

2705

1.24

3.88

1.5

1.4

25.54

29.20

iu/l

1.35

296

2276

Pneumonia, organism unspecified

1969

15573

0.91

3.87

1.5

1.4

24.49

27.33

iu/l

3.73

1639

13381

Nummular dermatitis

124

861

1.46

3.87

1.4

21.81

27.61

iu/l

1.56

108

727

Emotional disorders starting during childhood or adolescence

180

1329

1.37

3.86

1.7

8.15

9.49

iu/l

0.82

145

1025

Other congenital malformations of male genital organs

115

2.40

3.85

2.7

2.3

9.21

5.35

iu/l

0.79

GI-bleeding

335

2688

1.25

3.85

1.4

25.39

27.09

iu/l

0.43

288

2246

Pneumothorax

522

1.59

3.84

1.4

22.47

25.66

iu/l

0.43

444

Melanocytic naevi of other and unspecified parts of face

150

1083

1.41

3.84

1.3

24.83

27.21

iu/l

0.39

135

936

Spermatocele

179

2.02

3.83

1.7

1.5

12.21

10.55

iu/l

0.20

146

Lichen simplex chronicus and prurigo

110

749

1.49

3.82

1.4

31.36

32.32

iu/l

0.11

638

Melanoma in situ

229

1.91

3.81

1.1

1.3

28.42

30.63

iu/l

0.18

197

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

194

1.98

3.79

1.5

1.2

25.76

25.68

iu/l

0.01

165

247

1798

1.30

3.79

1.4

1.3

30.44

36.96

iu/l

2.61

213

1538

Sarcoidosis

257

2008

1.29

3.78

1.3

30.87

31.05

iu/l

0.03

214

1743

Unspecified misadventure during surgical and medical care

104

703

1.51

3.77

1.5

1.4

24.88

29.95

iu/l

0.92

601

Visual impairment including blindness (binocular or monocular)

653

1.52

3.77

2.0

1.5

23.51

25.87

iu/l

0.29

550

Other enthesopathy of foot (+metatarsalgia)

251

1959

1.30

3.76

1.4

1.3

31.14

32.68

iu/l

0.31

223

1678

Astigmatism

156

1137

1.40

3.75

1.8

1.6

18.55

20.79

iu/l

0.43

119

896

Cholelithiasis

1986

15199

0.91

3.75

1.4

1.3

29.95

30.83

iu/l

0.58

1737

13272

Meralgia paraesthetica

473

1.62

3.74

1.2

1.3

34.18

30.78

iu/l

0.33

414

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1561

10921

0.90

3.73

1.3

33.11

31.08

iu/l

1.40

1347

9629

Other viral diseases, not elsewhere classified

553

4680

1.19

3.73

1.5

1.4

22.54

25.78

iu/l

1.56

473

3927

Crohn disease

351

2853

1.25

3.73

1.4

23.03

24.95

iu/l

0.62

311

2416

Other and unspecified trigeminal disorders

233

1.91

3.71

1.5

1.3

33.90

30.22

iu/l

0.21

201

5-aminosalicylic acid

584

4977

1.18

3.71

1.4

26.94

26.26

iu/l

0.19

508

4272

Benign neoplasm of bone and articular cartilage

214

1640

1.33

3.71

1.5

1.3

25.30

27.29

iu/l

0.39

189

1402

Episcleritis

161

1186

1.39

3.70

1.4

1.3

31.61

29.67

iu/l

0.27

137

1020

Diagnoses used for exclusion with ILD

364

2965

1.23

3.69

1.4

1.3

30.83

30.96

iu/l

0.02

301

2558

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

3.14

3.68

1.7

1.3

21.75

20.69

iu/l

—

Mental and behavioural disorders due to opioids

109

750

1.49

3.67

1.4

14.83

17.74

iu/l

0.58

628

Other disorders of glucose regulation and pancreatic internal secretion

167

1234

1.37

3.67

1.4

25.61

23.67

iu/l

0.32

140

1018

Other nonscarring hair loss

229

1.95

3.67

1.8

1.3

19.54

22.92

iu/l

0.31

198

Provisional assignment of new diseases of uncertain etiology

1314

11826

1.12

3.66

1.4

1.3

23.09

24.46

iu/l

0.83

1072

10210

Correction of physiology of bite - demanding therapy visit

235

1831

1.31

3.66

1.5

1.3

26.24

28.13

iu/l

0.40

220

1565

Other diseases of the digestive system

338

2734

1.24

3.64

1.4

25.72

27.52

iu/l

0.46

289

2287

Acute nasopharyngitis (common cold)

200

1509

1.33

3.64

1.4

18.95

19.52

iu/l

0.11

180

1242

Anogenital herpesviral [herpes simplex] infection

263

2084

1.29

3.63

1.4

1.3

22.22

22.21

iu/l

0.00

214

1781

Diffuse brain injury

413

1.65

3.63

1.5

1.3

16.61

24.50

iu/l

1.78

350

Mental and behavioural disorders due to cannabinoids

541

1.57

3.62

1.4

1.5

12.14

13.59

iu/l

0.31

451

Gluteal tendinitis

614

1.53

3.60

1.3

1.4

33.62

34.43

iu/l

0.08

531

Cardiac arrhythmias

1936

13950

0.91

3.60

1.4

1.3

27.09

29.34

iu/l

2.22

1680

12151

Codes for special purposes

1314

11839

1.12

3.60

1.4

1.3

23.09

24.46

iu/l

0.84

1072

10222

Other viral hepatitis

170

1267

1.37

3.60

1.3

1.4

23.19

22.06

iu/l

0.17

120

1064

Major coronary heart disease event excluding revascularizations

351

2977

0.81

3.60

1.3

30.59

34.44

iu/l

1.25

296

2519

Congenital malformations of eyelid, lacrimal apparatus and orbit

152

2.14

3.59

1.7

2.1

11.90

12.84

iu/l

0.10

120

Renal cell carcinoma of kidney

117

2.25

3.59

1.4

1.3

57.94

29.46

iu/l

2.50

101

Other embolism and thrombosis

211

1618

1.32

3.59

1.4

27.17

31.08

iu/l

1.07

182

1393

Benign neoplasm: Transverse colon

507

1.57

3.58

1.3

26.45

30.67

iu/l

0.49

441

Superficial injury of abdomen, lower back and pelvis

351

2866

1.24

3.56

1.4

23.01

23.32

iu/l

0.06

280

2433

Flat foot [pes planus] (acquired)

203

1553

1.32

3.55

1.4

1.3

30.52

35.88

iu/l

1.62

184

1321

Intracranial injury

1212

10503

1.12

3.55

1.4

23.33

25.06

iu/l

1.16

1008

8931

Other/unspecified enthesopathies of lower limb, excluding foot

184

1390

1.34

3.55

1.4

24.76

30.34

iu/l

1.88

162

1203

HSIL lesion of the cervix uteri, vagina or vulva

1041

9301

1.13

3.54

1.3

25.32

26.28

iu/l

0.44

911

8155

Symptoms and signs involving the urinary system

1401

9773

1.11

3.54

1.4

26.62

28.48

iu/l

1.24

1188

8371

Campylobacter enteritis

410

1.65

3.54

1.4

1.3

28.33

27.37

iu/l

0.07

342

Mature T/NK-cell lymphomas, hilmo

2.76

3.53

2.1

1.4

25.15

28.10

iu/l

0.13

Hallux rigidus

181

1361

1.34

3.52

1.3

36.42

38.98

iu/l

0.43

152

1159

Lateral epicondylitis

363

2981

1.23

3.51

1.4

1.3

31.04

35.38

iu/l

1.73

320

2583

Small fibre neuropathy

222

1.89

3.51

1.6

1.4

25.58

27.04

iu/l

0.11

190

Acute appendicitis

2095

18216

1.09

3.51

1.3

26.55

27.48

iu/l

0.67

1821

15744

Autoimmune thyroiditis

405

1.67

3.50

1.5

1.3

32.36

24.88

iu/l

0.84

347

Follicular lymphoma

200

1.92

3.50

1.3

1.2

28.13

28.96

iu/l

0.04

176

Stroke, including SAH

484

4253

0.84

3.50

1.4

1.3

31.83

33.32

iu/l

0.40

393

3656

Manic episode

522

1.57

3.49

1.3

19.83

25.42

iu/l

0.89

451

Disorders of lacrimal system and orbit in diseases classified elsewhere

436

1.63

3.48

1.3

29.43

30.79

iu/l

0.13

380

Lichen ruber planus, wide definition including periferal and oral lichen planus

316

2556

1.25

3.47

1.4

1.3

29.50

35.07

iu/l

2.49

283

2194

Chondropathies

393

3258

1.22

3.46

1.5

1.4

23.30

26.79

iu/l

1.61

347

2780

Covid-19 suspected case

539

6300

0.85

3.45

1.4

1.3

22.60

25.03

iu/l

1.05

431

5429

All dysplastic lesions of the cervix uteri, vagina or vulva

1542

13987

1.11

3.45

1.3

26.06

27.04

iu/l

0.58

1348

12256

Other disorders of penis

402

1.63

3.44

1.7

8.64

8.54

iu/l

0.03

301

Other neurotic disorders

554

1.54

3.44

1.5

1.3

29.64

30.42

iu/l

0.08

471

Skin changes due to chronic exposure to nonionizing radiation

190

1362

1.32

3.44

1.4

33.42

38.15

iu/l

1.24

163

1164

Benign neoplasm of major salivary glands

129

924

1.41

3.43

1.3

35.35

30.66

iu/l

0.72

108

804

Disorders of orbit

102

703

1.48

3.41

1.4

28.86

30.78

iu/l

0.24

602

Retinal breaks without detachment

213

1647

1.30

3.41

1.3

34.60

36.23

iu/l

0.26

188

1414

Memory loss

466

1.58

3.41

1.4

1.3

27.95

30.68

iu/l

0.30

386

Hydrocephalus

498

1.56

3.41

2.2

1.5

25.33

28.60

iu/l

0.36

415

Benign neoplasm of ovary

360

2962

1.23

3.41

1.2

1.3

37.66

36.41

iu/l

0.28

318

2547

Budesonide

340

2783

1.23

3.40

1.4

26.06

27.40

iu/l

0.33

297

2402

Carpal tunnel syndrome

1549

12734

1.10

3.39

1.3

30.22

32.38

iu/l

1.87

1386

11110

Other benign neoplasms of connective and other soft tissue

208

1608

1.31

3.39

1.4

1.3

25.91

30.15

iu/l

1.17

191

1379

Embedded teeth, including avohilmo

325

2655

1.24

3.38

1.4

17.18

17.62

iu/l

0.08

281

2230

Other diseases of stomach and duodenum

596

1.51

3.38

1.3

30.34

32.88

iu/l

0.28

505

Concussion

1396

10946

1.11

3.38

1.4

1.3

23.87

26.75

iu/l

2.84

1176

9332

Superficial injury of lower leg

614

5297

1.17

3.37

1.3

1.4

23.35

26.18

iu/l

1.50

521

4487

Benign neoplasm: Brain, supratentorial

241

1.85

3.37

2.4

1.4

26.45

24.19

iu/l

0.15

200

Autism spe, excluding more controls

456

1.60

3.36

1.7

1.5

11.73

15.32

iu/l

0.72

372

Neuromuscular dysfunction of bladder

150

1107

1.37

3.35

1.7

1.4

27.49

29.52

iu/l

0.28

135

954

Amblyopia ex anopsia

107

748

1.46

3.34

1.7

1.6

22.28

18.81

iu/l

0.57

592

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2425

17748

0.93

3.34

1.5

1.3

26.30

27.70

iu/l

1.31

2053

15318

Other osteochondrodysplasias

164

2.06

3.33

1.8

1.5

20.36

20.52

iu/l

0.01

129

Hypoparathyroidism

369

1.66

3.33

1.4

1.3

27.38

30.47

iu/l

0.27

313

Artificial joint re-operation

292

1.73

3.31

1.3

30.73

39.70

iu/l

1.41

249

Benign lipomatous neoplasm of other sites/unspecified

103

713

1.46

3.31

1.3

28.57

31.59

iu/l

0.42

619

Other and unspecified coagulation defects

156

1167

1.37

3.31

1.3

1.4

25.08

24.96

iu/l

0.02

130

997

Tooth agenesis EXCLUDE clefts and syndromes

141

1039

1.39

3.30

1.8

1.6

16.72

15.84

iu/l

0.16

118

838

Constipation

2020

13327

1.09

3.30

1.4

28.48

30.72

iu/l

2.21

1709

11469

Benign neoplasm of other and unspecified sites

347

1.67

3.29

1.5

1.3

28.74

27.65

iu/l

0.08

306

Somnolence

214

1.90

3.29

1.5

1.4

16.35

21.67

iu/l

0.78

182

Mental retardation, excluding more controls

672

1.48

3.29

2.3

1.6

14.85

21.36

iu/l

1.47

532

Malignant neoplasm of brain

347

1.67

3.29

2.4

1.5

15.63

23.28

iu/l

1.66

288

Other disorders of veins

953

8476

1.13

3.29

1.3

30.15

33.32

iu/l

2.25

826

7423

Simple and mucopurulent chronic bronchitis

263

1.77

3.29

1.5

1.4

34.40

28.38

iu/l

0.48

222

Benign neoplasm: Connective and other soft tissue of head, face and neck

199

1.91

3.28

1.6

1.3

31.83

26.01

iu/l

0.40

171

Disorders of continuity of bone

221

1732

1.29

3.27

1.5

1.4

25.41

28.69

iu/l

0.69

193

1477

Malignant neoplasm of eye, brain and central nervous system

441

1.59

3.27

2.2

1.5

18.13

24.13

iu/l

1.10

367

Mixed disorders of conduct and emotions, excluding more controls

499

1.56

3.26

1.4

1.5

7.65

8.69

iu/l

0.36

399

Other symptoms and signs involving the circulatory and respiratory systems

120

858

1.42

3.26

1.4

27.27

27.53

iu/l

0.03

107

717

Other abnormal findings of blood chemistry

570

1.52

3.26

1.4

29.38

27.49

iu/l

0.20

480

Pollen allergy

740

6429

1.15

3.26

1.4

18.63

22.52

iu/l

3.37

635

5412

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

149

2.03

3.25

1.2

36.40

30.22

iu/l

0.40

131

Disorder of lipoprotein metabolism, unspecified

100

690

1.46

3.25

1.5

1.3

30.63

32.15

iu/l

0.17

590

Myocardial infarction

239

2170

0.79

3.25

1.3

1.4

30.98

33.20

iu/l

0.41

201

1831

Scleritis and episcleritis

174

1325

1.34

3.24

1.4

1.3

32.55

29.98

iu/l

0.40

149

1146

Complications of internal orthopaedic prosthetic devices, implants and grafts

194

1491

1.31

3.24

1.5

1.3

30.87

36.60

iu/l

1.66

161

1275

Other coagulation defects

206

1605

1.31

3.24

1.4

23.11

25.65

iu/l

0.62

172

1367

Other congenital malformations of skin

112

796

1.44

3.23

1.5

25.11

25.01

iu/l

0.01

663

Kela-code for severe mental illness

947

8438

1.13

3.22

1.4

1.3

21.21

26.06

iu/l

5.54

736

7291

Disorders of calcium metabolism

661

1.47

3.21

1.6

1.4

27.16

30.01

iu/l

0.32

565

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

108

764

1.45

3.21

1.3

1.4

23.30

25.34

iu/l

0.29

644

Umbilical hernia

478

4059

1.18

3.20

1.4

1.3

21.17

26.64

iu/l

4.17

414

3483

Rheumatoid arthritis

493

5253

0.85

3.20

1.3

33.66

32.93

iu/l

0.17

427

4524

Melanocytic naevi, other sites/unspecified

189

1457

1.32

3.20

1.3

26.19

27.26

iu/l

0.18

169

1250

Herpesviral [herpes simplex] infections

289

2345

1.25

3.19

1.4

1.3

28.16

28.17

iu/l

0.00

243

2008

Tongue abnormality

638

1.48

3.17

1.3

27.53

32.48

iu/l

0.75

536

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

552

4756

1.17

3.17

1.4

1.3

22.26

25.28

iu/l

1.45

428

4073

Other keratitis

261

2095

1.26

3.17

1.4

1.3

28.24

25.57

iu/l

0.60

216

1785

Assault

350

2898

1.22

3.16

1.3

1.4

20.13

22.30

iu/l

0.69

259

2433

Certain conditions originating in the perinatal period

283

2032

1.25

3.15

1.9

1.6

15.12

15.51

iu/l

0.08

224

1598

Other and unspecified disorders of vitreous body

451

3792

1.19

3.15

1.3

39.22

39.81

iu/l

0.12

388

3261

Sulfonylureas

1090

0.69

3.14

1.5

1.4

27.88

34.22

iu/l

1.35

915

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

375

1.63

3.13

1.4

30.49

27.36

iu/l

0.30

316

Other chromosome abnormalities, not elsewhere classified

101

2.38

3.11

2.6

1.9

13.05

18.36

iu/l

0.45

Protozoal diseases

284

1.73

3.11

1.6

1.4

38.81

28.01

iu/l

0.91

238

Specific development disorders of speech and language

143

1023

1.37

3.11

2.0

1.7

8.99

11.56

iu/l

0.78

101

777

Substance abuse, excluding more controls

1144

9021

1.11

3.09

1.4

1.3

21.10

26.64

iu/l

8.39

884

7847

Cardiac murmurs and other cardiac sounds

232

1821

1.27

3.09

1.5

1.6

20.19

22.51

iu/l

0.53

189

1489

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

608

1.48

3.09

1.4

1.3

29.04

30.42

iu/l

0.15

513

Other and unspecified nonorganic psychotic disorders

570

4931

1.17

3.08

1.4

20.04

24.49

iu/l

2.97

424

4223

Ulcerative colitis

616

5357

1.16

3.08

1.4

27.20

26.44

iu/l

0.22

544

4574

Maternal care for cervical incompetence

112

804

1.43

3.08

1.2

1.3

22.01

24.32

iu/l

0.33

101

678

Right bundle-branch block

188

1.88

3.07

1.5

26.68

26.33

iu/l

0.02

159

Nasal polyp

288

2341

1.24

3.07

1.3

27.39

30.87

iu/l

1.00

246

2028

Sequelae of injuries, of poisoning and of other consequences of external causes

498

4262

1.18

3.06

1.4

1.3

27.85

28.71

iu/l

0.23

422

3653

Algoneurodystrophy

109

782

1.43

3.03

1.6

1.3

30.81

28.95

iu/l

0.23

670

Use of ropinirole

161

1.95

3.01

1.5

1.3

29.31

30.73

iu/l

0.10

134

Hypoglycaemia, other or unspecified

137

1017

1.37

3.01

1.5

27.85

23.92

iu/l

0.65

116

850

Other/unspecified enthesopathies, not elsewhere classified

153

1154

1.34

3.00

1.2

1.3

29.83

33.01

iu/l

0.56

137

994

Dementia

805

0.68

2.99

1.5

1.4

40.21

33.38

iu/l

0.75

677

Vitamin D deficiency

304

1.70

2.99

1.7

1.4

18.69

24.38

iu/l

0.67

259

Other surgical follow-up care

542

1.51

2.98

1.4

18.54

22.55

iu/l

0.56

449

Inguinal or femoral hernia, bilateral

458

1.54

2.97

1.4

18.93

20.55

iu/l

0.17

371

Valvular heart disease excluding rheumatic fever

395

3431

0.84

2.97

1.5

1.4

28.92

30.53

iu/l

0.40

329

2861

Viral warts

245

1970

1.26

2.96

1.4

21.48

24.25

iu/l

0.79

214

1642

Endometriosis in cutaneous scar

2.50

2.95

1.3

1.4

48.48

24.96

iu/l

0.93

Non-rheumatic valve diseases

387

3362

0.84

2.95

1.4

29.53

30.93

iu/l

0.33

322

2812

Other specified and unspecified strabismus

193

1.89

2.94

1.5

1.6

31.00

23.09

iu/l

0.49

158

Benign neoplasm of breast

306

2522

1.23

2.94

1.4

1.3

30.37

32.35

iu/l

0.44

258

2187

Personal history of risk-factors, not elsewhere classified

230

1.80

2.93

1.4

23.98

18.95

iu/l

0.44

188

Other congenital malformations, not elsewhere classified

187

1.92

2.93

1.9

16.39

18.70

iu/l

0.13

149

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

149

1125

1.34

2.93

1.3

35.99

33.47

iu/l

0.38

134

968

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

955

0.65

2.93

1.3

1.4

33.47

31.66

iu/l

0.17

812

Obstructed labour due to malposition and malpresentation of fetus

1318

11354

1.11

2.93

1.3

30.15

29.03

iu/l

0.55

1192

9805

Injuries to unspecified part of trunk, limb or body region

180

1395

1.30

2.92

1.4

1.5

26.25

23.63

iu/l

0.50

149

1157

Abnormal findings in nipple discharge synovial fluid wound secretions

215

1.82

2.92

1.3

30.57

22.03

iu/l

0.55

179

Other peripheral vascular diseases

174

1344

1.31

2.92

1.4

25.40

28.23

iu/l

0.53

149

1162

Trigger finger

292

2394

1.23

2.92

1.4

1.3

33.33

35.09

iu/l

0.39

254

2066

Iron deficiency anaemia

815

7170

1.13

2.92

1.4

1.3

25.13

28.76

iu/l

2.31

687

6200

Zoster [herpes zoster]

230

1835

1.26

2.92

1.7

1.3

28.49

30.27

iu/l

0.35

201

1563

Galactorrhea

357

1.67

2.92

1.3

24.23

26.85

iu/l

0.23

313

Other specified disorders of kidney and ureter

367

1.61

2.92

1.3

34.35

28.78

iu/l

0.54

308

Finngen Rheumatological endpoints

3191

17114

1.07

2.90

1.4

1.3

27.61

26.32

iu/l

1.36

2772

14738

Disorders of optic nerve and visual pathways

258

2094

1.25

2.90

1.7

1.4

24.47

26.14

iu/l

0.33

218

1785

Medial epicondylitis

678

1.44

2.89

1.3

38.19

34.73

iu/l

0.42

585

Other congenital malformations of circulatory system

353

1.62

2.89

1.9

1.3

30.32

26.95

iu/l

0.28

301

Misadventures to patients during surgical and medical care

275

2244

1.24

2.89

1.4

1.3

27.21

29.92

iu/l

0.70

241

1941

Hypokalaemia

163

1248

1.32

2.88

1.5

1.3

25.67

32.17

iu/l

1.73

133

1068

Benign neoplasm: Pancreas

157

1.94

2.88

1.4

1.3

37.88

30.73

iu/l

0.44

138

Diseases of external ear

660

5794

1.15

2.88

1.5

1.4

23.35

27.41

iu/l

3.06

570

4923

Transitory endocrine and metabolic disorders specific to fetus and newborn

325

1.66

2.87

2.4

2.3

5.77

6.45

iu/l

0.22

211

Stroke, excluding SAH

412

3611

0.85

2.84

1.4

1.3

32.31

33.02

iu/l

0.15

332

3095

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

151

1.96

2.84

2.2

1.6

19.36

24.26

iu/l

0.37

130

Other gastritis (incl. Duodenitis)

299

2462

1.22

2.84

1.4

32.49

31.65

iu/l

0.15

259

2111

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

111

808

1.41

2.83

1.8

1.7

20.05

18.23

iu/l

0.21

639

Other papulosquamous disorders

124

2.08

2.83

1.3

1.6

29.52

24.94

iu/l

0.21

103

Melanocytic naevi of other and unspecified parts of face

150

1143

1.33

2.82

1.3

24.83

28.28

iu/l

0.64

135

972

Scoliosis

207

1643

1.27

2.82

1.6

1.4

20.79

19.76

iu/l

0.19

171

1351

Other/unspecified disorders of vestibular function

378

1.59

2.82

1.4

1.3

32.01

30.70

iu/l

0.11

324

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

263

2144

1.24

2.80

1.3

30.25

31.82

iu/l

0.33

229

1861

Cyst of Bartholin Gland

145

1105

1.35

2.80

1.4

1.3

29.39

28.16

iu/l

0.16

129

955

3.31

2.80

1.5

16.13

22.04

iu/l

—

Varicose veins of other sites

572

1.47

2.80

1.7

1.4

15.51

23.93

iu/l

2.43

476

Superficial injury of head

446

3814

1.18

2.79

1.3

1.4

25.52

26.53

iu/l

0.27

358

3208

Graves ophthalmopathy

453

1.54

2.79

1.3

28.45

30.60

iu/l

0.22

389

Hydronephrosis

161

1237

1.31

2.79

1.6

1.4

33.82

27.11

iu/l

1.41

143

1043

Viral pneumonia (unknown virus, not influenza)

128

953

1.36

2.79

1.4

20.80

23.30

iu/l

0.39

793

Chondrocostal junction syndrome [Tietze]

608

1.46

2.79

1.3

1.4

23.87

28.10

iu/l

0.61

514

Acute appendicitis, no complications

1746

16114

1.09

2.78

1.3

26.07

27.15

iu/l

0.73

1523

13922

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

323

1.62

2.78

1.7

1.3

35.13

30.55

iu/l

0.43

284

Benign neoplasm: Parotid gland

116

850

1.38

2.78

1.2

1.3

34.32

30.75

iu/l

0.47

733

Other and unspecified types of non-Hodgkin lymphoma, hilmo

217

1.77

2.78

1.5

1.3

25.76

26.32

iu/l

0.04

183

Myocardial infarction, strict

208

1910

0.79

2.78

1.3

1.4

30.55

32.17

iu/l

0.25

177

1607

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

313

1.66

2.78

2.1

2.3

5.82

6.54

iu/l

0.23

205

Nutritional anaemias

905

7894

1.12

2.77

1.4

1.3

25.82

29.08

iu/l

2.13

762

6822

Ulcerative colitis, NAS

347

2912

1.20

2.77

1.4

26.84

25.59

iu/l

0.28

308

2476

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

240

1.73

2.75

1.4

1.2

31.34

27.87

iu/l

0.25

211

Metabolic disorders

2064

13782

0.93

2.74

1.5

1.3

29.00

30.69

iu/l

1.37

1694

11946

Ulcerative rectosigmoiditis

203

1614

1.27

2.74

1.4

1.3

27.18

26.18

iu/l

0.16

172

1376

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

220

1.79

2.74

1.3

1.4

27.62

23.46

iu/l

0.30

185

Injuries to the ankle and foot

2219

18876

1.07

2.73

1.4

23.54

25.58

iu/l

2.32

1904

16154

Malignant neoplasm of breast, HER-negative

337

2818

1.20

2.73

1.4

1.3

46.09

37.40

iu/l

4.04

287

2461

Deep bite

306

2222

1.22

2.72

1.8

1.6

21.59

21.15

iu/l

0.08

248

1780

Benign neoplasm of mouth and pharynx

171

1330

1.30

2.72

1.4

32.04

30.98

iu/l

0.16

149

1140

Intermittent heterotropia

175

1370

1.30

2.71

1.9

1.5

17.74

18.52

iu/l

0.16

136

1080

Ischaemic Stroke, excluding all haemorrhages

356

3199

0.84

2.71

1.3

31.89

33.28

iu/l

0.31

291

2740

Elevated blood glucose level

143

1087

1.33

2.71

1.4

20.26

25.97

iu/l

1.27

113

909

Autonomic disorders

266

1.69

2.69

1.6

1.3

19.75

26.07

iu/l

0.90

228

Other/unspecified synovitis and tenosynovitis

246

2002

1.24

2.68

1.4

1.3

28.76

30.72

iu/l

0.42

218

1717

Disease of hard tissues of teeth, NOS

148

1.96

2.68

2.4

1.4

23.86

24.76

iu/l

0.05

123

Benign neoplasm: Colon

526

4472

1.16

2.67

1.4

1.3

30.39

35.05

iu/l

2.43

446

3843

Phlebitis and thrombophlebitis (not including DVT)

422

3609

1.18

2.67

1.4

1.3

29.03

31.82

iu/l

0.94

357

3137

Superficial injury of wrist and hand

543

4737

1.16

2.67

1.4

21.19

23.80

iu/l

1.26

463

3995

Failure and rejection of transplanted organs and tissues

148

1.95

2.67

1.6

1.4

22.15

22.23

iu/l

0.00

120

Other postsurgical states

116

857

1.37

2.67

1.5

1.4

26.62

28.91

iu/l

0.31

103

710

Toxic effect of other and unspecified substances

230

1.76

2.65

1.7

1.4

20.97

21.04

iu/l

0.01

194

Slow fetal growth and fetal malnutrition

149

1.99

2.65

3.2

2.5

8.98

6.39

iu/l

0.34

Guillain-Barre syndrome

170

1.87

2.64

1.2

1.3

38.11

24.39

iu/l

0.78

145

Chronic viral hepatitis

140

1069

1.33

2.62

1.3

1.4

19.00

21.98

iu/l

0.66

902

Benign neoplasm: Stomach

128

962

1.34

2.62

1.3

36.11

iu/l

0.00

110

829

Presence of cardiac and vascular implants and grafts

182

1745

0.79

2.61

1.2

1.4

28.01

29.93

iu/l

0.31

144

1456

ILD, hospital admissions 1, main diag only

680

1.40

2.61

1.5

1.4

31.25

30.57

iu/l

0.07

576

Myeloproliferative diseases

681

1.41

2.60

1.4

1.3

26.80

31.26

iu/l

0.81

578

Monoplegia

142

1.95

2.60

1.6

1.3

44.12

23.70

iu/l

1.41

125

Sicca syndrome [Sjögren]

189

1501

1.27

2.60

1.4

1.3

35.81

32.95

iu/l

0.48

167

1304

Wide developmental disorders

100

728

1.41

2.59

1.9

1.7

11.30

12.60

iu/l

0.25

561

Other and unspecified abdominal hernia

378

1.56

2.59

1.6

1.3

26.56

30.34

iu/l

0.35

321

Entropion and trichiasis of eyelid

229

1.71

2.59

1.4

1.3

36.26

29.83

iu/l

0.49

192

Inguinal hernia, bilateral

433

1.51

2.59

1.4

17.63

19.19

iu/l

0.17

348

Procedures for purposes other than remedying health state

519

1.48

2.59

1.3

33.73

31.11

iu/l

0.30

438

Benign neoplasm: Liver/bile ducts

478

1.50

2.58

1.4

1.3

25.48

27.75

iu/l

0.25

415

Hallux valgus (acquired)

647

5297

0.88

2.58

1.3

36.07

37.09

iu/l

0.32

567

4607

Seropositive rheumatoid arthritis, strict definition

187

2345

0.79

2.58

1.4

1.3

33.73

32.97

iu/l

0.11

162

2030

Anxious personality disorder

397

1.56

2.58

1.6

1.3

18.04

20.96

iu/l

0.32

334

Rotator cuff syndrome

1265

8591

1.10

2.57

1.4

1.3

31.06

34.66

iu/l

3.37

1120

7460

Malignant neoplasm of thyroid gland

150

1159

1.31

2.57

1.4

1.3

31.25

30.36

iu/l

0.12

130

996

Mental and behavioural disorders due to use of other stimulants, including caffeine

594

1.45

2.57

1.2

1.4

12.95

18.08

iu/l

1.44

504

Other and unspecified disorders of skin and subcutaneous tissue

822

0.65

2.57

1.4

1.3

31.64

29.65

iu/l

0.13

708

Hyperprolactinaemia, drug-induced

145

2.00

2.57

1.3

18.10

29.26

iu/l

1.72

127

Insulin, combination of fast acting with intermediate-acting or long-acting

847

8688

0.90

2.57

1.4

21.20

25.69

iu/l

4.33

695

7375

Benign neoplasm: Peripheral nerves and autonomic nervous system

150

1.91

2.56

1.4

1.2

31.77

26.49

iu/l

0.25

133

Lactose intolerance

586

1.45

2.55

1.4

28.52

24.05

iu/l

0.58

489

Carcinoma in situ of cervix uteri

403

3464

1.18

2.55

1.3

23.00

22.78

iu/l

0.05

367

3021

Otalgia

194

1550

1.27

2.55

1.4

1.5

24.55

25.66

iu/l

0.20

164

1280

Superficial injury of forearm

236

1926

1.24

2.55

1.5

1.4

25.08

22.65

iu/l

0.53

200

1596

Carcinoma in situ, bladder

2.44

2.54

1.1

1.2

25.06

19.27

iu/l

—

Mucosal proctocolitis

318

2672

1.20

2.54

1.4

26.31

24.59

iu/l

0.41

275

2271

Early lumbar disc prolapse, operated

374

3192

1.19

2.54

1.4

1.3

24.70

26.51

iu/l

0.50

325

2758

Other specified and unspecified retinal disorders

301

1.62

2.53

1.5

1.4

28.58

30.07

iu/l

0.11

247

Congenital malformations of the respiratory system

256

1.69

2.53

1.6

1.8

35.20

22.23

iu/l

1.36

202

Childhood asthma (age<16)

557

3875

1.15

2.52

1.5

1.4

15.36

16.67

iu/l

0.59

452

3202

Vitamin deficiency, wide

670

1.41

2.52

1.5

1.4

24.26

28.48

iu/l

0.60

570

Vitamin deficiency

670

1.41

2.52

1.5

1.4

24.26

28.48

iu/l

0.60

570

Bacterial pneumonia (organism specified)

672

5424

1.13

2.52

1.4

25.78

27.32

iu/l

0.61

562

4628

Congenital malformations of eye, ear, face and neck

185

1473

1.27

2.52

1.5

18.46

19.70

iu/l

0.24

146

1187

Childhood asthma (age<16), excluding more controls

557

3875

1.15

2.51

1.5

1.4

15.36

16.69

iu/l

0.60

452

3201

Purpura and other haemorrhagic conditions

241

1973

1.23

2.50

1.4

26.29

25.92

iu/l

0.06

199

1666

Localized skin eruption due to drugs and medicaments

152

1.91

2.50

1.1

1.4

19.15

25.23

iu/l

0.42

131

Other other unspecified disorders of the circulatory system

382

1.54

2.49

1.5

1.4

32.55

33.49

iu/l

0.08

321

466

1.50

2.49

1.5

6.73

10.93

iu/l

2.92

356

Eustachian salpingitis and obstruction

298

2501

1.21

2.48

1.4

24.59

21.78

iu/l

0.71

249

2162

Event of undetermined intent

142

1095

1.31

2.48

1.3

1.4

21.31

22.85

iu/l

0.25

107

913

Infections with a predominantly sexual mode of transmission

1205

11044

1.10

2.48

1.3

23.43

23.35

iu/l

0.03

989

9559

Bacterial Sepsis

468

3608

1.16

2.45

1.5

1.4

24.86

28.50

iu/l

1.69

379

3039

Dermatitis due to substances taken internally

119

897

1.35

2.45

1.5

1.4

25.46

25.20

iu/l

0.03

105

761

Benign neoplasm: Adrenal gland

707

1.39

2.44

1.4

1.3

33.05

34.58

iu/l

0.17

606

Parodontitis and operation codes

1719

14372

0.93

2.44

1.4

1.3

32.11

30.85

iu/l

0.81

1443

12504

Vocal cord dysfunction

363

2873

1.18

2.44

1.4

1.3

28.54

32.77

iu/l

1.59

317

2557

Chronic periapical parodontitis

332

2807

1.19

2.44

1.5

1.3

27.07

29.87

iu/l

0.85

264

2417

Lichen simplex chronicus

425

1.51

2.44

1.4

1.3

31.26

30.85

iu/l

0.04

366

Actinic keratosis

159

1178

1.28

2.44

1.4

33.82

38.57

iu/l

1.13

133

995

Autism

509

1.47

2.43

1.7

1.6

11.60

14.36

iu/l

0.53

408

Benign neoplasm: Skin of other and unspecified parts of face

150

1166

1.30

2.43

1.4

1.3

26.52

30.59

iu/l

0.85

130

1014

Type 1 diabetes, strict definition

199

2447

0.80

2.43

1.4

1.5

16.75

18.49

iu/l

0.38

160

1990

Other superficial mycoses

370

1.55

2.43

1.6

1.4

24.89

22.52

iu/l

0.24

313

Hypertrophic scar

165

1304

1.29

2.43

1.3

24.68

25.36

iu/l

0.10

139

1101

Presence of other devices

249

2048

1.22

2.43

1.3

27.88

31.97

iu/l

1.27

233

1769

Maternal care for other known or suspected fetal problems

1621

9663

1.09

2.42

1.3

22.21

26.84

iu/l

8.00

1450

8315

Scissor bite

608

1.43

2.42

2.0

2.1

11.69

11.75

iu/l

0.01

462

Acute pharyngitis

409

3500

1.17

2.42

1.4

18.34

18.29

iu/l

0.01

340

2898

Enteropathic arthropathies

477

1.48

2.41

1.3

28.08

28.58

iu/l

0.05

401

Vertical strabismus

543

1.45

2.40

1.4

25.02

27.20

iu/l

0.22

454

Osteoporosis with pathological fracture (FG)

289

1.60

2.40

1.5

1.3

42.95

42.80

iu/l

0.01

246

Ventral hernia

365

3116

1.18

2.39

1.3

26.53

32.18

iu/l

3.05

307

2669

Social disorders starting during childhood or adolecense, excluding more controls

155

1.89

2.39

2.0

1.7

4.70

10.47

iu/l

2.97

115

Benign neoplasm: Rectum, anus and anal canal

184

1469

1.26

2.39

1.5

1.3

34.70

34.02

iu/l

0.10

158

1259

Other and unspecified injuries of forearm

119

2.02

2.38

1.6

1.5

19.87

20.66

iu/l

0.04

104

Other specified/unspecified arthritis

604

5350

1.14

2.38

1.4

26.95

29.29

iu/l

0.99

533

4549

Prurigo nodularis

221

1.70

2.38

1.4

1.3

25.92

29.14

iu/l

0.29

192

Status epilepticus

346

1.55

2.38

1.7

1.5

23.53

26.87

iu/l

0.25

286

Other disorders of pigmentation

510

1.45

2.37

1.3

1.4

31.69

29.88

iu/l

0.16

435

Other meningitis

261

1.66

2.36

1.6

1.3

26.57

25.50

iu/l

0.07

219

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

593

1.41

2.36

1.3

35.50

29.59

iu/l

0.76

507

Nail disorders

161

1271

1.28

2.35

1.3

1.4

23.85

25.66

iu/l

0.30

131

1068

Assault by bodily force

200

1621

1.25

2.35

1.4

20.61

22.06

iu/l

0.27

147

1332

Macular pucker

476

1.46

2.34

1.3

44.96

37.44

iu/l

0.87

391

Retention of urine

304

2159

1.19

2.34

1.4

26.35

26.62

iu/l

0.04

255

1823

Hydrocele

346

1.54

2.34

1.7

1.6

13.79

9.47

iu/l

0.90

279

Bleeding

1133

9002

0.91

2.33

1.4

26.56

29.46

iu/l

2.24

946

7661

DVT of lower extremities

252

2087

1.21

2.33

1.3

34.94

32.43

iu/l

0.50

216

1799

Benign neoplasm: Choroid

536

1.43

2.33

1.4

1.3

30.11

34.02

iu/l

0.53

462

Other and unspecified intracranial injuries

324

1.57

2.33

1.3

1.4

24.61

24.43

iu/l

0.01

272

Ménière disease

142

1104

1.30

2.32

1.4

1.3

30.24

33.85

iu/l

0.67

120

946

Anisometropia and aniseikonia

430

1.49

2.32

1.5

23.79

26.70

iu/l

0.33

350

Dystonia

120

914

1.33

2.32

1.5

1.4

27.72

30.63

iu/l

0.45

108

779

Postpartum haemorrhage

1425

11505

1.09

2.31

1.3

26.88

27.72

iu/l

0.44

1296

9897

Stenosis and insufficiency of lacrimal passages

154

1211

1.28

2.31

1.4

33.81

30.57

iu/l

0.52

141

1033

Implicit fungal Sepsis

277

1.61

2.31

1.7

1.4

30.32

27.09

iu/l

0.21

236

Birth trauma

121

2.00

2.31

1.6

2.0

11.29

15.91

iu/l

0.39

Hereditary retinal dystrophy

201

1.74

2.31

1.6

1.5

30.48

25.06

iu/l

0.40

165

Inflammatory disease of cervix uteri

142

1108

1.30

2.30

1.2

1.3

34.32

34.06

iu/l

0.03

130

967

Organic, including symptomatic, mental disorders

218

1924

0.82

2.30

1.4

31.97

30.14

iu/l

0.31

176

1629

Family history of other conditions

312

1.60

2.30

1.5

1.4

16.62

22.42

iu/l

0.70

254

All-cause Heart Failure

246

2142

0.83

2.30

1.5

1.4

25.35

32.03

iu/l

2.63

202

1793

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

412

1.53

2.29

1.3

25.05

25.89

iu/l

0.06

362

Dementia, including avohilmo

889

0.74

2.29

1.6

1.4

37.65

33.06

iu/l

0.53

748

Other bursopathies

176

1407

1.26

2.29

1.3

29.18

32.91

iu/l

0.81

153

1198

Erythema nodosum

532

1.44

2.29

1.4

1.3

24.27

29.01

iu/l

0.67

459

Hypertrophic disorders of skin

176

1413

1.27

2.29

1.3

1.4

25.08

25.53

iu/l

0.06

149

1195

Carcinoma in situ of other and unspecified sites

2.24

2.28

1.1

1.3

24.03

22.78

iu/l

0.07

Fall on and from stairs and steps

486

4259

1.15

2.27

1.4

26.61

28.41

iu/l

0.61

384

3645

Ulcerative proctitis

162

1288

1.28

2.27

1.4

25.48

24.66

iu/l

0.11

140

1097

Disorders of speech understanding and production

646

1.39

2.27

2.3

1.8

9.63

11.30

iu/l

0.25

464

Vasomotor rhinitis (mode)

153

1207

1.28

2.27

1.3

1.4

26.80

29.34

iu/l

0.45

135

1032

Diseases of arteries, arterioles and capillaries

598

5029

0.89

2.26

1.4

1.3

28.31

30.91

iu/l

1.07

501

4318

Postpartum hemorraghe, all women as controls

1425

13183

1.09

2.25

1.3

26.88

25.99

iu/l

0.48

1296

11441

Malignant neoplasm of cervix uteri

395

1.52

2.25

1.2

1.3

50.31

26.47

iu/l

2.99

346

Benign neoplasm of middle ear and respiratory system

735

1.36

2.25

1.4

29.45

30.32

iu/l

0.09

620

Mental and behavioural disorders associated with the puerperium

414

1.52

2.25

1.3

25.05

24.38

iu/l

0.05

363

Single delivery by forceps and vacuum extractor

919

5094

1.11

2.24

1.3

25.43

24.17

iu/l

0.55

819

4232

Injury of muscle and tendon at hip and thigh level

187

1512

1.25

2.24

1.3

1.4

35.08

30.89

iu/l

0.87

155

1284

Crowding of teeth, including avohilmo

304

2125

1.19

2.24

1.9

1.6

15.25

15.16

iu/l

0.02

248

1680

Benign neoplasm of colon, rectum, anus and anal canal

685

5530

1.12

2.23

1.4

1.3

31.09

34.69

iu/l

1.98

579

4774

Diseases caused by chlamydiae

449

1.51

2.23

1.3

1.4

32.40

33.03

iu/l

0.05

397

Benign neoplasm: Connective and other soft tissue of head, face and neck

226

1.68

2.23

1.6

1.3

31.83

26.49

iu/l

0.36

193

Any dementia

666

0.70

2.23

1.5

1.4

44.32

33.23

iu/l

1.45

570

Endometriosis of fallopian tube

182

1.79

2.22

1.5

1.4

28.42

28.76

iu/l

0.02

155

Gonarthrosis

1364

8467

0.92

2.22

1.3

33.10

34.93

iu/l

1.20

1190

7370

Other congenital malformations of female genitalia

276

1.64

2.22

1.5

24.60

18.26

iu/l

0.48

230

Other diseases caused by chlamydiae

457

1.49

2.22

1.3

1.4

32.71

33.15

iu/l

0.03

405

Migraine without aura, drug-induced

291

1.61

2.22

1.3

20.47

28.06

iu/l

1.08

244

Benign neoplasm: Vertebral column

3.22

2.22

1.4

1.3

21.06

25.97

iu/l

—

Lesion of ulnar nerve

244

2028

1.21

2.22

1.3

27.91

31.76

iu/l

1.08

215

1741

Other specified/unspecified bacterial intestinal infections

100

746

1.35

2.22

1.5

1.4

20.54

29.97

iu/l

3.11

637

Benign neoplasm: Skin of eyelid, including canthus

213

1746

1.23

2.22

1.3

33.91

32.78

iu/l

0.19

180

1501

Car occupant injured in other and unspecified transport accidents

518

4572

1.14

2.22

1.4

1.3

20.81

23.85

iu/l

1.68

460

3906

ILD, hospital admission 2, with pulmonary infections

474

1.44

2.21

1.5

1.4

31.08

30.01

iu/l

0.08

396

Follicular lymphoma, hilmo

233

1.65

2.21

1.3

28.13

29.41

iu/l

0.07

201

Ulcerative ileocolitis

108

818

1.34

2.21

1.5

1.3

22.80

25.14

iu/l

0.36

695

Use of rotigotine

2.12

2.21

1.7

1.3

32.64

29.31

iu/l

0.16

Other neurological diseases

1210

8952

1.09

2.20

1.5

1.3

28.60

30.06

iu/l

0.77

1045

7691

Behavioural disorders, excluding more controls

419

1.49

2.20

1.5

17.75

16.71

iu/l

0.11

342

Disorders of vitreous body and globe

590

5111

1.13

2.20

1.4

1.3

36.22

36.59

iu/l

0.09

508

4412

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

262

2155

1.20

2.19

1.4

1.3

40.54

35.12

iu/l

1.48

216

1891

Other Crohn's disease

184

1491

1.25

2.19

1.4

23.45

24.56

iu/l

0.21

164

1266

Diseases of middle ear and mastoid

1870

14343

1.07

2.19

1.4

19.56

21.65

iu/l

2.42

1577

12241

Pain in throat and chest

2520

14536

1.06

2.19

1.4

1.3

28.02

27.85

iu/l

0.09

2116

12566

Retinal haemorrhage

151

1.81

2.18

1.9

1.4

23.27

31.16

iu/l

0.58

128

Other retinal disorders

640

5751

0.89

2.17

1.4

28.25

29.08

iu/l

0.23

527

4900

LSIL lesion of the cervix uteri

554

4937

1.14

2.15

1.3

25.92

26.29

iu/l

0.10

490

4302

Other necrotizing vasculopathies (FG)

478

1.44

2.14

1.3

1.4

28.85

31.34

iu/l

0.28

406

Other congenital malformations of brain

2.14

2.3

2.0

17.25

18.92

iu/l

0.07

Otitis externa

501

4422

1.14

2.14

1.4

21.75

26.92

iu/l

4.12

442

3767

Other and unspecified disease of Bartholin gland

472

1.45

2.14

1.2

1.3

20.27

29.18

iu/l

2.01

416

Urethritis and urethral syndrome

324

1.54

2.13

1.4

36.52

28.94

iu/l

0.66

278

Certolizumab pegol

391

1.50

2.13

1.3

1.4

21.75

20.96

iu/l

0.07

326

Other and unspecified myopathies

596

1.39

2.13

1.6

1.4

17.79

27.37

iu/l

2.20

501

Continuous positive airway pressure

254

1831

1.20

2.13

1.4

25.04

34.77

iu/l

5.04

206

1545

Disorders of vitreous body

571

4967

1.13

2.13

1.3

36.35

37.01

iu/l

0.16

493

4285

LeFortI or BSSRO operation

150

1196

1.28

2.13

1.2

1.3

26.96

26.59

iu/l

0.05

132

1014

Benign neoplasm of other and unspecified sites

389

1.49

2.12

1.5

1.3

28.74

29.90

iu/l

0.08

334

Haemorrhage, not elsewhere classified

205

1.68

2.12

1.7

1.5

30.75

26.69

iu/l

0.22

174

Other/unspecified soft tissue disorders related to use, overuse and pressure

515

1.42

2.12

1.4

28.90

29.70

iu/l

0.07

443

Type 1 diabetes, strict definition, subgroup 1

191

2320

0.81

2.12

1.4

1.5

16.87

17.94

iu/l

0.20

154

1884

Other disorders of thyroid

161

1.79

2.11

1.5

1.4

26.55

28.30

iu/l

0.10

139

Autism spe

508

1.43

2.10

1.7

11.73

14.18

iu/l

0.45

412

Other malignant neoplasms of skin (=non-melanoma skin cancer)

298

2767

0.85

2.10

1.4

1.3

34.99

37.69

iu/l

0.72

259

2376

Benign neoplasm: Spinal meninges

2.31

2.10

1.6

1.4

31.38

26.84

iu/l

0.15

conjunctival haemorrhage

598

1.38

2.10

1.5

1.4

27.31

32.23

iu/l

0.64

512

Other and unspecified injuries of lower leg

188

1535

1.24

2.10

1.4

20.42

25.52

iu/l

1.59

167

1285

Acute lymphadenitis

159

1275

1.26

2.10

1.5

1.4

26.12

23.61

iu/l

0.41

141

1071

Infective dermatitis

200

1641

1.23

2.10

1.3

1.4

27.73

28.62

iu/l

0.14

169

1401

Inflammation of lacrimal passages (acute and unspecified)

238

1.63

2.10

1.2

1.3

26.54

26.26

iu/l

0.01

207

Feeding problems of newborn

119

1.98

2.09

1.6

2.2

8.38

8.02

iu/l

0.04

Other infectious diseases

118

910

1.31

2.09

1.5

1.4

24.74

26.23

iu/l

0.20

107

770

Graves ophthalmopathy, strict

392

1.49

2.09

1.3

30.43

30.79

iu/l

0.03

340

Congenital deformities of hip

434

1.47

2.09

1.8

1.7

22.95

20.65

iu/l

0.21

337

Later onset COPD, excluding more controls

213

1.58

2.08

1.3

1.5

25.61

34.61

iu/l

0.86

171

Unspecific neurodegenerative disorder

521

0.67

2.08

1.4

52.00

32.62

iu/l

2.23

437

Nystagmus and other irregular eye movements

239

1.64

2.08

1.9

1.6

24.50

24.24

iu/l

0.01

197

Other disorders of bone density and structure

442

1.45

2.07

1.6

1.4

28.76

25.48

iu/l

0.34

377

Other cataract

366

3275

0.86

2.07

1.4

1.3

31.83

35.48

iu/l

1.20

293

2803

Disorders of sclera, cornea, iris and ciliary body

1281

11872

1.08

2.07

1.4

1.3

28.06

27.67

iu/l

0.15

1099

10232

Mental and behavioural disorders due to psychoactive substance use

1202

10478

1.09

2.06

1.4

21.56

25.47

iu/l

4.70

927

8989

Injury of muscle and tendon at wrist and hand level

227

1889

1.21

2.06

1.3

1.4

27.05

27.36

iu/l

0.05

188

1607

Crohn's disease of small intestine

175

1422

1.25

2.06

1.3

1.4

25.04

23.95

iu/l

0.18

152

1194

Hypoplasia of dental enamel, prenatal

2.74

2.05

3.2

2.5

5.13

8.68

iu/l

—

Fracture of rib(s), sternum and thoracic spine

331

2843

1.17

2.05

1.4

26.34

28.72

iu/l

0.71

281

2419

Melanocytic naevi, other sites/unspecified

189

1549

1.23

2.05

1.3

26.19

28.05

iu/l

0.36

169

1316

Other disorders originating in the perinatal period

290

1.59

2.04

1.8

2.1

14.43

14.61

iu/l

0.02

197

Cysts of oral region, not elsewhere classified

475

1.43

2.04

1.6

1.4

28.46

26.17

iu/l

0.20

404

Insulin, fast-acting (human)

280

3287

0.85

2.04

1.3

1.4

21.18

22.44

iu/l

0.29

246

2805

Torsion of testis

162

1.75

2.04

1.6

1.8

8.97

6.90

iu/l

0.47

121

Polypectomy (DHB20)

653

1.36

2.04

1.2

1.4

32.30

26.65

iu/l

0.81

549

552

1.40

2.04

2.4

2.2

7.77

6.94

iu/l

0.21

370

Hyperkinetic disorders (excl. ADHD)

424

1.46

2.04

1.6

1.8

16.59

14.29

iu/l

0.25

314

Sacroiliitis, not elsewhere classified

158

1273

1.26

2.04

1.4

1.3

18.82

24.41

iu/l

1.88

145

1086

Type1 diabetes, definitions combined, early onset

169

2064

0.81

2.03

1.4

1.6

13.09

15.22

iu/l

0.54

138

1650

Disorder of thyroid, unspecified

163

1.76

2.03

1.5

1.4

26.55

26.89

iu/l

0.02

143

Other salmonella infections

485

1.42

2.02

1.6

1.3

25.35

26.59

iu/l

0.12

414

Pneumonia due to other infectious organisms, not elsewhere classified

344

1.50

2.02

1.6

1.4

27.44

27.33

iu/l

0.01

298

Benign neoplasm: Liver/bile ducts

504

1.42

2.02

1.4

1.3

25.48

28.68

iu/l

0.39

436

ILD, hospital admissions 3, with pneumonia sepsis

351

1.49

2.02

1.4

32.97

30.98

iu/l

0.14

297

Other conjunctival vascular disorders and cysts

264

1.58

2.01

1.2

1.3

32.26

31.24

iu/l

0.08

224

Papillary adenocarcinoma of thyroid gland

116

900

1.31

2.01

1.4

1.3

31.79

30.70

iu/l

0.13

102

766

Cardiovascular disorders originating in the perinatal period

2.06

2.01

2.2

2.6

23.99

9.07

iu/l

0.71

Early onset COPD

230

1920

1.20

2.01

1.4

1.3

29.10

33.29

iu/l

1.28

192

1635

Malignant neoplasm of bone and articular cartilage

2.08

1.99

2.6

1.8

17.46

22.50

iu/l

0.27

Benign neoplasm: Liver

455

1.44

1.99

1.4

1.3

24.71

28.07

iu/l

0.38

395

Other infective otitis externa

121

945

1.30

1.99

1.5

1.4

22.54

27.84

iu/l

1.10

102

795

343

1.49

1.99

1.8

1.3

25.52

25.68

iu/l

0.01

289

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

333

3852

0.86

1.99

1.4

1.3

34.36

33.26

iu/l

0.22

288

3330

Nail dystrophy

2.43

1.98

1.2

1.5

31.69

24.84

iu/l

0.25

Other disorders of nervous system

648

1.36

1.98

1.7

1.4

24.43

32.19

iu/l

1.65

554

Substance abuse

1144

10101

1.09

1.98

1.4

21.10

25.49

iu/l

5.62

884

8663

Heart failure, strict

257

2191

0.84

1.98

1.5

1.4

25.23

31.94

iu/l

2.72

210

1837

Abnormality of red blood cells

2.54

1.97

1.7

1.5

23.35

25.94

iu/l

0.10

Other disorders of breast and lactation associated with childbirth

586

1.39

1.97

1.2

1.3

16.50

16.83

iu/l

0.04

498

Other disorders of conjunctiva

171

1390

1.24

1.97

1.4

1.3

28.71

32.99

iu/l

0.99

156

1198

Mental retardation, wide definition

103

789

1.32

1.97

2.3

1.7

15.51

19.69

iu/l

0.78

607

Barrett oesophagus

249

1.58

1.96

1.3

1.4

29.97

29.32

iu/l

0.04

210

Benign neoplasm: Peripheral nerves and autonomic nervous system

165

1.73

1.95

1.4

1.3

31.77

25.59

iu/l

0.31

146

Nontoxic diffuse goitre

464

1.42

1.95

1.5

1.3

36.54

33.63

iu/l

0.27

402

Other congenital malformations of limb(s)

174

1.74

1.95

1.5

1.8

13.87

15.03

iu/l

0.08

133

Superficial injury of ankle and foot

326

2819

1.17

1.94

1.5

1.4

21.26

22.26

iu/l

0.25

275

2350

ILD, hospital admissions

104

797

1.31

1.93

1.4

33.54

30.42

iu/l

0.37

680

ILD medications: azathioprine

365

3182

1.16

1.92

1.5

1.4

24.89

25.61

iu/l

0.16

316

2713

Motorcycle rider injured in other and unspecified transport accidents

112

870

1.30

1.92

1.3

1.5

12.55

18.11

iu/l

2.05

712

Carcinoma in situ of skin

266

1.55

1.92

1.1

1.3

28.55

32.36

iu/l

0.33

235

Contact with other hot fluids

525

1.40

1.92

1.4

1.5

17.03

21.83

iu/l

0.91

427

Diseases of the myoneural junction and muscle

154

1242

1.25

1.92

1.6

1.4

22.28

28.34

iu/l

1.74

116

1047

Parkinson's disease, strict definition, excluding more controls

324

1.49

1.91

1.4

35.09

33.08

iu/l

0.13

269

Hirsprung

3.93

1.91

1.8

2.1

20.85

11.77

iu/l

—

Presbyopia

162

1319

1.24

1.91

1.3

33.16

35.45

iu/l

0.36

141

1141

Benign neoplasm: Long bones of lower limb

560

1.38

1.90

1.6

1.4

21.97

24.29

iu/l

0.25

471

Bacterial pneumonia, not elsewhere classified

594

4717

1.12

1.90

1.4

25.44

28.10

iu/l

1.24

504

4038

Transport accidents

1317

10868

1.08

1.90

1.4

1.3

21.58

25.62

iu/l

5.54

1145

9360

Volume depletion

583

1.36

1.90

1.6

1.5

20.52

24.33

iu/l

0.56

480

Alcohol abuse, main dg, excluding more controls

258

2191

1.18

1.90

1.4

1.3

19.51

25.32

iu/l

2.83

196

1885

Colectomy operation

173

1414

1.23

1.89

1.4

1.3

28.97

30.21

iu/l

0.17

150

1195

Peritonsillar abscess

648

5857

1.11

1.89

1.3

22.90

24.80

iu/l

0.88

565

5050

Calcific tendinitis of shoulder

135

1077

1.27

1.89

1.3

30.65

36.61

iu/l

1.35

120

938

Failed attempted abortion

550

1.41

1.89

1.4

1.3

18.90

24.28

iu/l

0.86

480

Other disorders of optic disc

198

1.66

1.89

1.4

24.92

21.00

iu/l

0.26

168

Other/unspecified seropositive rheumatoid arthritis

337

3878

0.87

1.89

1.4

1.3

34.58

33.35

iu/l

0.25

292

3353

Non-allergic asthma

150

1209

1.25

1.89

1.4

24.59

27.82

iu/l

0.62

121

976

Cerebrovascular diseases (FINNGEN)

571

4556

0.89

1.89

1.4

1.3

32.11

34.87

iu/l

1.05

474

3987

Interstitial lung disease

104

800

1.31

1.89

1.4

33.53

30.39

iu/l

0.38

683

Interstitial lung disease endpoints

104

800

1.31

1.89

1.4

33.53

30.39

iu/l

0.38

683

Myocardial infarction, unclassifiable

529

0.66

1.89

1.2

1.4

39.82

29.24

iu/l

0.52

448

Benign neoplasm: Skin of trunk

543

1.38

1.88

1.6

1.4

28.54

26.77

iu/l

0.17

469

Intestinal malabsorption

716

1.33

1.88

1.6

1.4

18.95

26.34

iu/l

1.87

602

Melanocytic naevi of scalp and neck

409

1.45

1.88

1.4

1.3

26.68

24.05

iu/l

0.24

354

Azathioprine

365

3188

1.15

1.88

1.5

1.4

24.89

25.53

iu/l

0.14

316

2720

Papulosquamous disorders

716

6501

1.11

1.88

1.4

1.3

28.01

30.88

iu/l

1.61

611

5580

Use of disulfiram, acamprosate or naltrexone

156

1265

1.24

1.87

1.4

25.39

27.69

iu/l

0.41

122

1081

Acute generalized exanthematous pustulosis

708

1.33

1.87

1.5

1.4

25.88

26.91

iu/l

0.11

603

Inflammatory disorders of breast

229

1935

1.20

1.87

1.3

23.88

24.98

iu/l

0.22

191

1666

Other interstitial pulmonary diseases

104

801

1.30

1.87

1.4

33.53

30.42

iu/l

0.37

684

Fungal Sepsis

301

1.51

1.87

1.7

1.4

29.68

27.07

iu/l

0.17

256

Mental and behavioural disorders of puerperium, not classified elsewhere

431

1.46

1.86

1.3

25.05

24.44

iu/l

0.05

374

Retinal detachments and breaks

365

3185

1.15

1.86

1.3

35.46

34.48

iu/l

0.20

319

2741

Basal cell carcinoma, including avohilmo

343

3108

0.87

1.86

1.3

35.46

37.30

iu/l

0.46

298

2661

Allergic urticaria

230

1942

1.20

1.86

1.4

30.30

25.24

iu/l

1.31

196

1627

Infections of breast associated with childbirth

169

1392

1.24

1.86

1.3

28.55

24.17

iu/l

0.86

150

1194

Psoriatic and enteropathic arthropathies

258

2197

1.18

1.86

1.4

1.3

29.53

31.21

iu/l

0.39

232

1910

Benign neoplasm of thyroid gland

426

1.43

1.86

1.4

1.3

30.60

29.72

iu/l

0.07

368

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1237

11492

1.08

1.86

1.4

22.56

23.89

iu/l

0.82

1062

9822

Pilonidal cyst

220

1850

1.20

1.85

1.5

1.4

16.08

21.38

iu/l

2.79

188

1559

Other diseases of spinal cord

385

1.45

1.84

1.4

26.16

26.91

iu/l

0.05

333

L04AD Calcineurin inhibitors

214

1795

1.20

1.84

1.7

1.5

25.19

26.17

iu/l

0.13

174

1490

Schizoaffective disorder

199

1660

1.21

1.84

1.3

23.05

26.02

iu/l

0.65

143

1421

Superficial injury of hip and thigh

193

1601

1.21

1.83

1.3

1.4

27.63

24.66

iu/l

0.56

166

1335

Benign neoplasm of major salivary glands

129

1026

1.27

1.83

1.3

35.35

31.78

iu/l

0.50

108

885

Hyperplasia of prostate

127

568

1.28

1.83

1.3

1.4

10.25

9.96

iu/l

0.09

103

448

Benign neoplasm: Rectum

153

1240

1.24

1.82

1.5

1.3

35.98

33.95

iu/l

0.31

131

1065

Parkinson's disease, excluding more controls

382

1.43

1.82

1.4

33.89

34.43

iu/l

0.04

321

Deficiency of other B group vitamins

215

1.61

1.82

1.4

1.3

28.03

28.83

iu/l

0.04

190

Carrier of infectious disease

429

1.43

1.82

1.3

1.4

20.11

24.09

iu/l

0.51

360

Other injuries of upper limb, level unspecified

131

1.80

1.82

1.5

31.41

19.41

iu/l

0.78

112

Schizophrenia or delusion

781

7137

1.10

1.82

1.4

20.92

25.89

iu/l

4.77

590

6122

Impetigo

127

1013

1.27

1.82

1.7

1.5

20.11

23.09

iu/l

0.51

101

824

Any dementia, excluding more controls

630

0.73

1.82

1.5

1.4

44.32

34.26

iu/l

1.25

535

2303

15217

0.95

1.81

1.4

1.3

24.90

27.53

iu/l

3.57

1929

13085

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2303

15217

0.95

1.81

1.4

1.3

24.90

27.53

iu/l

3.57

1929

13085

Torticollis

338

1.49

1.81

1.4

1.5

19.61

24.09

iu/l

0.59

285

Other inflammatory liver diseases

113

887

1.29

1.81

1.5

1.4

25.22

27.74

iu/l

0.41

102

747

Mixed conductive and sensorineural hearing loss

136

1090

1.25

1.80

1.3

1.4

32.81

31.83

iu/l

0.12

116

925

Atherosclerosis, excluding cerebral and coronary sclerosis

128

1282

0.80

1.80

1.3

1.4

29.95

32.34

iu/l

0.28

100

1080

Bilateral sagittal split ramus osteotomy operation

125

999

1.28

1.80

1.2

1.4

29.04

27.71

iu/l

0.16

111

847

Hyperlipidaemia, other/unspecified

271

2194

1.17

1.79

1.4

1.3

29.84

34.55

iu/l

1.47

214

1881

Other misadventures during surgical and medical care

232

1.58

1.79

1.4

1.3

21.43

26.51

iu/l

0.51

196

Mental retardation

766

1.31

1.79

2.3

1.7

14.85

19.66

iu/l

0.96

586

Benign neoplasm: salivary glands, exclude unknown (D119)

121

959

1.27

1.78

1.2

1.3

36.23

31.33

iu/l

0.71

101

828

Overjet

626

1.35

1.78

2.0

14.57

14.31

iu/l

0.03

478

Convalescence

121

961

1.27

1.78

1.4

22.53

28.78

iu/l

1.61

104

819

Suggestive for eosinophilic asthma

133

1066

1.26

1.78

1.4

28.50

30.39

iu/l

0.29

112

923

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

192

1.62

1.77

1.2

45.72

28.07

iu/l

1.47

165

Congenital malformations of anterior segment of eye

148

1.75

1.77

1.7

1.5

17.02

22.85

iu/l

0.46

123

Adjustment and management of implanted device

117

923

1.27

1.76

1.4

1.5

29.19

26.77

iu/l

0.26

763

Basal cell carcinoma

325

2977

0.87

1.76

1.3

34.72

37.31

iu/l

0.70

283

2551

Diabetic neuropathy

891

0.73

1.76

1.2

1.3

26.07

22.86

iu/l

0.39

766

Benign lipomatous neoplasm of other sites/unspecified

103

801

1.29

1.76

1.3

28.57

32.94

iu/l

0.69

685

Benign neoplasm: Skin, unspecified

533

1.37

1.76

1.4

30.51

29.04

iu/l

0.13

467

Tic and related disorders

218

1.60

1.75

1.7

9.92

14.25

iu/l

0.78

167

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

362

1.44

1.75

1.4

1.3

26.53

31.45

iu/l

0.58

309

Onycholysis

111

1.88

1.75

1.2

1.3

31.65

26.38

iu/l

0.20

Other noninflammatory disorders of cervix uteri

559

1.36

1.74

1.3

31.30

38.20

iu/l

0.91

494

Shoulder lesions

1884

10882

1.06

1.74

1.4

1.3

30.88

31.50

iu/l

0.33

1665

9457

Poisoning by medicine, drug-induced

251

1.56

1.74

1.2

1.3

21.31

28.48

iu/l

0.90

217

Sub-endpoint used in defining T1D endpoints

505

5536

0.89

1.74

1.4

20.58

22.59

iu/l

0.76

419

4627

Eosinophilic disease (BM)

171

1.67

1.74

1.6

1.4

26.91

29.14

iu/l

0.10

148

Perioral dermatitis

537

1.37

1.74

1.2

1.3

30.01

27.53

iu/l

0.25

464

Benign neoplasm: Ascending colon

662

1.32

1.73

1.3

35.71

33.46

iu/l

0.20

575

Other and unspecified aplastic anaemias

1.92

1.73

2.2

1.6

26.01

22.13

iu/l

0.14

Congenital malformations of trachea and bronchus

1.96

1.73

1.4

1.8

36.06

22.01

iu/l

0.84

Crohn's disease NAS

162

1334

1.23

1.73

1.4

23.01

24.50

iu/l

0.27

147

1109

Carcinoma in situ of breast, other/unspecified

118

1.82

1.73

1.4

1.2

38.82

33.85

iu/l

0.28

105

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

163

1.68

1.73

1.2

39.28

35.55

iu/l

0.31

146

Glaucoma suspect

411

3637

1.13

1.73

1.3

32.78

35.33

iu/l

0.82

362

3144

Schizophrenia, schizotypal and delusional disorders

779

7138

1.10

1.73

1.4

21.08

25.85

iu/l

4.39

588

6124

Anorexia

393

1.44

1.73

1.5

1.4

20.68

24.80

iu/l

0.51

336

Mixed disorders of conduct and emotions

571

1.36

1.73

1.4

1.6

7.65

8.98

iu/l

0.49

443

Bacterial pneumoniae

637

5111

1.11

1.72

1.4

25.42

27.99

iu/l

1.25

532

4370

Mesial bite

204

1.62

1.72

1.7

23.32

14.67

iu/l

0.83

168

Vitamin B12 deficiency anaemia

105

821

1.29

1.72

1.3

34.81

33.50

iu/l

0.13

698

Diabetic retinopathy, strict definition

193

2020

0.83

1.71

1.2

1.4

23.16

20.62

iu/l

0.44

165

1709

Allergic contact dermatitis

421

3743

1.13

1.71

1.3

27.35

29.69

iu/l

0.75

380

3247

Single spontaneous delivery

1028

5911

0.92

1.71

1.3

1.4

27.07

25.31

iu/l

0.93

887

4899

Localized adiposity

120

1.85

1.71

1.6

1.3

23.80

30.72

iu/l

0.55

103

Other necrotizing vasculopathies

578

1.34

1.70

1.4

30.61

30.58

iu/l

0.00

492

Disorders of lipoprotein metabolism and other lipidaemias

1114

7542

0.93

1.70

1.4

1.3

29.72

34.66

iu/l

4.79

911

6542

Impingement syndrome of shoulder

385

3398

1.14

1.70

1.3

36.22

36.98

iu/l

0.15

343

2912

Exposure to other and unspecified animate mechanical forces

651

1.33

1.70

1.5

1.4

28.05

24.99

iu/l

0.32

548

Fracture of foot, except ankle

604

5476

1.11

1.69

1.4

27.69

26.33

iu/l

0.43

511

4666

Bitten or struck by other mammals

335

2938

1.15

1.69

1.3

1.4

24.63

25.74

iu/l

0.25

294

2511

Other maltreatment syndromes

572

1.35

1.69

1.4

20.41

23.16

iu/l

0.36

485

Dermatitis due to ingested food

117

899

1.27

1.69

2.0

1.8

9.38

11.11

iu/l

0.42

670

Other and unspecified injuries of wrist and hand

659

1.32

1.69

1.4

30.19

23.22

iu/l

0.97

541

Divergent concomitant strabismus

214

1814

1.19

1.69

1.3

1.4

32.60

28.64

iu/l

0.92

175

1552

Seropositive rheumatoid arthritis, wide

346

3937

0.88

1.69

1.4

1.3

34.65

33.26

iu/l

0.30

300

3406

Mumps

461

1.39

1.68

1.3

1.4

26.56

30.57

iu/l

0.38

399

Desensitization to allergens

204

1726

1.20

1.68

1.4

20.49

21.04

iu/l

0.09

178

1449

Other respiratory diseases principally affecting the interstitium

128

1028

1.25

1.68

1.5

1.4

32.43

31.12

iu/l

0.15

102

871

Spondylopathies

1650

10642

0.94

1.68

1.4

1.3

31.20

31.83

iu/l

0.31

1425

9244

Fracture of lumbar spine and pelvis

218

1844

1.18

1.67

1.3

1.4

26.10

27.39

iu/l

0.24

184

1558

Lichen planus, including avohilmo

241

2060

1.18

1.67

1.3

28.70

34.65

iu/l

2.31

214

1756

Haemolytic anaemias

393

1.42

1.67

1.4

1.5

25.30

23.42

iu/l

0.14

333

Prolapse and hernia of ovary and fallopian tube

2.28

1.67

1.8

1.5

50.90

43.31

iu/l

0.25

Fall on same level involving ice and snow

1226

11455

1.07

1.66

1.3

1.4

29.53

28.87

iu/l

0.27

1052

9846

Schizoid personality disorder

221

1.57

1.65

1.5

1.3

25.92

27.47

iu/l

0.09

184

Melanocytic naevi of lip

128

1.77

1.65

1.2

27.01

24.90

iu/l

0.10

109

Other lesions of median nerve

205

1.58

1.64

1.3

38.66

30.67

iu/l

0.54

177

Other mental disorders due to brain damage and dysfunction and to physical disease

651

1.31

1.64

1.4

25.86

29.03

iu/l

0.44

545

Congenital malformations of the circulatory system

322

2732

1.15

1.63

2.0

1.5

22.45

22.82

iu/l

0.07

265

2209

Other arthritis (FG)

692

6326

1.10

1.63

1.4

26.78

29.29

iu/l

1.23

604

5431

144

1.73

1.63

1.2

1.3

23.24

30.11

iu/l

0.57

123

Other and unspecified follicular disorders

628

1.32

1.63

1.3

21.99

24.67

iu/l

0.35

536

Myeloproliferative diseases (CML excluded)

600

1.33

1.63

1.3

26.74

31.36

iu/l

0.76

510

Heart failure and coronary heart disease

611

0.73

1.63

1.4

24.38

29.46

iu/l

0.57

502

Keratitis

778

7151

1.09

1.63

1.4

1.3

27.57

27.37

iu/l

0.06

660

6136

Adhesive capsulitis of shoulder

282

2447

1.16

1.63

1.3

35.65

36.42

iu/l

0.12

244

2112

Other vitreous opacities

353

1.43

1.62

1.6

1.3

25.16

30.84

iu/l

0.72

293

Benign neoplasm: Conjunctiva

345

1.44

1.62

1.4

1.3

28.73

27.31

iu/l

0.10

301

Unspecified jaundice

336

1.44

1.62

1.4

1.5

25.85

27.20

iu/l

0.11

276

Dizziness and giddiness

1714

13139

1.06

1.61

1.4

1.3

28.33

29.36

iu/l

0.61

1451

11411

Recurrent dislocation of patella

214

1827

1.19

1.60

1.4

23.54

22.96

iu/l

0.10

186

1550

Optic atrophy

223

1.55

1.60

3.1

1.5

16.84

24.25

iu/l

0.74

187

Missing teeth due to accident, extraction or parodontitis

149

1226

1.22

1.59

1.5

1.3

34.32

31.47

iu/l

0.43

119

1070

Personal history of allergy to analgesic agent

115

1.82

1.59

1.4

1.3

18.33

24.21

iu/l

0.52

101

Benign neoplasm: Transverse colon

602

1.32

1.59

1.3

26.45

32.51

iu/l

0.82

513

Dislocation, sprain and strain of joints and ligaments of head

113

906

1.27

1.59

1.4

27.88

24.07

iu/l

0.54

102

754

Mixed connective tissue disease

156

1294

1.22

1.58

1.3

32.17

30.85

iu/l

0.18

136

1118

Occupant of pick-up truck or van injured in other and unspecified transport accidents

2.11

1.58

1.2

1.4

22.54

18.88

iu/l

0.24

Nontoxic single thyroid nodule

143

1175

1.23

1.58

1.4

1.3

29.75

32.93

iu/l

0.55

127

1022

Chronic periodontitis

169

1409

1.20

1.58

1.5

1.3

32.20

31.30

iu/l

0.10

133

1220

Injuries to the elbow and forearm

1460

14009

0.94

1.58

1.4

26.03

26.97

iu/l

0.49

1213

11942

Diseases of spleen

168

1.64

1.58

1.4

39.23

22.68

iu/l

1.33

144

Hypersomnia

249

1.52

1.57

1.6

1.4

19.47

24.64

iu/l

0.50

213

LSIL lesion of the cervix uteri, vagina or vulva

665

6099

1.10

1.57

1.3

27.38

27.78

iu/l

0.11

575

5352

Benign neoplasm: Liver

477

1.37

1.57

1.4

1.3

24.71

28.77

iu/l

0.49

413

Other disorders of the genitourinary system

183

1539

1.20

1.57

1.3

36.91

35.97

iu/l

0.12

160

1332

Presence of other functional implants

421

3342

0.89

1.56

1.4

1.3

33.39

36.15

iu/l

0.88

354

2836

Schizophrenia

265

3049

0.86

1.56

1.4

22.76

27.19

iu/l

1.70

208

2620

Residual foreign body in soft tissue

684

1.30

1.56

1.3

1.4

24.99

24.30

iu/l

0.06

579

Contact with heat and hot substances

105

835

1.27

1.56

1.3

1.5

18.99

21.90

iu/l

0.50

677

Benign neoplasm: Sigmoid colon

155

1283

1.21

1.56

1.3

1.4

34.77

34.72

iu/l

0.01

128

1099

Conjunctivitis (acute, non atopic)

718

6572

1.09

1.56

1.4

24.26

26.18

iu/l

0.88

586

5595

Tuberculosis, IBD comorbidity

347

1.42

1.55

1.5

1.3

24.81

28.97

iu/l

0.46

293

Long labour

1331

10936

1.07

1.55

1.3

24.42

27.34

iu/l

2.71

1191

9424

Other diseases of pancreas

570

1.32

1.55

1.2

1.3

41.17

30.29

iu/l

1.55

475

Toxic effect of alcohol

249

1.51

1.55

1.6

1.3

29.36

26.50

iu/l

0.13

211

Spondylopathies (FG)

373

3314

1.13

1.55

1.4

1.3

24.04

27.18

iu/l

1.15

322

2864

Social disorders starting during childhood or adolescence

178

1.63

1.55

2.0

1.9

4.70

10.94

iu/l

3.33

129

Respiratory and cardiovascular disorders specific to the perinatal period

519

1.33

1.54

2.3

10.65

7.55

iu/l

0.50

337

Other appendicitis

193

1636

1.19

1.54

1.5

1.3

23.32

30.47

iu/l

2.62

171

1397

Paraplegia, diplegia of upper limbs

225

1.53

1.54

1.2

1.4

28.47

27.68

iu/l

0.05

187

Monocytic leukaemia

3.44

1.54

3.6

1.1

21.84

17.29

iu/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

503

1.35

1.54

1.5

1.3

26.22

30.60

iu/l

0.57

428

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

444

4004

1.13

1.54

1.3

24.50

30.64

iu/l

4.43

394

3530

Abnormal findings on antenatal screening of mother

374

4185

0.88

1.54

1.3

17.81

20.95

iu/l

1.52

339

3602

Chronic iridocyclitis

775

1.28

1.53

1.3

1.4

30.34

27.20

iu/l

0.40

641

Hypertrophy of (infrapatellar) fat pad

170

1.63

1.53

1.3

1.4

22.93

26.27

iu/l

0.25

155

Other and specified injuries of hip and thigh

185

1.59

1.53

1.2

1.4

21.73

20.38

iu/l

0.10

157

Retinal detachment with retinal break

124

1006

1.24

1.52

1.3

35.54

32.34

iu/l

0.46

111

851

Postpartum care and examination

862

5095

1.09

1.52

1.3

21.74

27.98

iu/l

7.85

790

4352

Hypoplasia of dental enamel, prenatal , including avohilmo

102

1.86

1.52

2.6

15.82

8.87

iu/l

—

Psoriatic arthropathies

198

1683

1.18

1.52

1.4

1.3

30.81

32.16

iu/l

0.24

176

1449

Otosclerosis

112

900

1.25

1.52

1.4

41.27

34.02

iu/l

1.22

103

769

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

606

3764

1.10

1.52

1.3

31.46

35.77

iu/l

2.50

516

3269

Malignant neoplasm of head and neck

408

1.38

1.52

1.4

26.97

29.02

iu/l

0.19

349

Ethmoidectomy

270

2352

1.16

1.51

1.3

26.27

28.78

iu/l

0.68

236

2026

Condition for Implicit Sepsis (Organ dysfunction codes)

1548

11911

0.94

1.51

1.4

1.3

26.95

28.03

iu/l

0.61

1274

10218

Previous suicide attempt

195

1.59

1.51

1.3

1.4

21.63

19.71

iu/l

0.13

164

Viral agents as the cause of diseases classified to other chapters

411

1.39

1.51

1.3

1.4

26.65

23.62

iu/l

0.26

346

Benign neoplasm: Spinal meninges

1.98

1.51

1.6

1.4

31.38

28.64

iu/l

0.09

Tubulo-interstitial nephritis, not specified as acute or chronic

130

1064

1.23

1.50

1.3

1.4

27.96

27.45

iu/l

0.06

106

901

Spondyloarthritis

394

3518

1.13

1.50

1.4

1.3

24.30

27.41

iu/l

1.19

342

3047

Other and unspecified primary disorders of muscles

117

1.77

1.50

1.2

1.6

13.11

25.43

iu/l

1.19

Glaucoma-related operations

234

1.50

1.49

1.2

1.4

33.80

27.97

iu/l

0.42

197

Intracerebral haemorrhage

547

1.32

1.49

1.4

35.45

28.80

iu/l

0.70

457

Other symptoms and signs involving general sensations and perceptions

368

1.40

1.49

1.3

1.5

21.16

21.06

iu/l

0.01

300

Sequelae of other external causes

708

1.28

1.47

1.3

27.09

28.87

iu/l

0.18

603

484

1.35

1.47

2.5

2.2

8.67

6.90

iu/l

0.46

316

Open bite that required surgery (Lefort1 or BSSRO)

271

1.49

1.47

1.1

1.3

23.61

21.86

iu/l

0.11

232

Fasciculation

188

1.58

1.47

1.5

1.3

19.12

24.28

iu/l

0.48

159

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

525

1.34

1.47

1.3

1.4

32.02

26.56

iu/l

0.61

447

Patellar tendinitis

286

1.46

1.47

1.2

1.4

22.37

20.76

iu/l

0.11

245

Infectious mononucleosis

286

2512

1.15

1.47

1.3

1.4

19.82

18.15

iu/l

0.44

237

2093

Disorder of the sleep-wake schedule

303

1.45

1.46

1.4

1.6

21.82

19.47

iu/l

0.14

253

Respiratory insufficiency

317

1.42

1.46

1.8

1.5

26.00

32.28

iu/l

0.73

268

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

204

1.55

1.46

1.5

19.05

18.08

iu/l

0.08

173

Heart failure,strict

257

2134

0.87

1.46

1.5

1.4

25.23

32.10

iu/l

2.82

210

1793

Benign neoplasm: Rectosigmoid junction

171

1.59

1.46

1.3

1.2

31.73

31.47

iu/l

0.01

149

Oesophagitis

472

1.34

1.46

1.4

27.07

28.00

iu/l

0.09

402

Eosinophilia

180

1.58

1.45

1.6

1.4

26.91

25.69

iu/l

0.05

154

Spinal stenosis

507

3594

1.11

1.45

1.3

36.28

37.22

iu/l

0.26

430

3086

Acute gastritis

101

807

1.26

1.45

1.2

1.3

28.28

30.26

iu/l

0.25

689

Paralytic ileus

261

1.47

1.44

1.3

41.96

30.98

iu/l

0.56

226

Lesion of plantar nerve

773

1.27

1.43

1.3

31.85

36.87

iu/l

0.88

667

Other secondary coxarthrosis

337

1.41

1.43

1.7

1.3

29.71

32.36

iu/l

0.20

286

Other specified/unspecified systemic involvement of connective tissue

142

1181

1.22

1.43

1.4

1.3

32.96

30.72

iu/l

0.32

121

1010

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

364

1.40

1.43

1.8

1.6

40.99

18.60

iu/l

1.81

281

Other or ill-defined heart diseases

561

1.31

1.42

1.3

1.4

32.88

25.33

iu/l

0.92

472

Acute pancreatitis

239

2073

1.16

1.42

1.4

24.99

29.38

iu/l

1.38

194

1760

Open wound of lower leg

228

1972

1.16

1.42

1.5

1.4

22.06

23.88

iu/l

0.42

194

1623

Seropositive rheumatoid arthritis

346

3875

0.89

1.42

1.4

1.3

34.65

33.77

iu/l

0.17

300

3359

Carcinoma in situ of cervix uteri

403

3629

1.12

1.42

1.3

23.00

23.54

iu/l

0.13

367

3138

Tuberculosis, wide

354

1.39

1.41

1.5

1.3

24.81

29.37

iu/l

0.52

299

Fracture of neck

406

1.36

1.40

1.3

21.62

24.53

iu/l

0.32

340

Maternal care for known or suspected malpresentation of fetus

1237

8694

1.07

1.40

1.3

24.20

27.03

iu/l

2.54

1099

7514

Degenerative diseases of the nervous system

540

0.74

1.40

1.4

57.06

33.39

iu/l

3.24

454

Other disorders of binocular movement

540

1.32

1.39

1.5

1.4

36.30

23.35

iu/l

1.04

456

Phakomatoses, not elsewhere classified

224

1.51

1.38

2.2

1.6

5.80

21.02

iu/l

11.20

185

Type 1 diabetes, wide definition

449

4952

0.90

1.38

1.4

20.80

23.20

iu/l

0.86

370

4135

Traumatic ischaemia of muscle

159

1.60

1.37

1.3

1.4

26.12

23.13

iu/l

0.16

133

MS-disease / Multiple Sclerosis

193

2240

0.85

1.37

1.3

30.60

26.93

iu/l

0.75

175

1941

Glucagon-like peptide-1 (GLP-1) analogues

448

4076

0.90

1.37

1.3

26.49

35.96

iu/l

9.04

368

3501

Other fall from one level to another

441

3985

1.11

1.37

1.5

1.4

21.58

21.45

iu/l

0.03

364

3293

Other protozoal intestinal diseases

266

1.46

1.36

1.9

1.4

17.41

23.27

iu/l

0.72

219

Assault by other specified means

184

1.57

1.36

1.4

19.31

20.83

iu/l

0.08

153

Arthropathic psoriasis

213

1842

1.16

1.35

1.4

1.3

30.02

30.66

iu/l

0.11

187

1600

Generalized skin eruption due to drugs and medicaments

620

1.29

1.35

1.6

1.4

27.84

25.89

iu/l

0.21

528

Other epidermal thickening

505

1.32

1.35

1.5

1.4

28.36

27.41

iu/l

0.08

419

Extreme obesity with alveolar hypoventilation

471

1.33

1.34

1.3

23.66

33.92

iu/l

1.98

409

Inflammatory disorders of male genital organs, not elsewhere classified

2.16

1.34

1.0

1.3

13.41

6.02

iu/l

—

Contusion of toe(s) with damage to nail

201

1.53

1.34

1.4

1.5

20.51

20.90

iu/l

0.03

169

Urticaria due to cold and heat

177

1.58

1.34

1.4

27.04

24.21

iu/l

0.13

147

Maltreatment syndromes

158

1338

1.19

1.34

1.4

18.40

21.52

iu/l

0.85

129

1121

Juvenile osteochondrosis

684

1.27

1.34

1.5

14.64

19.09

iu/l

1.21

562

Congenital malformations of larynx

2.05

1.33

1.7

3.0

15.18

14.34

iu/l

—

Maternal care for known or suspected disproportion

295

2630

1.15

1.33

1.3

31.80

30.62

iu/l

0.23

273

2302

Early lumbar disc prolapse operation

384

3459

1.12

1.33

1.4

1.3

24.54

25.70

iu/l

0.29

334

2983

Type 1 diabetes, strict (exclude DM2)

237

2700

0.87

1.33

1.4

1.5

17.15

19.35

iu/l

0.58

194

2195

Unspecified abortion

203

1759

1.17

1.33

1.4

1.3

37.17

38.86

iu/l

0.26

172

1543

Congenital deformities of feet

526

1.31

1.32

1.6

1.5

18.74

22.75

iu/l

0.54

429

Maxillary retrognathism

387

1.37

1.32

1.7

12.59

16.53

iu/l

0.81

310

Need for immunization against other single viral diseases

209

1.51

1.32

1.6

1.4

25.42

23.32

iu/l

0.12

171

Effects of foreign body entering through natural orifice

417

3767

1.11

1.32

1.4

21.19

23.33

iu/l

0.81

357

3160

Other osteochondropathies

156

1320

1.19

1.32

1.5

1.4

25.77

26.03

iu/l

0.04

140

1115

Other and unspecified neuropathies

2.43

1.31

2.9

1.3

16.40

19.75

iu/l

—

Lactose intolerance, other/unspecified

509

1.32

1.31

1.4

29.03

23.82

iu/l

0.61

425

Biomechanical lesions, not elsewhere classified

605

1.29

1.31

1.4

1.3

27.81

28.85

iu/l

0.11

519

Other congenital malformations of tongue, mouth and pharynx

267

1.45

1.31

1.6

2.0

16.59

8.64

iu/l

0.78

188

Other and unspecified iridocyclitis

641

1.28

1.31

1.3

1.4

29.04

26.71

iu/l

0.23

548

Foreign body entering into or through eye or natural orifice

131

1091

1.21

1.31

1.4

20.41

22.34

iu/l

0.32

110

895

Synovial cyst of popliteal space [Baker]

711

1.26

1.31

1.3

1.4

28.85

32.74

iu/l

0.53

603

Atrial fibrillation and flutter

411

2974

0.90

1.30

1.3

28.62

36.49

iu/l

4.76

348

2573

Chronic conjunctivitis

518

1.31

1.30

1.4

32.20

28.84

iu/l

0.30

429

Oral leukoplakia and related diseases, including avohilmo

102

828

1.24

1.30

1.4

30.22

32.66

iu/l

0.39

704

Acute alcohol intoxication ICD-9

259

1.44

1.30

1.2

1.3

35.46

30.49

iu/l

0.43

221

Melanocytic naevi of scalp and neck

440

1.34

1.30

1.4

26.68

24.36

iu/l

0.21

381

Other localized connective tissue disorders

260

1.45

1.30

1.3

24.31

29.43

iu/l

0.38

218

Personal history of certain other diseases

494

1.32

1.29

1.5

1.3

17.60

17.02

iu/l

0.06

411

Dialysis, with operation codes

141

1183

1.20

1.29

1.6

1.4

27.30

25.73

iu/l

0.15

108

973

Benign neoplasm: Connective and other soft tissue of thorax

2.35

1.29

1.4

1.2

27.10

20.32

iu/l

—

Striking against or struck by other objects

715

6628

1.08

1.27

1.4

21.42

22.68

iu/l

0.54

589

5564

Type 1 diabetes, definitions combined

240

2721

0.87

1.27

1.4

1.5

17.19

19.45

iu/l

0.61

196

2214

Disorders of eyelid in diseases classified elsewhere

529

1.30

1.27

1.3

1.4

28.29

28.58

iu/l

0.03

455

Pedestrian injured in collision with pedal cycle

389

1.35

1.26

1.6

1.4

26.07

28.03

iu/l

0.15

331

Rheumatoid arthritis, including avohilmo

591

6415

0.92

1.26

1.3

32.99

31.84

iu/l

0.33

513

5558

Other benign neoplasm of uterus: Cervix uteri

124

1.68

1.26

1.2

1.3

28.07

28.53

iu/l

0.02

110

Calculus of lower urinary tract

244

1.44

1.26

1.4

1.3

30.46

24.14

iu/l

0.50

204

Delirium, not induced by alcohol and other psychoactive substances

466

1.31

1.25

1.2

1.3

34.65

27.74

iu/l

0.68

386

Mental and behavioural disorders due to alcohol, excluding acute intoxication

712

6599

1.08

1.25

1.3

1.4

22.08

26.20

iu/l

3.31

538

5634

Coronary revascularization (ANGIO or CABG)

199

1604

0.86

1.24

1.3

1.4

26.35

30.35

iu/l

0.93

171

1334

Symptoms and signs involving appearance and behaviour

132

1.63

1.24

1.6

1.3

29.79

21.34

iu/l

0.32

112

Other respiratory disorders and diseases

158

1344

1.18

1.24

1.6

1.4

29.04

29.12

iu/l

0.01

123

1127

Other diseases of the respiratory system

158

1344

1.18

1.24

1.6

1.4

29.04

29.12

iu/l

0.01

123

1127

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

341

2609

0.89

1.23

1.4

1.3

34.94

36.26

iu/l

0.30

300

2257

Other skin changes

227

1987

1.15

1.23

1.4

26.64

29.36

iu/l

0.65

201

1680

Respiratory distress of newborn

332

1.37

1.22

2.6

2.4

6.81

6.44

iu/l

0.09

193

Other and unspecified disorders of adult personality and behaviour

125

1.66

1.22

1.6

1.3

12.24

19.37

iu/l

0.60

103

Secondary hypertension

120

989

1.21

1.22

1.6

1.4

28.80

28.09

iu/l

0.06

103

840

Other and unspecified injuries of shoulder and upper arm

418

1.33

1.22

1.3

1.4

23.69

26.03

iu/l

0.23

358

Streptococcal septicaemia

736

1.24

1.22

1.6

1.5

23.28

26.34

iu/l

0.45

604

Benign neoplasm: Long bones of lower limb

604

1.28

1.21

1.6

1.4

21.97

24.46

iu/l

0.27

504

Nephropathy related operations

140

1182

1.19

1.21

1.6

1.4

26.42

25.61

iu/l

0.07

106

973

Thalassaemia

2.01

1.21

2.5

1.4

11.64

19.57

iu/l

0.48

Melanocytic naevi of lip

141

1.60

1.21

1.2

1.3

27.01

27.55

iu/l

0.02

120

Osteomalacia

141

1.60

1.21

1.5

1.3

29.60

23.88

iu/l

0.37

124

COPD (mode)

188

1287

1.16

1.20

1.4

1.3

26.87

34.91

iu/l

2.96

148

1091

Foreign body in respiratory tract

103

847

1.23

1.20

1.6

1.5

20.49

25.70

iu/l

1.13

686

Gonococcal infection

358

1.35

1.20

1.5

1.4

34.32

31.42

iu/l

0.22

302

Other hearing loss

228

1965

1.14

1.20

1.4

27.76

32.23

iu/l

1.31

197

1677

Other obstructed labour

288

2574

1.13

1.20

1.3

28.60

30.67

iu/l

0.53

254

2219

Unspecified visual impairment (binocular)

165

1.54

1.20

1.9

1.7

15.01

22.66

iu/l

0.78

140

Contracture of joint

157

1.56

1.20

1.5

1.3

34.20

32.46

iu/l

0.11

136

Respiratory tuberculosis

230

1.44

1.19

1.6

1.3

23.87

26.40

iu/l

0.20

191

Respiratory tuberculosis, confirmed and not-confirmed

230

1.44

1.19

1.6

1.3

23.87

26.40

iu/l

0.20

191

Enduring personality changes

1.88

1.19

2.0

1.7

23.29

26.09

iu/l

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

224

1.47

1.19

1.7

1.9

22.54

16.00

iu/l

0.47

174

Other congenital malformations of the digestive system

771

1.24

1.19

1.7

20.21

17.45

iu/l

0.34

577

Major anomalies of jaw size

526

1.29

1.19

1.5

19.68

26.81

iu/l

1.06

438

Paralytic strabismus

712

1.24

1.18

2.0

1.4

25.55

28.79

iu/l

0.38

603

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

317

2442

0.89

1.18

1.3

34.60

36.68

iu/l

0.51

277

2108

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

335

2566

0.90

1.18

1.3

35.35

36.72

iu/l

0.31

292

2216

Otitis externa, unspecified

254

2251

1.14

1.18

1.4

21.10

25.87

iu/l

1.99

224

1909

Injury of eye and orbit

266

2364

1.13

1.17

1.3

1.4

24.89

23.78

iu/l

0.21

225

1981

Diseases of arteries, arterioles and capillaries (FINNGEN)

229

1820

0.88

1.17

1.4

1.3

29.12

34.46

iu/l

1.42

192

1569

Carcinoma in situ of breast, other/unspecified

134

1.59

1.16

1.4

1.3

38.82

36.68

iu/l

0.11

114

Other and unspecified injuries of head

796

1.23

1.16

1.6

1.4

22.37

26.18

iu/l

0.56

658

Injuries involving multiple body regions

617

1.26

1.15

1.6

1.4

23.71

24.30

iu/l

0.05

522

Other and unspecified mental retardation

336

1.37

1.15

2.4

1.9

19.67

16.39

iu/l

0.22

239

Mandibular retrognathia

209

1829

1.15

1.4

1.5

25.73

23.76

iu/l

0.39

182

1524

Injuries to the shoulder and upper arm

1488

13098

0.95

1.15

1.4

25.38

28.35

iu/l

3.17

1271

11152

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

307

1.29

1.15

1.7

1.3

11.62

10.34

iu/l

0.31

247

Impacted cerumen

101

832

1.22

1.15

1.5

26.09

27.41

iu/l

0.15

683

Open wound of ankle and foot

178

1542

1.16

1.15

1.4

18.90

22.28

iu/l

1.01

150

1262

Behavioural disorders

476

1.30

1.15

1.5

17.75

14.80

iu/l

0.40

380

Crushed, pushed or stepped on by crowd or human stampede

169

1460

1.17

1.15

1.5

18.29

19.18

iu/l

0.15

138

1190

Other orthopaedic follow-up care

752

1.23

1.14

1.5

1.4

31.38

28.93

iu/l

0.26

638

Sequelae of cerebrovascular disease

190

1915

0.87

1.14

1.4

1.3

37.60

32.87

iu/l

0.90

155

1630

Coeliac disease

276

2464

1.13

1.14

1.4

27.12

26.83

iu/l

0.05

235

2061

Explicit bacterial Sepsis

126

1061

1.19

1.14

1.5

1.4

22.01

24.04

iu/l

0.34

100

881

FESS (DNB20)

257

2285

1.13

1.14

1.3

25.73

28.70

iu/l

0.85

226

1972

Benign neoplasm: Connective and other soft tissue of thorax

2.05

1.14

1.4

1.3

27.10

23.71

iu/l

—

Acute pancreatitis (for exclusion)

239

2113

1.13

1.14

1.4

24.99

29.01

iu/l

1.21

194

1802

Von Willebrand disease

321

1.37

1.12

1.7

1.3

21.49

26.97

iu/l

0.61

271

Melanocytic naevi of upper limb, including shoulder

372

1.34

1.12

1.3

21.51

25.76

iu/l

0.52

313

Conduct disorder

469

1.30

1.12

1.5

1.6

17.75

14.97

iu/l

0.37

371

Ankle and foot

112

1.65

1.11

1.2

1.4

36.03

27.20

iu/l

0.51

102

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

673

1.24

1.11

1.3

1.4

35.50

30.73

iu/l

0.57

571

Contact with sharp object, undetermined intent

303

1.37

1.11

1.3

1.5

20.89

20.22

iu/l

0.05

258

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

576

1.27

1.11

1.5

25.30

25.64

iu/l

0.03

475

Pyogenic arthritis

655

1.24

1.11

1.4

27.32

28.09

iu/l

0.07

546

Chronic laryngitis and laryngotracheitis

242

2147

1.13

1.11

1.4

1.3

32.54

33.53

iu/l

0.15

210

1873

Peripheral artery disease

177

1641

0.87

1.11

1.3

1.4

25.85

31.67

iu/l

1.31

138

1389

Benign neoplasm: Skin of ear and external auricular canal

311

1.36

1.11

1.2

19.17

29.59

iu/l

2.08

268

Myositis

243

1.41

1.11

1.5

1.4

20.17

28.33

iu/l

0.92

201

Seborrhoeic dermatitis

140

1195

1.18

1.10

1.5

1.4

25.30

26.87

iu/l

0.21

127

1000

Anomalies of pupillary function

400

1.32

1.10

1.2

1.5

53.32

24.95

iu/l

1.63

343

Carcinoma in situ of cervix uteri, endocervix

465

1.31

1.10

1.3

31.79

26.54

iu/l

0.48

409

Paroxysmal tachycardia

528

4119

1.09

1.4

25.69

30.30

iu/l

2.36

448

3551

Emergency coronary revascularization (for ACS)

205

1679

0.88

1.09

1.3

1.4

26.66

29.95

iu/l

0.72

175

1403

Benign neoplasm: Skin of lower limb, including hip

347

1.34

1.09

1.2

1.3

26.75

28.73

iu/l

0.15

295

Gastroduodenal ulcer

200

1748

1.14

1.09

1.3

1.4

31.17

32.32

iu/l

0.19

166

1483

Golimumab

777

1.23

1.09

1.4

20.98

25.79

iu/l

0.75

652

Problems related to lifestyle

223

1972

1.14

1.09

1.4

1.3

18.85

22.38

iu/l

1.14

169

1679

Toxic liver disease

194

1.47

1.09

1.5

1.3

22.51

26.51

iu/l

0.30

165

Benign neoplasm: Larynx

185

1.47

1.09

1.3

34.99

24.91

iu/l

0.75

163

Embedded and impacted teeth

933

7475

1.07

1.09

1.4

14.19

16.01

iu/l

1.30

798

6260

Fall on same level

3295

19007

0.97

1.09

1.4

26.44

26.09

iu/l

0.23

2754

16353

Nonspecific lymphadenitis

167

1450

1.16

1.09

1.3

35.52

31.99

iu/l

0.53

141

1247

Contusion of toe(s) without damage to nail

534

1.27

1.08

1.3

1.4

22.88

22.38

iu/l

0.05

445

Bursitis of shoulder

339

1.34

1.08

1.3

31.82

30.33

iu/l

0.11

288

Burn and corrosion of trunk

365

1.33

1.08

1.4

1.5

15.19

23.06

iu/l

1.47

302

Other pleural conditions

478

1.28

1.08

1.4

25.89

31.06

iu/l

0.64

404

Injury of unspecified body region

123

1041

1.19

1.08

1.4

1.5

26.94

24.46

iu/l

0.36

105

865

L01XX Other antineoplastic agents

227

1.42

1.08

1.3

37.67

32.19

iu/l

0.45

194

Mild mental retardation

454

1.30

1.07

2.3

1.7

11.10

18.64

iu/l

2.56

358

Disorders in reading

358

1.34

1.07

1.9

1.8

6.66

12.27

iu/l

3.37

274

Other and unspecified tonsillitis

1116

8970

1.06

1.07

1.4

17.62

19.73

iu/l

1.79

929

7599

Use of antiglaucoma preparations and miotics

321

1.34

1.07

1.4

1.3

31.61

31.34

iu/l

0.02

271

Chronic tubulo-interstitial nephritis

569

1.26

1.07

1.4

38.94

31.47

iu/l

0.92

491

Osteonecrosis

506

1.27

1.07

1.8

1.3

25.33

32.24

iu/l

0.91

433

Focal epilepsy, strict definition

335

3033

1.11

1.07

1.5

1.4

29.24

25.79

iu/l

0.96

265

2522

Ulcerative enterocolitis

615

1.25

1.07

1.4

1.3

21.08

25.01

iu/l

0.53

523

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

2.07

1.07

1.2

1.3

41.60

22.19

iu/l

—

Non-ischemic cardiomyopathy

151

1439

0.86

1.07

1.5

1.4

27.17

32.25

iu/l

1.11

127

1204

Viral conjunctivitis

473

1.29

1.07

1.4

1.3

25.56

26.71

iu/l

0.11

398

Other and unspecified psoriasis

777

1.22

1.06

1.5

1.4

28.46

30.51

iu/l

0.26

660

Other obstetric trauma

223

2502

0.88

1.06

1.3

25.38

26.82

iu/l

0.28

197

2145

Other spirochaetal diseases

439

4029

1.09

1.06

1.4

31.57

31.82

iu/l

0.05

370

3459

Cardiodefibrillation

169

1464

1.15

1.06

1.3

1.4

21.59

29.85

iu/l

3.27

143

1213

Benign neoplasm: Skin of trunk

597

1.25

1.06

1.6

1.4

28.54

29.06

iu/l

0.05

512

Lung diseases due to external agents

104

867

1.20

1.06

1.4

31.02

28.81

iu/l

0.26

734

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2312

15625

0.96

1.06

1.4

1.3

31.60

29.90

iu/l

1.53

2002

13600

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

352

3096

1.11

1.05

1.9

1.5

24.24

21.97

iu/l

0.56

292

2518

Inflammatory diseases of the central nervous system

157

1359

1.16

1.05

1.5

1.4

27.15

26.61

iu/l

0.07

134

1147

Carcinoma in situ of skin

305

1.35

1.05

1.1

1.3

28.55

33.05

iu/l

0.41

257

Spirochaetal infections, other/unspecified

127

1081

1.18

1.05

1.6

1.4

28.37

30.63

iu/l

0.32

107

916

Other disorders of the musculoskeletal system and connective tissue

207

1826

1.14

1.05

1.4

1.3

31.14

32.28

iu/l

0.20

184

1563

Other and unspecified vasculitis limited to skin

229

1.41

1.05

1.6

1.3

19.23

28.08

iu/l

1.04

191

Demyelinating diseases of the central nervous system

232

2601

0.88

1.05

1.3

28.68

26.90

iu/l

0.34

212

2255

Type 1 diabetes, wide definition, subgroup 1

439

4769

0.92

1.05

1.4

20.96

23.04

iu/l

0.69

363

3990

Malignant neoplasm of thymus

2.13

1.05

1.3

1.4

47.96

26.31

iu/l

—

Glomerular disorders in diseases classified elsewhere

100

1196

0.83

1.05

1.4

29.78

24.58

iu/l

0.57

1011

Complications following abortion and ectopic and molar pregnancy

590

1.25

1.04

1.2

1.3

41.52

36.72

iu/l

0.45

509

Crohn's disease of large intestine

125

1065

1.18

1.04

1.4

26.91

24.40

iu/l

0.43

113

895

Other diseases of pericardium

306

1.35

1.04

1.4

1.5

27.85

27.89

iu/l

0.00

258

Congenital malformations of uterus and cervix

766

1.23

1.04

1.1

1.3

21.59

22.68

iu/l

0.11

649

Ingrowing nail

789

1.21

1.04

1.4

21.84

23.14

iu/l

0.16

657

Erythema multiforme

307

1.35

1.04

1.3

1.5

25.78

26.34

iu/l

0.04

264

Dislocation, sprain and strain of joints and ligaments of knee

1773

15797

1.04

1.03

1.3

24.59

27.28

iu/l

3.26

1559

13583

Benign neoplasm: Conjunctiva

377

1.31

1.03

1.4

28.73

29.56

iu/l

0.06

326

Thyrotoxicosis with toxic multinodular goitre

572

1.25

1.03

1.3

40.87

33.58

iu/l

0.91

487

Alzheimer disease, including avohilmo

369

0.74

1.03

1.4

56.89

34.59

iu/l

2.49

308

Other assisted single delivery

109

927

1.21

1.03

1.3

27.27

26.22

iu/l

0.13

102

788

Other disorders of skin and subcutaneous tissue, not elsewhere classified

149

1720

0.86

1.02

1.4

1.3

28.06

29.47

iu/l

0.19

129

1483

Disorders of synovium and tendon in diseases classified elsewhere

222

1.41

1.02

1.5

1.3

27.47

27.88

iu/l

0.02

187

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

818

1.21

1.02

1.7

1.3

35.62

35.21

iu/l

0.05

717

Atopic conjunctivitis

115

976

1.19

1.01

1.4

28.15

24.67

iu/l

0.42

808

Meningitis

828

1.21

1.01

1.6

1.4

25.30

26.72

iu/l

0.16

704

Pre-eclampsia

871

8227

1.06

1.01

1.3

26.95

29.19

iu/l

1.32

786

7177

Benign neoplasm: Skin of other and unspecified parts of face

150

1298

1.16

1.01

1.4

1.3

26.52

31.68

iu/l

1.21

130

1117

Other acquired deformities of musculoskeletal system and connective tissue

601

1.24

1.01

1.4

1.3

35.07

30.19

iu/l

0.58

505

Mental and behavioural disorders due to alcohol

894

8210

1.06

1.01

1.4

21.82

25.60

iu/l

3.55

685

7029

Laparoscopic right hemicolectomy

239

1.39

1.00

1.3

37.26

32.67

iu/l

0.28

201

Gastric ulcer

137

1177

1.17

1.00

1.3

32.91

32.43

iu/l

0.05

114

987

Injury of intra-abdominal organs

335

1.33

1.00

1.3

1.4

13.15

20.48

iu/l

1.01

280

!Aliquae complicationes praecoces traumatis

512

1.26

1.00

1.4

26.29

24.35

iu/l

0.18

427

Early complications of trauma

512

1.26

1.00

1.4

26.29

24.35

iu/l

0.18

427

Dislocation, sprain and strain of joints and ligaments of thorax

441

1.28

1.00

1.4

21.81

25.95

iu/l

0.50

374

Chalazion

223

1986

1.13

0.99

1.5

1.4

26.46

27.78

iu/l

0.24

187

1687

Angina pectoris

375

2773

0.91

0.99

1.3

30.93

36.09

iu/l

2.22

315

2337

Foreign body or object entering through skin

107

903

1.19

0.99

1.5

1.4

19.15

22.26

iu/l

0.52

752

Tobacco use

849

0.81

0.99

1.3

20.53

23.71

iu/l

0.45

722

Preparatory care for dialysis

320

0.68

0.99

1.2

1.4

40.70

26.48

iu/l

0.39

263

Xanthelasma of eyelid

1.66

0.99

1.1

1.4

25.72

29.32

iu/l

0.18

Conductive hearing loss, unspecified

147

1274

1.16

0.99

1.4

30.84

28.54

iu/l

0.32

124

1057

Other and unspecified mononeuropathies, also in other diseases

327

1.33

0.98

1.3

1.4

34.80

30.95

iu/l

0.27

288

Postpartum hemorraghe, parous women as controls

1425

11947

1.05

0.98

1.3

26.88

27.74

iu/l

0.45

1296

10549

Other diseases of pleura

365

2953

1.10

0.98

1.5

1.4

27.83

30.04

iu/l

0.66

302

2499

Erosion and ectropion of cervix uteri

310

1.33

0.98

1.3

1.4

30.28

33.33

iu/l

0.25

278

Generalized epilepsy, strict definition

506

1.26

0.98

1.5

22.49

22.47

iu/l

0.00

419

Persistent delusional disorders

114

969

1.18

0.97

1.4

1.3

24.09

30.05

iu/l

1.27

824

Lichen planus

148

1284

1.16

0.97

1.5

1.3

28.32

34.87

iu/l

1.93

133

1102

Acute inflammation of orbit

1.73

0.97

1.5

1.4

15.81

23.22

iu/l

—

Parkinson's disease, including avohilmo

486

1.26

0.97

1.4

1.3

32.37

33.54

iu/l

0.09

410

Benign neoplasm of thyroid gland

479

1.27

0.97

1.4

1.3

30.60

32.33

iu/l

0.16

412

Bronchiectasis

451

1.27

0.96

1.4

1.3

39.74

36.49

iu/l

0.23

383

Psoriasis

530

4927

1.08

0.96

1.4

1.3

27.78

30.17

iu/l

0.98

448

4225

Rubella [German measles]

157

1.47

0.96

1.3

18.47

15.76

iu/l

0.17

132

Special screening examination for other diseases and disorders

163

1426

1.15

0.96

1.3

1.4

24.51

23.56

iu/l

0.14

133

1208

IBD patients in KELA-register

597

5577

1.07

0.96

1.4

26.26

25.41

iu/l

0.25

521

4757

Type 1 diabetes

503

5408

0.93

0.96

1.4

20.59

23.44

iu/l

1.24

417

4527

Lyme disease

428

3947

1.09

0.96

1.4

31.93

31.91

iu/l

0.00

359

3396

Burns and corrosions of external body surface, specified by site

206

1832

1.13

0.95

1.4

18.68

21.98

iu/l

0.95

164

1501

Dependent personality disorder

312

1.33

0.95

1.6

1.3

23.76

30.79

iu/l

0.73

264

Pneumonia due to Streptococcus pneumoniae

426

1.28

0.95

1.3

1.4

30.62

24.66

iu/l

0.55

356

Lichen sclerosus et atrophicus

146

1269

1.16

0.95

1.4

32.52

34.73

iu/l

0.31

120

1105

Psoriatic arthropathies, ICD10

197

1748

1.13

0.95

1.4

1.3

30.76

30.30

iu/l

0.07

176

1514

Alcohol-induced acute pancreatitis

225

1.39

0.95

1.2

1.4

14.72

21.65

iu/l

0.93

184

Tuberculosis

242

1.37

0.94

1.6

1.3

23.87

27.26

iu/l

0.29

203

Distal bite

115

978

1.18

0.94

2.1

1.9

14.94

16.43

iu/l

0.23

764

Other ulcerative colitis

131

1132

1.17

0.94

1.4

27.99

24.50

iu/l

0.56

121

953

Marasmic kwashiorkor

2.23

0.94

3.0

2.3

3.18

15.99

iu/l

—

Multiple gestation

514

4795

1.08

0.93

1.3

29.97

29.01

iu/l

0.25

456

4174

Deep bite that required surgery

332

1.33

0.93

1.2

1.3

30.68

27.40

iu/l

0.23

286

Use of interferon beta-1a

827

0.81

0.93

1.3

33.07

26.80

iu/l

0.70

714

Systemic lupus erythematosus, unspecified

636

1.23

0.93

1.4

36.53

28.51

iu/l

1.02

539

Localized scleroderma [morphea]

201

1.42

0.93

1.2

1.3

23.15

29.55

iu/l

0.62

170

Asymmetry of jaw

367

1.31

0.93

1.1

1.4

24.43

24.23

iu/l

0.01

313

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

101

860

1.20

0.93

1.3

25.80

26.29

iu/l

0.05

734

Drug-induced cataract

261

1.36

0.93

1.5

30.86

27.69

iu/l

0.13

227

Coronary artery bypass grafting

560

0.80

0.92

1.3

1.4

19.69

24.42

iu/l

0.55

451

Other congenital malformations of skull and face bones

1.76

0.92

2.3

2.7

3.70

8.87

iu/l

—

Fall on and from ladder

472

1.26

0.92

1.5

1.4

25.98

22.93

iu/l

0.27

395

Other disorders of cornea

145

1264

1.15

0.91

1.4

33.66

29.47

iu/l

0.79

125

1080

Heart failure and antihypertensive medication

203

1507

0.89

0.91

1.5

1.3

23.72

36.32

iu/l

6.63

163

1282

Carcinoma in situ of cervix uteri, endocervix

478

1.27

0.91

1.3

31.79

26.28

iu/l

0.52

418

Foreign body in alimentary tract

664

1.21

0.91

1.4

1.5

20.49

23.98

iu/l

0.61

545

Keratoconus

350

1.30

0.90

1.3

1.4

30.76

24.49

iu/l

0.58

303

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

103

1204

0.85

0.90

1.3

30.79

30.39

iu/l

0.03

1046

Use of anticholinesterases

376

0.75

0.90

1.3

1.4

60.58

33.83

iu/l

2.68

315

N06DA Anticholinesterases

376

0.75

0.90

1.3

1.4

60.58

33.83

iu/l

2.68

315

Other acute viral hepatitis

220

1.39

0.90

1.3

1.4

26.27

23.80

iu/l

0.14

187

Postpartum haemorrhage due to retained placenta

648

6100

1.07

0.90

1.3

28.76

28.79

iu/l

0.01

592

5417

Tic disorders

246

1.37

0.90

1.7

1.9

10.10

13.46

iu/l

0.55

182

Impacted maxillary molar

180

1598

1.14

0.90

1.4

12.44

13.61

iu/l

0.33

152

1313

Multifocal fibrosclerosis

1.94

0.89

1.4

27.61

22.43

iu/l

—

Heart failure and bmi 25plus

154

1212

0.87

0.89

1.4

1.3

22.25

29.33

iu/l

2.07

122

1031

Alcohol dependence

348

3192

1.09

0.89

1.4

1.3

22.38

27.59

iu/l

2.71

254

2736

Follow-up care involving plastic surgery

727

0.80

0.89

1.6

1.3

28.75

31.76

iu/l

0.30

624

Assault by sharp object

220

1.38

0.89

1.4

23.30

20.35

iu/l

0.22

183

Other acute skin changes due to ultraviolet radiation

386

1.28

0.89

1.4

1.3

21.17

31.12

iu/l

1.63

332

Leiomyoma of uterus

2361

12991

1.04

0.89

1.3

32.39

33.42

iu/l

0.73

2083

11457

Pre-eclampsia or eclampsia

901

8559

1.06

0.89

1.3

26.89

29.19

iu/l

1.43

814

7461

Perforation of tympanic membrane

169

1493

1.14

0.89

1.4

26.30

24.55

iu/l

0.31

148

1243

Plasmodium falciparum malaria

1.90

0.88

1.4

1.3

22.21

22.65

iu/l

—

Focal brain injury

520

1.24

0.88

1.4

1.3

19.44

26.27

iu/l

1.17

433

Fracture of forearm

1005

9888

0.95

0.88

1.3

1.4

28.27

28.57

iu/l

0.10

833

8444

Suppurative otitis media, unspecified

369

1.29

0.88

1.6

1.5

14.64

13.79

iu/l

0.09

300

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

144

1.47

0.88

1.2

24.29

24.69

iu/l

0.02

128

Parkinson's disease, strict definition

386

1.27

0.87

1.4

1.3

35.09

33.24

iu/l

0.12

324

Congenital malformations of posterior segment of eye

1.71

0.87

1.9

2.0

12.30

19.17

iu/l

—

Other and unspecified disorders of binocular movement

104

1.58

0.87

1.5

1.4

23.98

24.60

iu/l

—

Sequelae of injuries of head

704

1.20

0.87

1.4

25.34

26.18

iu/l

0.07

596

Other arrhythmias

1456

11613

0.96

0.87

1.4

1.3

27.64

29.71

iu/l

1.61

1278

10041

Fatigue fracture of vertebra

1.86

0.87

1.6

2.6

28.02

14.59

iu/l

—

Injuries to the thorax

635

5964

1.07

0.87

1.4

24.80

27.46

iu/l

1.41

529

5077

Aneurysms, operations, SAH

208

1864

1.12

0.86

1.4

1.3

31.98

34.48

iu/l

0.47

175

1611

Iridocyclitis

439

4076

1.08

0.86

1.3

1.4

29.34

28.74

iu/l

0.13

380

3501

Other renal tubulo-interstitial diseases

561

1.23

0.85

1.2

1.3

27.31

29.15

iu/l

0.17

477

Other and unspecified epidermal thickening

362

1.28

0.85

1.5

1.4

29.51

25.57

iu/l

0.33

300

Focal epilepsy

383

3536

1.09

0.85

1.5

1.4

29.15

25.57

iu/l

1.14

306

2962

Other diseases of oesophagus

100

852

1.18

0.85

1.5

1.3

31.36

30.50

iu/l

0.08

724

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

187

1.39

0.85

1.4

31.84

28.94

iu/l

0.13

158

Peripheral retinal degeneration

470

1.25

0.85

1.4

1.3

24.49

32.25

iu/l

0.91

402

Recurrent dislocation and subluxation of joint

214

1926

1.12

0.85

1.4

1.3

26.36

27.43

iu/l

0.19

195

1645

Parkinson's disease

451

1.24

0.84

1.4

1.3

33.89

33.49

iu/l

0.03

377

Reactive arthropathies

169

1500

1.13

0.84

1.4

24.39

29.19

iu/l

1.32

150

1285

Oral leukoplakia and related diseases

398

1.26

0.84

1.3

37.48

35.26

iu/l

0.20

336

Superficial injuries involving multiple body regions

444

1.25

0.84

1.6

1.3

23.35

24.05

iu/l

0.05

375

Congenital malformations of ovaries, fallopian tubes and broad ligaments

243

2208

1.11

0.84

1.3

25.11

26.91

iu/l

0.40

208

1912

Benign neoplasm: Colon

522

3735

1.07

0.84

1.4

1.3

30.42

34.61

iu/l

1.99

444

3248

Tic and related disorders

258

1.34

0.84

1.7

1.8

9.92

13.76

iu/l

0.68

199

Dronedarone medication

1.76

0.84

1.1

1.3

17.62

30.08

iu/l

—

Myocarditis

652

1.20

0.83

1.4

26.61

28.66

iu/l

0.21

559

Seborrhoeic keratosis

221

1991

1.11

0.83

1.4

1.3

34.66

36.81

iu/l

0.39

199

1724

Benign neoplasm: Skin of scalp and neck

319

1.30

0.83

1.4

1.3

20.76

26.90

iu/l

0.73

271

Olecranon bursitis

327

1.29

0.83

1.2

1.4

18.91

23.86

iu/l

0.63

275

Cholecystitis

143

1255

1.14

0.83

1.4

1.3

27.80

30.25

iu/l

0.39

115

1068

Arterial embolism and thrombosis

283

1.31

0.83

1.6

1.3

28.37

24.87

iu/l

0.27

239

Other and unspecified disorders of psychological development

237

1.35

0.83

1.9

2.0

10.55

11.60

iu/l

0.12

165

Pacemaker

152

1301

1.14

0.83

1.4

1.5

29.89

28.93

iu/l

0.12

121

1076

Lesion of femoral nerve

1.60

0.83

1.2

1.4

30.18

31.01

iu/l

0.03

Abscess of Bartholin gland

822

1.18

0.83

1.4

1.3

28.11

25.95

iu/l

0.24

713

Charcot foot

165

0.60

0.83

1.2

1.3

43.59

27.31

iu/l

—

138

Delivery

1070

5932

0.95

0.82

1.3

1.4

26.27

25.26

iu/l

0.44

925

4916

Benign neoplasm: Rectosigmoid junction

197

1.38

0.82

1.3

31.73

32.47

iu/l

0.03

167

Alcohol use disorder, ICD-based

659

6214

1.06

0.82

1.3

22.21

26.30

iu/l

3.06

500

5305

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

105

662

1.17

0.82

1.4

33.56

38.54

iu/l

0.66

566

Bruxism

547

1.23

0.82

1.5

1.3

27.47

28.03

iu/l

0.05

468

Cholecystectomy

1744

14875

1.04

0.81

1.3

29.64

31.85

iu/l

2.04

1531

12998

Benign neoplasm: Skin, unspecified

600

1.21

0.81

1.4

30.51

30.66

iu/l

0.01

513

Premature separation of placenta [abruptio placentae]

111

965

1.17

0.81

1.2

1.3

24.28

29.06

iu/l

0.83

821

SLE, strict definition

702

1.19

0.81

1.4

34.79

28.66

iu/l

0.75

596

SLE, ICD10

702

1.19

0.81

1.4

34.79

28.66

iu/l

0.75

596

Acute suppurative otitis media

917

8155

1.05

0.81

1.5

1.4

18.33

18.03

iu/l

0.12

747

6881

Injuries to the knee and lower leg

3382

18856

1.03

0.81

1.4

25.91

26.32

iu/l

0.32

2923

16156

Vestibular neuronitis

125

1091

1.15

0.80

1.4

1.3

27.93

31.11

iu/l

0.51

100

929

Puerperal sepsis

307

2821

1.09

0.80

1.3

31.71

33.83

iu/l

0.50

268

2458

Other congenital malformations of ear

322

1.30

0.80

1.4

1.6

19.66

14.20

iu/l

0.52

252

Emphysema

276

1.31

0.80

1.3

33.80

31.65

iu/l

0.14

231

Other benign neoplasm of uterus: Cervix uteri

140

1.47

0.80

1.2

1.3

28.07

28.93

iu/l

0.04

122

Primary coxarthrosis, bilateral

168

1494

1.13

0.80

1.4

1.3

36.26

38.62

iu/l

0.43

152

1279

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.66

0.80

1.3

1.2

14.29

26.68

iu/l

1.34

Open wound of wrist and hand

938

8852

1.05

0.80

1.3

1.4

22.53

24.00

iu/l

0.78

796

7522

Insulin, intermediate and long-acting

742

7679

0.95

0.80

1.4

21.90

26.07

iu/l

3.28

606

6489

Congenital malformations of heart and great arteries

275

2435

1.10

0.79

2.0

1.5

20.71

22.11

iu/l

0.32

228

1946

Venous complications and haemorrhoids in pregnancy

852

0.83

0.79

1.2

1.3

22.77

26.18

iu/l

0.46

730

Disorder of external ear, unspecified

393

1.26

0.79

1.6

1.3

28.44

30.71

iu/l

0.17

338

Transient ischemic attack

465

3594

1.07

0.79

1.3

35.84

34.39

iu/l

0.37

395

3097

LSIL lesion of the vagina

393

0.75

0.79

1.4

1.3

40.01

28.70

iu/l

0.73

337

COPD-related respiratory insufficiency

410

1.25

0.79

1.3

33.13

31.18

iu/l

0.17

349

Dementia due to Parkinson's disease

0.00

0.79

0.0

1.2

—

24.38

—

Operations 1 for CAVS

0.00

0.79

0.0

1.6

—

16.90

—

Other disorders of prostate

1.67

0.78

1.6

1.2

11.39

13.34

iu/l

—

Gout

130

1037

1.14

0.78

1.5

1.3

25.59

29.37

iu/l

0.54

848

Caught, crushed, jammed or pinched in or between objects

787

1.18

0.78

1.5

22.02

21.84

iu/l

0.02

649

Toxic effect of ethanol

732

1.18

0.78

1.5

1.4

24.82

21.21

iu/l

0.37

606

Nontraumatic intracranial haemmorrhage

150

1327

1.13

0.78

1.5

1.4

32.18

33.35

iu/l

0.14

116

1137

Inflammatory bowel disease, strict (require KELA)

597

5628

1.06

0.78

1.4

26.26

25.21

iu/l

0.33

521

4802

Benign neoplasm: Connective and other soft tissue, unspecified

115

1.50

0.78

1.6

1.2

26.39

24.78

iu/l

0.08

Viral infections of the central nervous system

149

1321

1.13

0.78

1.4

1.3

24.44

26.02

iu/l

0.25

126

1118

Melanocytic naevi of upper limb, including shoulder

395

1.26

0.77

1.3

1.4

21.51

26.60

iu/l

0.67

329

Other and unspecified paralytic syndromes

209

1.36

0.77

1.4

29.90

26.05

iu/l

0.26

180

Effects of other external causes

513

1.22

0.77

1.3

1.4

21.43

20.59

iu/l

0.09

429

Calcific aortic valvular stenosis, operated

807

0.84

0.77

1.4

29.09

29.51

iu/l

0.03

665

Calcific aortic valvular stenosis

807

0.84

0.77

1.4

29.09

29.51

iu/l

0.03

665

201

1.37

0.77

1.5

1.3

20.85

19.18

iu/l

0.10

161

COPD

298

2255

1.09

0.77

1.3

29.55

33.46

iu/l

1.33

244

1908

Ankylosing spondylitis

178

1596

1.12

0.77

1.4

24.19

27.73

iu/l

0.78

154

1377

Other psoriatic arthropathies

190

1710

1.12

0.77

1.4

1.3

31.10

30.59

iu/l

0.08

169

1477

Opening and dilatation of root channel of tooth

114

1304

0.87

0.76

1.5

1.4

27.50

26.17

iu/l

0.16

1098

Exophthalmic conditions

124

1.47

0.76

1.6

1.3

32.67

25.76

iu/l

0.33

104

Sequelae of injuries of lower limb

185

1664

1.12

0.76

1.4

1.3

26.34

28.55

iu/l

0.41

156

1432

Other sexually transmitted chlamydial diseases

233

2124

1.11

0.76

1.3

1.4

17.22

15.07

iu/l

0.52

182

1780

Iron deficiency anaemia secondary to blood loss (chronic)

213

1929

1.11

0.76

1.4

1.3

24.35

31.07

iu/l

2.49

189

1658

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

361

3356

1.08

0.75

1.3

28.57

27.69

iu/l

0.19

322

2921

Cholangitis (primary sclerosing, PSC), with reimbursement 202

289

1.30

0.75

1.3

1.5

33.06

23.72

iu/l

0.64

238

Other condition

271

2485

1.09

0.75

1.3

1.4

25.68

26.59

iu/l

0.19

251

2096

Disorders of sphingolipid metabolism and other lipid storage disorders

1.89

0.75

2.4

1.3

47.19

25.86

iu/l

—

Other specified/unspecified deforming dorsopathies

443

1.24

0.74

1.6

1.3

26.38

31.01

iu/l

0.46

387

Failed induction of labour

245

2671

0.91

0.74

1.3

19.18

21.37

iu/l

0.64

219

2275

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

235

2144

1.10

0.74

1.4

1.3

25.51

27.94

iu/l

0.59

215

1833

Oesophageal varices

236

1.32

0.74

1.5

1.4

31.06

24.89

iu/l

0.40

188

Superficial injury of thorax

231

2104

1.10

0.74

1.3

1.4

24.73

26.53

iu/l

0.41

190

1788

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

387

1.24

0.74

1.2

1.3

44.77

32.00

iu/l

1.46

339

Viral meningitis

849

1.17

0.74

1.4

23.73

24.29

iu/l

0.06

723

Reactive arthropathies, FINNGEN

147

1308

1.13

0.73

1.4

22.50

28.20

iu/l

1.77

130

1114

Exposure to other specified factors

1943

17656

1.03

0.73

1.4

25.61

26.08

iu/l

0.26

1641

15113

Valvular operations

689

0.83

0.73

1.6

26.42

24.28

iu/l

0.17

558

Acute peritonitis

598

1.19

0.73

1.4

23.27

28.55

iu/l

0.71

507

Alzheimer disease

304

0.77

0.73

1.4

63.67

35.21

iu/l

3.28

256

Other diseases of biliary tract

653

1.18

0.73

1.3

1.4

38.14

31.07

iu/l

0.84

539

Vasculitis limited to skin, not elsewhere classified

255

1.31

0.72

1.6

1.3

18.66

28.29

iu/l

1.25

215

Adenocarcinoma and ductal carcinoma of pancreas

106

0.56

0.72

1.2

1.3

46.53

27.07

iu/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

382

3561

1.08

0.72

1.3

1.4

28.42

25.02

iu/l

1.09

331

3037

Ectropion of eyelid

1.67

0.72

1.9

1.3

31.35

23.56

iu/l

—

AV-block

761

1.16

0.72

1.3

1.5

27.66

27.80

iu/l

0.01

641

Cleft lip

1.62

0.72

1.4

46.18

24.70

iu/l

1.22

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

1.55

0.71

2.7

2.5

4.44

7.47

iu/l

—

Other and unspecified mononeuropathies of upper limb

445

1.22

0.71

1.3

1.4

33.30

28.34

iu/l

0.43

381

Mandibular retrognathia AND surgery (BSSRO)

751

1.17

0.71

1.2

1.3

27.45

28.00

iu/l

0.05

634

Contusion of ankle

703

1.18

0.70

1.5

22.39

21.81

iu/l

0.06

571

Other abortion

294

1.29

0.70

1.2

1.3

28.65

26.96

iu/l

0.09

260

Intrahepatic Cholestasis of Pregnancy (ICP)

353

3293

1.08

0.70

1.3

28.24

27.13

iu/l

0.25

316

2866

Injuries to the hip and thigh

606

5247

1.06

0.70

1.4

29.82

28.01

iu/l

0.64

519

4459

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.59

0.70

1.3

14.29

30.30

iu/l

1.94

Nonsuppurative otitis media

624

5109

1.06

0.70

1.6

1.4

15.39

15.29

iu/l

0.03

518

4196

Corneal ulcer

376

3508

1.08

0.70

1.4

26.54

26.92

iu/l

0.08

323

3006

Contact with other sharp object(s)

141

1257

1.13

0.70

1.4

22.41

21.33

iu/l

0.16

120

1041

Later onset COPD

277

1.25

0.70

1.2

1.5

26.92

27.29

iu/l

0.02

225

Chronic suppurative otitis media

1028

0.86

0.70

1.4

1.5

18.33

21.96

iu/l

0.57

849

Motor neuron disease (with DMD)

1.52

0.70

2.1

1.4

26.94

33.95

iu/l

—

Chronic Coagulation defects

613

1.19

0.69

1.5

1.4

19.80

25.34

iu/l

1.07

515

Pre-eclampsia or poor fetal growth

1466

14139

1.04

0.69

1.3

26.33

26.92

iu/l

0.30

1308

12323

Unspecified kidney failure

409

1.23

0.69

2.0

1.4

34.44

26.46

iu/l

0.62

341

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

144

1.41

0.69

1.1

1.2

37.09

26.80

iu/l

0.46

121

Separation of retinal layers (serosa)

410

1.23

0.69

1.4

1.3

26.33

27.98

iu/l

0.10

346

Use of fingolimod

371

0.76

0.68

1.6

1.3

29.95

24.34

iu/l

0.44

320

severe traumatic brain injury, does not include concussion

174

1570

1.11

0.68

1.4

22.77

26.00

iu/l

0.71

142

1319

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

104

909

1.15

0.68

1.2

1.3

41.91

33.02

iu/l

1.35

777

Human immunodeficiency virus [HIV] disease resulting in other conditions

214

1.32

0.68

1.2

1.4

15.77

20.57

iu/l

0.47

180

Toxic effects of substances chiefly nonmedicinal as to source

222

2032

1.10

0.67

1.5

1.4

20.43

23.48

iu/l

0.75

176

1684

Injury of nerves at wrist and hand level

540

1.19

0.67

1.4

1.3

21.46

23.95

iu/l

0.25

453

Glomerular diseases

206

2257

0.91

0.67

1.4

28.63

25.58

iu/l

0.53

180

1900

Gout, FINNGEN

130

1155

1.13

0.66

1.5

1.4

25.59

27.47

iu/l

0.23

956

Crohn disease (strict definition, require KELA)

155

1395

1.12

0.66

1.4

21.11

22.47

iu/l

0.25

133

1174

Twin gestation

491

4642

1.07

0.66

1.3

30.08

28.89

iu/l

0.32

436

4038

Diseases of oesophagus, stomach and duodenum

2932

17380

1.03

0.66

1.4

1.3

27.67

27.87

iu/l

0.12

2513

15011

Haemorrhagic and haematological disorders of fetus and newborn

447

1.21

0.66

2.5

2.3

5.62

7.80

iu/l

0.76

284

Calcific aortic valvular stenosis, diagnosis (helper)

793

0.85

0.66

1.4

29.09

29.64

iu/l

0.05

658

Operations 2 for CAVS

793

0.85

0.66

1.4

29.09

29.64

iu/l

0.05

658

Other and unspecified diseases of spleen

1.62

0.66

1.3

1.2

39.86

24.48

iu/l

—

Other secondary gonarthrosis

467

1.21

0.66

1.4

1.3

25.80

33.25

iu/l

1.32

397

Other congenital malformations of peripheral vascular system

278

1.28

0.66

1.4

1.5

22.80

21.49

iu/l

0.09

224

Malignant neoplasm of prostate

520

0.85

0.65

1.7

1.3

12.51

12.32

iu/l

0.03

411

Congenital musculoskeletal deformities of head, face, spine and chest

198

1.33

0.65

2.0

1.8

19.97

16.95

iu/l

0.19

156

Malignant neoplasm of oral cavity

180

1.34

0.65

1.3

28.32

26.36

iu/l

0.11

155

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

394

1.22

0.65

1.2

1.3

44.77

31.75

iu/l

1.50

344

Other chronic obstructive pulmonary disease

274

2103

1.08

0.65

1.3

28.80

33.84

iu/l

1.88

222

1783

Pedal cyclist injured in other and unspecified transport accidents

197

1797

1.10

0.65

1.5

1.4

23.93

25.02

iu/l

0.18

164

1501

Diseases of peritoneum

144

1292

1.12

0.64

1.4

27.59

30.86

iu/l

0.62

132

1102

Other bullous disorders

323

1.25

0.64

1.3

1.4

29.47

29.98

iu/l

0.03

271

Myocardial infarction, with ST-elevation

548

0.82

0.64

1.3

1.4

25.60

25.91

iu/l

0.02

457

Degenerative macular diseases

569

1.18

0.64

1.2

1.3

38.26

31.41

iu/l

0.89

481

Benign neoplasm: Skin of lower limb, including hip

378

1.23

0.64

1.2

1.3

26.75

29.89

iu/l

0.27

318

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

425

3999

1.07

0.64

1.3

1.4

28.73

25.42

iu/l

1.16

371

3413

Pedal cyclist injured in collision with motor vehicle

442

1.21

0.63

1.3

1.4

24.31

23.36

iu/l

0.07

370

Disorders of optic nerve, not elsewhere classified

155

1.37

0.63

1.4

1.3

38.97

27.95

iu/l

0.50

131

Psoriasis (vulgaris), strict definition

415

1.21

0.63

1.3

1.4

24.94

27.66

iu/l

0.26

349

Psoriasis vulgaris

311

2896

1.08

0.63

1.4

25.73

29.23

iu/l

1.19

262

2478

UC patients in KELA-register (code 208), prior to 1994

544

1.18

0.62

1.2

1.3

36.93

34.61

iu/l

0.22

465

Asthma and opportunity respiratory infection

315

1.24

0.62

1.4

40.79

34.25

iu/l

0.43

272

Contact with lifting and transmission devices, not elsewhere classified

173

1.34

0.62

1.2

1.4

19.20

22.95

iu/l

0.19

141

Discharge of firework

0.00

0.62

0.0

1.2

—

17.91

—

Erysipelas

675

5868

1.05

0.62

1.3

27.78

31.22

iu/l

2.02

568

5051

Alcoholic liver disease

610

0.83

0.62

1.2

1.4

31.68

28.67

iu/l

0.26

514

Benign neoplasm: Small intestine

226

1.29

0.61

1.4

1.2

25.56

32.31

iu/l

0.54

195

Idiopathic urticaria

491

1.20

0.61

1.5

1.4

35.55

23.77

iu/l

1.52

414

Disorders resulting from impaired renal tubular function

316

1.24

0.61

1.7

1.5

26.38

28.66

iu/l

0.18

259

Colorectal adenocarcinoma

932

0.87

0.61

1.2

1.4

39.39

32.97

iu/l

0.87

789

Cerebral aneurysm, nonruptured

127

1136

1.12

0.61

1.3

30.27

34.87

iu/l

0.78

107

982

Pulmonary oedema

1.61

0.61

1.6

1.3

17.94

25.87

iu/l

—

Car occupant injured in noncollision transport accident

648

1.17

0.61

1.3

1.4

26.20

21.87

iu/l

0.56

546

Intentional self-harm by drowning and submersion

0.00

0.61

0.0

1.3

—

20.23

—

Other interventions on the root canals of the tooth

317

1.24

0.61

1.5

1.4

20.64

24.26

iu/l

0.41

272

Cirrhosis of liver, NAS

271

1.26

0.61

1.4

27.05

29.20

iu/l

0.13

231

Implicit Sepsis

1183

8870

1.04

0.61

1.5

1.4

27.33

27.68

iu/l

0.12

966

7583

Tibial collateral bursitis [Pellegrini-Stieda]

148

1.37

0.61

1.3

36.06

29.78

iu/l

0.32

129

Chloasma

1.57

0.61

1.4

1.3

34.61

28.95

iu/l

0.20

Acute alcohol intoxication

358

3355

1.07

0.61

1.4

21.29

25.24

iu/l

1.87

271

2847

Colorectal cancer, excluding all cancers (controls excluding all cancers)

161

1410

1.11

0.61

1.2

1.3

40.39

33.91

iu/l

1.32

130

1217

Other hammer toe(s) (acquired)

152

1287

1.11

0.60

1.4

1.3

39.17

41.51

iu/l

0.37

133

1093

Use of glatiramer acetate

614

1.18

0.60

1.2

1.3

35.00

27.35

iu/l

0.90

523

Respiratory tuberculosis, not confirmed

139

1.37

0.60

1.8

1.3

27.36

28.38

iu/l

0.05

115

Ulcerative colitis (strict definition, all Crohn cases excluded)

331

3097

1.07

0.60

1.3

1.4

28.03

24.93

iu/l

0.83

284

2637

Other disorders affecting eyelid function

1.55

0.60

1.8

1.3

22.33

23.62

iu/l

0.06

Disorders of eyelid, lacrimal system and orbit

2055

15694

1.03

0.59

1.4

1.3

30.06

29.72

iu/l

0.17

1747

13636

Osteomyelitis

531

0.83

0.59

1.6

1.5

23.95

23.80

iu/l

0.01

441

Lumbosacral root disorders, not elsewhere classified

1.46

0.59

1.3

40.10

35.61

iu/l

0.18

Ulcerative colitis (strict definition, require KELA)

396

3729

1.07

0.59

1.3

1.4

28.18

25.17

iu/l

0.95

343

3184

Chronic hepatitis, not elsewhere classified

455

1.20

0.59

1.4

1.3

34.37

30.02

iu/l

0.33

381

Acute alcohol intoxication, ICD10

322

3011

1.07

0.59

1.4

19.91

24.19

iu/l

2.03

242

2524

Tuberculosis of other organs

1.45

0.59

1.4

27.26

30.58

iu/l

—

LSIL lesion of the vulva

112

1001

1.13

0.59

1.3

32.45

33.60

iu/l

0.12

872

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

361

3397

1.07

0.58

1.3

28.57

28.17

iu/l

0.08

322

2996

Calcific aortic valvular stenosis, including rheumatic fever

803

0.86

0.58

1.4

29.83

29.45

iu/l

0.03

667

Intentional self-harm by unspecified means

247

1.27

0.58

1.2

1.5

12.97

18.65

iu/l

0.72

206

Background retinopathy and retinal vascular changes

184

1.31

0.58

1.5

1.3

12.21

24.96

iu/l

2.94

156

Insulin, fast-acting or short human

599

6280

0.95

0.58

1.4

21.24

24.30

iu/l

1.61

497

5292

Congenital malformations of the urinary system

110

980

1.13

0.58

1.5

1.6

32.23

22.47

iu/l

1.38

797

Habit and impulse disorders

301

1.24

0.58

1.4

16.60

20.58

iu/l

0.51

256

Additional codes for the location of defect, injury or illness

820

1.14

0.58

1.3

1.4

32.36

26.54

iu/l

0.93

692

Benign neoplasm: Skin of ear and external auricular canal

346

1.22

0.58

1.2

1.3

19.17

29.52

iu/l

2.11

293

Pathological resorption of teeth

429

1.20

0.57

1.7

1.4

27.12

25.25

iu/l

0.14

370

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

168

1534

1.10

0.57

1.4

20.53

23.40

iu/l

0.69

146

1294

Sixth [abducent] nerve palsy

292

1.24

0.57

2.4

1.4

25.27

27.34

iu/l

0.16

249

Pericarditis

292

1.24

0.57

1.3

1.5

21.50

24.53

iu/l

0.25

253

Systemic lupus erythematosus

728

1.15

0.57

1.4

35.59

29.01

iu/l

0.82

615

All dysplastic lesions of the vagina

687

0.85

0.57

1.4

1.3

37.40

29.78

iu/l

0.76

588

Suppurative and unspecified otitis media

1188

10185

1.04

0.57

1.5

1.4

18.04

19.39

iu/l

0.94

983

8623

Palmar fascial fibromatosis [Dupuytren]

670

1.15

0.57

1.5

1.4

23.85

31.20

iu/l

1.32

562

Benign neoplasm: Connective and other soft tissue, unspecified

124

1.39

0.56

1.6

1.3

26.39

25.96

iu/l

0.02

105

Generalized epilepsy, mode (most common among epilepsy diagnosis)

710

1.15

0.56

1.4

1.5

21.99

23.99

iu/l

0.26

588

Fracture at wrist and hand level

662

6327

1.05

0.56

1.4

23.83

25.31

iu/l

0.59

570

5315

Reimbursement for rheumatic diseases

1244

12815

0.97

0.56

1.3

30.82

29.49

iu/l

0.68

1083

11059

Ankylosis of joint

1.64

0.56

1.5

1.3

6.95

34.36

iu/l

—

Impacted teeth

616

5478

1.05

0.55

1.5

1.4

12.59

14.30

iu/l

1.20

523

4559

Acute and transient psychotic disorders

263

2451

1.08

0.55

1.3

24.10

27.92

iu/l

1.14

195

2116

SLE (Finngen)

730

1.15

0.55

1.4

35.59

30.58

iu/l

0.57

632

Acute and subacute iridocyclitis

371

3497

1.06

0.55

1.4

1.3

29.62

28.74

iu/l

0.18

321

3017

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

353

3330

1.07

0.55

1.3

28.24

27.68

iu/l

0.11

316

2935

Other nutritional anaemias

1.59

0.54

1.5

7.35

29.65

iu/l

—

Retrobulbar neuritis in diseases classified elsewhere

0.61

0.54

1.5

1.3

38.03

22.00

iu/l

—

Hydatidiform mole

490

1.18

0.54

1.3

27.75

30.34

iu/l

0.25

431

Disorder of carbohydrate metabolism, other/unspecified

1.57

0.54

1.5

32.42

27.50

iu/l

—

Pleural effusion

806

1.13

0.53

1.5

1.4

29.19

30.20

iu/l

0.12

684

Burns and corrosions

265

2475

1.07

0.53

1.4

20.85

23.45

iu/l

0.78

209

2054

Other (seronegative) rheumatoid arthritis, wide

247

2650

0.93

0.53

1.3

34.93

32.44

iu/l

0.47

210

2285

Convergent concomitant strabismus

167

1533

1.10

0.53

1.6

1.4

26.39

23.98

iu/l

0.43

133

1268

Other and unspecified acne

278

1.24

0.53

1.5

1.4

19.61

20.15

iu/l

0.03

229

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

117

1.38

0.52

1.6

1.3

18.48

26.21

iu/l

0.57

100

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

1.43

0.52

1.7

1.3

18.59

22.95

iu/l

—

Speech disturbances, not elsewhere classified

779

1.13

0.52

1.5

1.4

25.24

30.05

iu/l

0.73

664

Thyroiditis, unspecified

324

1.22

0.52

1.2

1.4

31.28

30.45

iu/l

0.04

281

Amputation of ankle bones

0.62

0.52

1.0

1.3

13.63

24.70

iu/l

—

Dental pulpitis 3

413

2817

1.06

0.52

1.6

6.33

7.76

iu/l

2.92

326

2223

Infections of genitourinary tract in pregnancy

258

2758

0.93

0.52

1.3

21.34

22.74

iu/l

0.33

220

2362

Other specific arthropathies, wide

324

1.21

0.52

1.5

1.3

22.40

33.84

iu/l

1.68

276

Filling of root of tooth

444

1.18

0.51

1.5

1.4

24.76

26.73

iu/l

0.16

376

Left bundle-branch block

434

1.18

0.51

1.3

1.4

39.71

34.72

iu/l

0.50

370

Other obstructive and reflux uropathy

810

1.13

0.51

1.4

23.71

21.63

iu/l

0.19

680

Juvenile rheumatoid arthirtis

669

0.86

0.51

1.3

1.4

29.82

25.54

iu/l

0.39

568

Crohn disease (strict definition, require KELA, min 2 HDR)

149

1363

1.10

0.51

1.4

21.11

22.53

iu/l

0.25

127

1145

Cholangitis (primary sclerosing, PSC)

593

1.15

0.51

1.3

1.4

27.82

27.08

iu/l

0.05

487

Ankyloglossia

333

1.21

0.51

1.7

1.9

14.87

7.90

iu/l

0.78

233

Other/unspecified reactive arthropathies

126

1143

1.11

0.51

1.4

21.16

26.70

iu/l

1.73

112

972

Benign neoplasm: Skin of scalp and neck

343

1.20

0.51

1.4

20.76

27.33

iu/l

0.80

287

Peripheral artery operations in Hilmo

466

0.84

0.50

1.2

1.3

15.55

27.20

iu/l

2.94

388

Infections specific to the perinatal period

271

1.23

0.50

2.0

2.4

4.49

7.73

iu/l

2.85

182

Muscular dystrophy

110

1.38

0.50

2.2

1.7

15.68

24.18

iu/l

—

Benign neoplasm: Ascending colon

773

1.13

0.49

1.3

35.71

33.99

iu/l

0.15

660

Tuberculosis of other organs, strict

101

1.39

0.49

1.4

27.26

30.52

iu/l

—

Alcohol abuse, main dg

258

2415

1.07

0.49

1.4

19.51

23.59

iu/l

1.63

196

2031

Other encephalitis

381

1.19

0.49

1.3

1.4

35.27

24.43

iu/l

1.01

311

Other/unspecified rheumatoid arthritis

118

1302

0.90

0.49

1.3

1.4

33.43

32.70

iu/l

0.07

1119

Benign neoplasm: Descending colon

316

1.21

0.49

1.4

1.3

37.27

33.04

iu/l

0.26

277

Exposure to other and unspecified inanimate mechanical forces

125

1136

1.11

0.49

1.4

24.59

23.36

iu/l

0.17

101

930

Colorectal cancer

116

1281

0.90

0.49

1.2

1.3

38.32

33.75

iu/l

0.63

1086

Glucosamine medication

301

2258

1.06

0.49

1.3

39.45

41.31

iu/l

0.49

264

1920

Generalized epilepsy

111

1004

1.11

0.49

1.4

1.5

25.09

23.28

iu/l

0.25

823

Malignant neoplasm of skin

522

3751

1.05

0.48

1.3

31.31

36.86

iu/l

3.41

439

3228

Cardiomyopathy, other and unspecified

624

1.14

0.48

1.5

1.4

28.98

29.88

iu/l

0.08

527

Dementia in other diseases classified elsewhere

244

1.23

0.48

1.7

1.4

25.60

27.25

iu/l

0.10

210

Burn and corrosion of hip and lower limb, except ankle and foot

327

1.20

0.48

1.5

18.58

21.32

iu/l

0.21

274

Symptoms and signs involving cognition, perception, emotional state and behaviour

2413

17263

0.98

0.48

1.4

1.3

27.77

28.29

iu/l

0.32

2033

14966

Insulin, fast-acting

597

6219

0.96

0.48

1.4

21.13

24.23

iu/l

1.64

495

5243

Anterior Iridocyclitis

387

3674

1.06

0.48

1.4

30.06

28.78

iu/l

0.29

335

3162

Autoimmune diseases excluding thyroid diseases

2864

15587

1.02

0.47

1.4

27.62

25.88

iu/l

1.88

2468

13319

Allergic purpura

551

1.15

0.47

1.3

1.4

19.37

24.05

iu/l

0.72

459

Arthropod-borne viral fevers and viral haemorrhagic fevers

116

1277

0.91

0.47

1.4

28.10

28.85

iu/l

0.08

109

1095

Congenital malformations of lung

1.46

0.47

1.7

2.3

39.64

24.33

iu/l

—

Extracorporeal dialysis

516

0.85

0.47

1.8

1.4

10.88

25.41

iu/l

3.00

422

Chronic myringitis

1.45

0.46

1.3

1.5

24.23

20.68

iu/l

—

Other diseases of gallbladder

430

1.17

0.46

1.2

1.3

33.83

31.30

iu/l

0.21

362

Other specified/unspecified hearing loss

740

1.12

0.46

1.4

28.40

31.32

iu/l

0.33

628

Pedestrian injured in transport accident

106

959

1.11

0.46

1.5

1.4

23.70

25.08

iu/l

0.18

817

Human immunodeficiency virus [HIV] disease

237

1.23

0.46

1.2

1.4

15.23

21.35

iu/l

0.70

201

Other specified and unspecified disorders of iris and ciliary body

1.42

0.45

1.9

1.6

22.20

21.29

iu/l

—

Neovascular glaucoma

375

1.18

0.45

1.2

1.4

28.85

26.32

iu/l

0.19

317

Glaucoma secondary to other eye disorders

375

1.18

0.45

1.2

1.4

28.85

26.65

iu/l

0.16

319

Other otitis externa (chronic)

112

1018

1.10

0.45

1.6

1.4

23.53

28.27

iu/l

1.13

101

853

Systemic sclerosis (FG)

416

0.83

0.45

1.5

1.3

33.42

33.49

iu/l

0.00

351

Traumatic subdural haemorrhage

451

1.16

0.45

1.3

1.4

31.22

27.88

iu/l

0.28

383

Burn and corrosion of wrist and hand

648

1.13

0.45

1.4

1.5

20.46

22.76

iu/l

0.29

528

Use of teriflunomide

359

1.19

0.45

1.4

1.3

34.96

27.41

iu/l

0.57

311

Intentional self-harm by sharp object

527

1.15

0.44

1.2

1.4

11.72

17.82

iu/l

1.08

430

Conduction disorders

278

2178

1.06

0.44

1.4

30.55

29.68

iu/l

0.16

220

1830

Malignant neoplasm of corpus uteri

480

0.85

0.43

1.4

1.3

36.67

41.12

iu/l

0.46

411

Other early complications of trauma

0.00

0.43

0.0

1.6

—

13.41

—

Systemic sclerosis

414

0.84

0.43

1.5

1.3

33.42

31.61

iu/l

0.10

349

Contact with nonpowered hand tool

452

1.16

0.43

1.3

1.4

25.39

21.05

iu/l

0.42

381

Intrauterine hypoxia

0.00

0.43

0.0

3.2

—

18.68

—

Cardiomyopathy

145

1337

1.09

0.43

1.4

28.73

28.22

iu/l

0.06

111

1116

Hypertensive Heart Disease

693

1.11

0.43

1.3

1.4

25.86

33.00

iu/l

1.31

580

Paranoid personality disorder

341

1.18

0.43

1.4

1.3

15.58

26.55

iu/l

1.77

292

Chronic myeloproliferative disease

1.44

0.42

1.4

1.2

19.03

21.90

iu/l

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

0.42

0.0

1.4

—

21.84

—

Discharge from other and unspecified firearms

1.58

0.42

2.8

1.6

9.90

11.00

iu/l

—

Night blindness

0.00

0.42

0.0

1.5

—

24.40

—

Benign neoplasm: Larynx

221

1.23

0.42

1.3

1.4

34.99

26.64

iu/l

0.59

193

Colorectal neuroendocrine tumor and carcinoma

158

1.28

0.42

1.1

1.3

37.09

26.77

iu/l

0.46

134

Superficial injury of shoulder and upper arm

189

1764

1.07

0.42

1.4

23.31

26.37

iu/l

0.74

165

1478

Noonan syndrome

1.54

0.42

2.2

2.3

4.26

11.99

iu/l

—

Mucinosis of skin

0.00

0.41

0.0

1.2

—

34.78

—

Primary gonarthrosis, bilateral

462

3869

1.05

0.41

1.3

31.56

39.95

iu/l

7.45

400

3303

Erectile dysfunction, exclusion

0.00

0.41

0.0

1.3

—

5.49

—

Kidney transplant status

636

0.88

0.41

2.0

1.5

24.64

24.78

iu/l

0.01

519

Fracture of lower leg, including ankle

1071

10374

1.03

0.41

1.4

27.91

29.36

iu/l

0.78

904

8885

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1087

0.91

0.41

1.5

1.4

26.04

28.30

iu/l

0.30

932

Horner syndrome

141

1.29

0.41

1.3

15.61

27.16

iu/l

1.33

120

Open wound of hip and thigh

436

1.15

0.41

1.6

1.4

31.61

19.95

iu/l

1.35

355

Other and unspecified corneal deformities and disorders

493

1.14

0.40

1.3

38.76

30.96

iu/l

0.88

421

Chronic periodontitis, complicated

853

1.10

0.40

1.4

1.3

34.12

31.43

iu/l

0.29

721

Hypertensive encephalopathy

0.00

0.40

0.0

1.3

—

21.60

—

Neonatal jaundice from other and unspecified causes

351

1.17

0.40

2.8

2.4

4.69

6.26

iu/l

0.79

217

Intracranial trauma

1515

11579

0.98

0.40

1.4

1.3

23.82

26.80

iu/l

3.24

1269

9881

Toxic colitis

1.45

0.40

1.2

1.4

36.46

22.88

iu/l

—

Disorders of aromatic amino-acid metabolism

1.45

0.40

2.4

9.70

17.28

iu/l

—

Fetal death of unspecified cause

1.36

0.39

1.0

1.3

33.51

28.16

iu/l

—

Hyperkalaemia

214

1.22

0.39

1.5

1.4

28.71

29.14

iu/l

0.02

174

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

1.41

0.39

1.1

1.2

50.07

23.21

iu/l

—

Assault by unspecified means

382

1.16

0.39

1.3

1.4

19.83

20.09

iu/l

0.02

323

Melanoma in situ of lower limb, including hip

1.38

0.39

1.0

1.2

27.39

26.54

iu/l

—

Premature rupture of membranes

1230

8825

1.03

0.39

1.3

21.22

26.09

iu/l

6.79

1099

7588

Arthrosis

1933

10413

1.02

0.38

1.4

1.3

31.03

31.81

iu/l

0.45

1703

9048

Aortic aneurysm

831

1.10

0.38

1.4

23.50

24.58

iu/l

0.13

689

Other predominantly sexually transmitted diseases, not elsewhere classified

633

6121

1.04

0.38

1.4

1.3

23.41

23.09

iu/l

0.09

531

5300

Encephalitis

420

1.15

0.38

1.3

1.4

34.22

24.55

iu/l

0.94

345

Foreign body on external eye

180

1685

1.07

0.38

1.3

1.4

20.77

iu/l

0.00

152

1401

Duodenal ulcer

504

1.13

0.38

1.3

31.30

30.25

iu/l

0.08

429

Alcohol use disorder, Swedish definition

913

8237

1.03

0.38

1.4

23.14

26.20

iu/l

2.28

708

7033

Fibrosis and cirrhosis of liver

647

1.12

0.38

1.4

29.55

32.89

iu/l

0.39

549

Hypertension

2473

13751

1.02

0.37

1.4

1.3

29.78

31.40

iu/l

1.58

2096

12031

Unspecified urinary incontinence

1028

0.91

0.37

1.5

1.4

24.13

32.52

iu/l

1.88

871

Acute renal failure

130

1204

1.08

0.37

1.5

1.4

31.57

26.93

iu/l

0.64

100

1000

Acute thyroiditis

1.28

0.37

1.2

1.4

36.12

27.43

iu/l

—

Granulomatous disorders of skin and subcutaneous tissue

479

1.13

0.36

1.4

22.68

26.54

iu/l

0.42

405

Viral encephalitis, not elsewhere classified/unspecified

226

1.20

0.36

1.4

1.3

21.89

22.55

iu/l

0.04

182

Other chronic obstructive pulmonary disease, including avohilmo

400

3188

1.04

0.36

1.3

29.37

33.68

iu/l

2.02

328

2712

Allergic colitis

545

1.13

0.36

1.9

12.28

12.99

iu/l

0.10

386

Vertigo of central origin

125

0.72

0.35

1.7

1.3

26.30

28.78

iu/l

—

109

Hand

1.39

0.35

2.0

1.3

28.72

22.83

iu/l

—

Fitting and adjustment of other devices

256

2507

0.95

0.35

1.4

29.17

32.65

iu/l

1.03

239

2133

Small cell lung cancer

1.40

0.35

1.5

1.3

68.22

29.55

iu/l

—

Small cell lung cancer, helper endpoint

1.40

0.35

1.5

1.3

68.22

29.55

iu/l

—

Benign neoplasm: Eye, unspecified

1.38

0.35

1.5

1.4

4.87

28.91

iu/l

—

Relapsing fevers

1.36

0.34

1.0

1.8

20.12

20.50

iu/l

—

Other bursitis of hip

246

1.19

0.34

1.4

1.3

29.92

33.48

iu/l

0.23

213

Examination and encounter for administrative purposes

405

1.14

0.34

1.7

1.3

22.61

24.82

iu/l

0.23

344

Hypertensive diseases

2474

13776

1.02

0.34

1.4

1.3

29.77

31.37

iu/l

1.56

2097

12049

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

566

1.11

0.34

1.4

1.3

38.24

32.45

iu/l

0.66

492

Amiodarone users

358

1.15

0.34

1.4

34.06

26.59

iu/l

0.58

290

Family history of certain disabilities and chronic diseases leading to disablement

139

1299

1.08

0.34

1.4

21.94

23.40

iu/l

0.23

128

1096

Aortic valve malfunction, age under 60 years

126

1172

1.08

0.34

1.4

1.5

29.36

28.86

iu/l

0.05

105

973

Systemic sclerosis, icd10

403

0.86

0.33

1.5

1.3

33.42

30.92

iu/l

0.15

339

Septal defects

140

1280

1.07

0.33

2.1

1.7

18.76

20.75

iu/l

0.33

110

969

ILD medications: immunosuppressive drugs

1595

15003

1.02

0.33

1.5

1.3

27.28

27.79

iu/l

0.24

1362

12888

Other lack of coordination

182

1.22

0.33

2.5

1.4

47.83

22.88

iu/l

1.66

146

Cholesteatoma of middle ear

387

1.14

0.33

1.2

1.3

25.39

27.43

iu/l

0.16

322

Melanocytic naevi of ear and external auricular canal

0.66

0.33

1.2

1.3

20.22

23.28

iu/l

—

COPD, early/later onset

274

2203

1.05

0.33

1.3

1.4

28.80

32.89

iu/l

1.37

222

1865

All dysplastic lesions of the vulva

139

1301

1.07

0.33

1.2

1.3

33.56

32.87

iu/l

0.08

113

1129

Coronary angioplasty

160

1309

0.94

0.33

1.4

28.00

30.44

iu/l

0.41

138

1096

COPD, hospital admissions

273

2201

1.05

0.33

1.3

1.4

28.69

32.92

iu/l

1.44

221

1864

Other contact dermatitis

176

1659

1.06

0.33

1.3

26.11

29.30

iu/l

0.71

162

1426

Pediculosis, acariasis and other infestations

904

1.09

0.33

1.5

1.4

23.70

23.37

iu/l

0.04

758

Maternal care for (suspected) damage to fetus from alcohol

138

1.27

0.32

1.4

1.3

24.22

22.75

iu/l

—

124

Hereditary deficiency of other clotting factors

239

1.19

0.32

1.1

1.4

20.40

23.21

iu/l

0.21

209

malignant neoplasm of female genital organs

174

1640

1.06

0.32

1.5

1.3

40.81

36.86

iu/l

0.66

144

1421

Malignant neoplasm of digestive organs

203

2110

0.95

0.32

1.3

39.06

33.51

iu/l

1.16

168

1803

Chronic pancreatitis

914

1.08

0.32

1.4

22.97

27.50

iu/l

0.84

760

Fracture of femur

149

1275

1.07

0.32

1.5

1.4

26.30

27.85

iu/l

0.23

126

1057

Congenital malformations of cardiac septa

147

1334

1.07

0.32

2.1

1.6

19.07

21.04

iu/l

0.34

116

1017

L04AC Interleukin inhibitors

103

954

1.08

0.32

1.2

1.4

24.16

26.12

iu/l

0.31

808

Hypertension, essential

2246

13019

0.98

0.32

1.4

1.3

30.08

32.34

iu/l

2.54

1894

11435

Childhood allergy (age < 16)

479

3812

1.04

0.32

1.7

1.5

7.55

8.24

iu/l

0.71

386

3046

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

282

2301

0.95

0.31

1.3

38.57

33.85

iu/l

1.19

232

1980

COPD, hospital admissions 1, only main diagnosis

158

1430

0.94

0.31

1.3

1.4

27.99

31.05

iu/l

0.69

131

1202

Liver disorders in diseases classified elsewhere

1.32

0.31

1.3

35.13

24.89

iu/l

—

Exposure to excessive heat of man-made origin

1.33

0.31

1.9

1.3

12.77

22.99

iu/l

—

Impacted maxillary canine

175

1.21

0.31

3.0

2.1

7.21

9.36

iu/l

0.48

131

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

101

937

1.08

0.31

1.6

1.5

20.46

17.35

iu/l

0.45

742

Acute myringitis

120

1.27

0.31

1.6

20.08

20.51

iu/l

0.02

Unstable angina pectoris

174

1361

1.06

0.30

1.3

1.4

28.12

33.02

iu/l

1.34

151

1148

Other abnormal immunological findings in serum

410

1.13

0.30

1.4

1.5

30.35

24.40

iu/l

0.58

344

Other hereditary haemolytic anaemias

1.33

0.30

1.4

19.15

25.20

iu/l

—

Myocardial infarction, without ST-elevation

161

1399

1.06

0.30

1.2

1.4

29.53

32.26

iu/l

0.50

136

1178

Dermatophytosis

147

1382

1.07

0.30

1.5

1.4

21.69

28.74

iu/l

2.24

121

1153

Hypertrophic cardiomyopathy

268

1.16

0.30

1.4

1.5

29.30

26.65

iu/l

0.13

221

Sequelae of infectious and parasitic diseases

141

1325

1.07

0.30

1.3

22.51

27.18

iu/l

1.12

121

1132

Preterm labour and delivery

950

9287

1.02

0.30

1.3

32.16

31.61

iu/l

0.18

848

8033

316

1.14

0.29

1.4

1.3

40.65

38.55

iu/l

0.12

272

Accidental poisoning by and exposure to alcohol

260

0.84

0.29

1.5

1.4

9.82

13.91

iu/l

0.46

213

Thoracic aortic aneurysm

620

1.10

0.29

1.4

25.89

25.68

iu/l

0.02

517

Burn and corrosion of ankle and foot

148

1.22

0.29

1.2

1.4

12.34

21.77

iu/l

1.27

122

Chronic nephritic syndrome

430

0.88

0.29

1.4

1.3

25.05

28.82

iu/l

0.28

364

Benign neoplasm: Small intestine

250

1.16

0.29

1.4

1.3

25.56

34.37

iu/l

0.78

212

Subarachnoid haemorrhage

861

1.08

0.29

1.5

1.3

32.30

34.44

iu/l

0.23

740

Fracture of shoulder and upper arm

474

4586

1.03

0.29

1.6

1.4

24.42

27.69

iu/l

1.46

393

3826

Other disorders of amniotic fluid and membranes

699

7101

0.97

0.29

1.3

22.24

25.64

iu/l

2.37

623

6099

Coxarthrosis, primary

444

3984

0.97

0.29

1.4

1.3

36.98

38.89

iu/l

0.56

391

3406

Fall involving playground equipment

186

1.20

0.29

2.1

2.2

14.73

10.56

iu/l

0.26

126

Gonarthrosis, primary, with knee surgery

397

3359

0.96

0.29

1.3

34.49

41.16

iu/l

4.27

351

2860

Guttate psoriasis

242

1.17

0.28

1.3

35.05

25.95

iu/l

0.52

205

Type of accident

546

5303

1.03

0.28

1.3

1.4

24.36

25.97

iu/l

0.59

490

4503

Statin medication

2376

13510

0.99

0.28

1.3

30.59

30.81

iu/l

0.12

2037

11834

Exposure to other specified electric current

233

1.17

0.28

1.3

1.5

14.53

16.60

iu/l

0.23

196

Superficial injury of neck

432

1.12

0.28

1.3

1.4

17.44

21.10

iu/l

0.56

365

Contusion of other and unspecified parts of foot

120

1126

1.07

0.28

1.6

1.5

20.25

22.22

iu/l

0.31

921

Dislocation, sprain and strain of joints and ligaments of elbow

137

1291

1.06

0.28

1.4

20.77

24.84

iu/l

0.93

117

1062

Other overlap syndromes

299

1.14

0.28

1.2

36.25

29.56

iu/l

0.42

255

Hordeolum and other deep inflammation of eyelid

102

952

1.07

0.27

1.6

1.4

29.56

25.71

iu/l

0.50

788

Ascites

522

0.90

0.27

1.4

34.03

32.47

iu/l

0.12

433

Prolonged pregnancy

810

7555

0.98

0.27

1.3

23.14

24.83

iu/l

0.87

732

6475

Spinal instabilities

481

1.11

0.27

1.3

1.4

24.73

31.10

iu/l

0.80

412

Other arthrosis

952

6955

0.98

0.27

1.3

33.31

36.18

iu/l

1.80

835

6029

Sequelae of injuries of neck and trunk

357

1.12

0.26

1.5

1.4

25.46

26.36

iu/l

0.06

301

Juvenile arthritis (FINNGEN)

129

1367

0.94

0.26

1.4

1.5

24.42

20.94

iu/l

0.57

110

1121

Benign neoplasm: Caecum

500

1.10

0.26

1.5

1.3

33.51

33.40

iu/l

0.01

440

Contact with sharp glass

761

1.08

0.26

1.1

1.4

25.62

20.05

iu/l

0.87

642

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

132

1246

1.06

0.26

1.3

30.03

29.22

iu/l

0.10

118

1067

Brain astrocytoma

1.25

0.26

1.7

1.4

18.59

22.43

iu/l

—

Mitochondrial myopathy

1.25

0.26

1.1

1.3

25.81

23.05

iu/l

—

Labour and delivery complicated by umbilical cord complications

178

1866

0.95

0.26

1.3

31.75

29.49

iu/l

0.39

162

1608

Adenocarcinoma of pancreas

0.66

0.26

1.2

1.3

42.38

26.75

iu/l

—

Amputation of toe

263

1.14

0.25

1.1

1.4

17.71

27.25

iu/l

1.44

218

Use of levodopa decarboxylase inhibitor

358

1.12

0.25

1.5

1.3

37.23

30.50

iu/l

0.48

294

Polyarthritis, unspecified

512

1.10

0.25

1.3

1.4

23.82

31.64

iu/l

1.07

424

Unspecified parasitic disease

1.26

0.25

1.8

1.3

29.42

30.77

iu/l

0.04

Left ventricular outflow tract obstruction (LVOTO), broad definition

145

1375

1.06

0.25

1.5

27.67

27.08

iu/l

0.07

121

1128

Congenital malformations of great arteries

447

1.11

0.24

2.6

2.0

15.62

13.59

iu/l

0.26

308

Alopecia areata

561

1.09

0.24

1.3

1.4

21.12

27.51

iu/l

1.02

477

Other benign neoplasm of uterus: Corpus uteri

1.29

0.24

1.4

1.2

25.50

28.82

iu/l

—

Labour and delivery complicated by fetal stress [distress]

1546

10464

0.98

0.24

1.3

22.87

25.06

iu/l

1.96

1348

8999

Otorrhoea

1.33

0.23

1.8

2.3

18.64

19.08

iu/l

—

Cerebral palsy

380

1.11

0.23

2.3

1.5

18.46

19.76

iu/l

0.09

305

Chronic ulcer of skin, not elsewhere classified

504

1.09

0.23

1.3

21.04

30.24

iu/l

2.21

422

Pyoderma

256

1.14

0.23

1.6

1.3

32.82

28.38

iu/l

0.29

215

Malignant neoplasm of rectum

443

0.90

0.23

1.2

1.3

44.55

33.04

iu/l

1.14

375

Burns and corrosions of multiple and unspecified body regions

256

1.14

0.23

1.2

1.6

20.32

20.82

iu/l

0.04

217

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

1.32

0.23

1.0

1.2

28.14

28.68

iu/l

—

Methotrexate

254

2635

0.96

0.23

1.5

1.4

29.92

31.13

iu/l

0.23

223

2270

Care involving dialysis

702

0.92

0.23

1.6

1.4

22.53

26.97

iu/l

0.29

575

Sudden idiopathic hearing loss

109

1028

1.06

0.23

1.3

1.4

26.46

31.44

iu/l

0.97

878

Injuries to the wrist and hand

2725

19529

1.01

0.23

1.4

24.05

26.50

iu/l

3.79

2314

16768

Blood alcohol or alcohol intoxication level

358

0.89

0.22

1.3

1.4

22.33

18.62

iu/l

0.28

299

Unspecified multiple injuries

1.26

0.22

2.2

1.4

27.92

24.81

iu/l

—

Glaucoma secondary to eye inflammation

0.75

0.22

1.4

1.5

46.61

23.29

iu/l

—

Coxarthrosis, primary, with hip surgery

269

2642

0.96

0.22

1.4

1.3

38.66

39.25

iu/l

0.10

241

2251

Open wound of abdomen, lower back and pelvis

448

1.10

0.22

1.2

1.5

17.13

21.03

iu/l

0.35

372

Rheumatic fever with heart involvement

1.26

0.22

3.0

1.4

14.40

21.15

iu/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

307

2970

1.03

0.22

1.4

31.37

25.92

iu/l

1.77

249

2474

Herpesviral keratitis and keratoconjunctivitis

554

1.09

0.22

1.6

1.3

24.09

28.78

iu/l

0.63

468

Adenocarcinoma and Papillary adenocarcinoma of kidney

1.25

0.22

1.2

1.3

27.26

21.48

iu/l

—

Lesion of lateral popliteal nerve

545

1.09

0.22

1.3

1.4

23.51

27.89

iu/l

0.69

467

Dental caries 1 and operation codes, only avohilmo

776

3821

1.02

0.22

1.4

25.86

24.53

iu/l

0.51

651

3279

Parodontitis, operation under 40 years and operation codes

292

2827

1.04

0.22

1.4

13.99

11.26

iu/l

1.01

233

2369

Benign neoplasm of colon, rectum, anus and anal canal

677

4732

1.02

0.21

1.4

1.3

31.26

34.07

iu/l

1.31

574

4119

Other zoonotic bacterial diseases, not elsewhere classified

0.00

0.21

0.0

1.1

—

26.52

—

Inflammation of lacrimal passages (chronic)

107

1.22

0.21

1.2

1.5

34.14

24.23

iu/l

0.41

Crushing injury of forearm

0.00

0.21

0.0

1.5

—

21.99

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.21

0.0

1.4

—

22.64

—

Respiratory disorders in diseases classified elsewhere

156

0.83

0.21

1.3

40.29

25.13

iu/l

0.95

132

Struck by thrown, projected or falling objec

691

1.07

0.21

1.3

1.4

14.68

21.82

iu/l

1.92

568

Benign neoplasm: Renal pelvis

0.00

0.21

0.0

1.2

—

22.59

—

Fracture of spine, level unspecified

0.00

0.21

0.0

1.3

—

31.43

—

Unspecified acute lower respiratory infection

246

2375

1.04

0.21

1.4

23.70

23.37

iu/l

0.06

203

2015

Leiomyosarcoma

1.17

0.21

1.0

1.3

60.42

29.34

iu/l

—

Postpartum haemorrhage due to anatomy

525

5134

1.03

0.21

1.3

23.87

22.50

iu/l

0.46

482

4542

Primary angle-closure glaucoma

173

1.16

0.21

1.3

45.57

33.05

iu/l

0.64

146

Injury of other and unspecified intrathoracic organs

537

1.08

0.21

1.6

1.3

18.54

24.23

iu/l

0.96

449

Hereditary factor VIII deficiency

1.27

0.20

1.5

33.95

15.36

iu/l

—

therapeutic use

198

0.86

0.20

1.2

37.92

32.72

iu/l

0.23

164

Bacterial sepsis of newborn

144

0.82

0.20

1.7

2.6

4.41

7.01

iu/l

—

Open wound of forearm

116

1221

0.95

0.20

1.3

1.4

17.61

20.96

iu/l

0.77

1004

Other infective (teno)synovitis

1.26

0.20

1.0

1.3

40.85

28.13

iu/l

—

Gout, strict definition

518

1.08

0.20

1.3

1.4

23.16

24.99

iu/l

0.16

429

Obstructed labour due to maternal pelvic abnormality

415

4256

0.97

0.20

1.3

36.44

36.98

iu/l

0.12

369

3687

Brain glioblastoma and astrocytoma

136

1.18

0.20

1.6

1.3

18.48

23.24

iu/l

0.33

117

Dental pulpitis 3, only avohilmo

366

2600

1.03

0.20

1.5

1.6

5.96

7.25

iu/l

3.26

290

2039

Parodontitis, under 40 years and operation codes

291

2825

1.03

0.19

1.4

13.87

11.28

iu/l

0.94

232

2367

Sequelae of other and unspecified infectious and parasitic diseases

133

1271

1.05

0.19

1.3

22.99

27.18

iu/l

0.90

115

1085

Gout, unspecified

694

1.07

0.19

1.4

1.3

27.72

26.35

iu/l

0.10

570

Optic neuritis

126

1203

1.05

0.19

1.5

1.3

25.37

26.62

iu/l

0.15

112

1033

Injury of muscle and tendon at lower leg level

190

1972

0.96

0.19

1.3

1.4

32.47

28.14

iu/l

0.88

162

1671

Seronegative rheumatoid arthritis

161

1675

0.96

0.18

1.4

1.3

37.82

33.32

iu/l

0.76

140

1444

Pregnancy, childbirth and the puerperium

763

3921

1.02

0.18

1.3

1.4

22.90

22.48

iu/l

0.13

662

3222

Motorcycle rider injured in noncollision transport accidents

415

1.09

0.18

1.3

1.5

16.03

16.39

iu/l

0.04

338

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

376

1.09

0.18

1.2

1.3

33.26

32.01

iu/l

0.09

326

Follicular adenocarcinoma of thyroid gland

1.21

0.18

1.3

21.69

20.21

iu/l

—

Atypical mycobacterium lung infection

1.21

0.18

1.6

28.77

20.04

iu/l

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

1.21

0.18

1.4

1.3

18.34

24.63

iu/l

—

Renal failure

286

2690

0.97

0.18

1.5

1.4

32.32

28.14

iu/l

0.84

231

2253

Circumscribed brain atrophy

1.19

0.18

1.7

1.3

39.06

30.16

iu/l

—

Cardiomyopathy (excluding other)

804

1.06

0.18

1.5

1.4

26.93

27.62

iu/l

0.06

666

Arthropathies in other diseases classified elsewhere

507

0.92

0.18

1.2

1.3

33.94

29.91

iu/l

0.22

423

Retinal vascular disorders

497

0.92

0.18

1.4

1.3

33.49

31.89

iu/l

0.10

413

Vitreous haemorrhage

101

961

1.05

0.17

1.4

1.3

24.11

28.05

iu/l

0.65

816

Dental caries 3 and operation codes, only avohilmo

963

4764

1.02

0.17

1.4

25.62

24.30

iu/l

0.58

802

4075

Donors of organs and tissues

243

1.12

0.17

1.6

1.3

26.53

24.47

iu/l

0.12

210

Measles

427

1.09

0.17

1.3

30.97

31.72

iu/l

0.05

380

Benign neoplasm: Caecum

589

0.93

0.17

1.5

1.3

33.51

34.62

iu/l

0.09

499

Other congenital malformations of heart

148

1.16

0.17

3.1

2.1

9.33

16.56

iu/l

1.29

114

Encephalopathy

1.11

0.17

2.7

1.4

15.77

21.85

iu/l

—

Crohn disease (strict definition, all UC cases excluded)

106

1012

1.05

0.17

1.3

1.4

22.31

23.70

iu/l

0.20

847

Retinal vascular occlusion

485

0.93

0.17

1.4

1.3

34.30

31.64

iu/l

0.17

403

Polyhydramnios

218

2116

1.03

0.16

1.2

1.3

24.12

23.71

iu/l

0.06

193

1815

Crushing injury of wrist and hand

120

1.17

0.16

1.5

1.4

21.16

21.55

iu/l

0.02

Colon adenocarcinoma

443

0.92

0.16

1.2

1.3

33.26

34.39

iu/l

0.08

370

Poor fetal growth

657

6465

1.02

0.16

1.3

25.12

24.10

iu/l

0.35

578

5635

Exclusion endpoint for supernumerary teeth

283

1.10

0.16

1.4

1.5

25.52

18.97

iu/l

0.49

217

Amputation

370

0.92

0.16

1.1

1.4

16.56

26.67

iu/l

1.88

308

Sequelae of other and unspecified effects of external causes

0.76

0.16

1.5

1.4

31.75

23.05

iu/l

—

Melanocytic naevi of ear and external auricular canal

0.76

0.16

1.2

20.22

22.42

iu/l

—

Benign neoplasm of other and unspecified female genital organs

672

1.06

0.15

1.4

1.3

28.50

29.81

iu/l

0.12

584

Secondary right heart disease

193

0.88

0.15

1.4

34.63

24.07

iu/l

0.52

160

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.21

0.15

1.2

1.4

12.55

23.51

iu/l

—

Bronchitis, not specified as acute or chronic

106

1107

0.96

0.15

1.5

1.4

22.70

25.48

iu/l

0.41

946

Other benign neoplasm of uterus: Corpus uteri

1.21

0.15

1.4

1.3

25.50

29.74

iu/l

—

Melanoma in situ of lower limb, including hip

1.16

0.15

1.0

1.3

27.39

31.57

iu/l

—

Other blood glucose lowering drugs, excl. Insulins

119

1142

1.04

0.15

1.2

1.4

29.11

35.41

iu/l

1.42

101

975

Pulmonary eosinophilia, not elsewhere classified

0.75

0.15

1.0

1.3

41.80

25.92

iu/l

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.76

0.15

1.2

46.53

27.46

iu/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

596

5860

1.02

0.15

1.3

1.4

24.09

25.74

iu/l

0.66

529

4983

Familial hypercholesterolemia

672

1.06

0.15

1.4

24.12

28.80

iu/l

0.65

566

Other disorders of skin and subcutaneous tissue

1247

11293

1.01

0.15

1.4

1.3

28.70

30.25

iu/l

0.85

1063

9748

Biological medication for rheuma

387

3950

0.98

0.15

1.4

23.89

25.93

iu/l

0.67

344

3365

Disorders of brain, other and unspecified

0.80

0.14

1.4

20.27

23.49

iu/l

—

Abnormalities of forces of labour

512

5034

1.02

0.14

1.3

29.90

32.91

iu/l

1.36

461

4359

Malignant neoplasm of colon

748

0.95

0.14

1.2

1.3

35.34

33.83

iu/l

0.12

633

Adhesive middle ear disease

223

0.89

0.14

1.5

1.4

19.33

18.88

iu/l

0.02

187

Delivery, wide proxy

907

4889

0.99

0.14

1.3

1.4

23.83

23.11

iu/l

0.27

787

4020

Endovascular or surgical operations to intracerebral aneurysms

684

1.05

0.14

1.3

1.4

33.77

35.12

iu/l

0.12

593

Primary open-angle glaucoma, strict

112

1074

1.04

0.14

1.3

39.73

37.70

iu/l

0.23

910

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

230

2360

0.97

0.14

1.3

26.67

29.05

iu/l

0.57

210

2059

Evidence of alcohol involvement determined by blood alcohol level

191

0.89

0.14

1.3

1.4

24.23

19.95

iu/l

0.19

159

Ankylosing spondylitis, ICD10

175

1699

1.03

0.13

1.4

24.27

27.00

iu/l

0.55

153

1453

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

773

1.05

0.13

1.2

1.3

39.39

33.52

iu/l

0.76

657

Iliotibial band syndrome

201

0.89

0.13

1.2

1.4

38.09

30.23

iu/l

0.35

170

Leisure time condition

287

2935

0.98

0.13

1.4

22.83

24.69

iu/l

0.47

253

2472

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2505

17821

1.01

0.13

1.5

1.3

26.85

28.07

iu/l

1.03

2099

15418

Peripheral arterial reconstruction

383

1.07

0.13

1.2

1.4

18.32

29.49

iu/l

1.52

318

Unspecified human immunodeficiency virus [HIV] disease

117

0.85

0.13

1.2

1.4

13.06

19.03

iu/l

—

Monoarthritis, not elsewhere classified

717

1.05

0.12

1.3

1.4

24.51

28.44

iu/l

0.55

614

Degeneration of macula and posterior pole

206

1655

1.03

0.12

1.3

1.4

40.51

36.36

iu/l

0.87

160

1413

Acute appendicitis, with complications

349

3425

1.02

0.12

1.4

1.3

28.97

31.33

iu/l

0.66

298

2951

Burns and corrosions confined to eye and internal organs

467

0.94

0.12

1.3

1.4

31.24

26.63

iu/l

0.42

397

Malignant neoplasm of ovary

551

1.05

0.12

1.9

1.4

33.85

34.50

iu/l

0.05

474

Femoral hernia

336

1.07

0.12

1.5

1.3

31.03

30.06

iu/l

0.05

286

Pneumococcal septicemia

346

1.07

0.12

1.6

1.5

22.16

19.65

iu/l

0.23

284

Chronic kidney disease

166

1698

0.97

0.12

1.5

1.4

30.14

26.61

iu/l

0.44

140

1411

COPD related to multimorbidity

188

1543

1.03

0.11

1.3

1.4

30.11

33.21

iu/l

0.66

151

1301

Pustular psoriasis

700

1.04

0.11

1.5

1.3

35.16

33.95

iu/l

0.11

594

Congenital malformations of pulmonary and tricuspid valves

167

0.89

0.11

3.8

2.0

13.19

13.29

iu/l

0.00

121

Transient synovitis

163

1.11

0.11

2.1

1.6

22.92

18.63

iu/l

0.22

139

Nonischemic cardiomyopathy

424

0.94

0.11

1.6

1.4

31.59

27.25

iu/l

0.29

350

Gestational [pregnancy-induced] hypertension

1253

12604

0.99

0.11

1.3

25.91

26.73

iu/l

0.41

1122

10998

Spontaneous rupture of synovium and tendon

819

1.04

0.10

1.4

30.30

33.51

iu/l

0.43

703

Scabies

721

1.04

0.10

1.5

1.4

22.58

22.75

iu/l

0.02

592

Unspecified event, undetermined intent

407

1.06

0.10

1.4

20.72

23.05

iu/l

0.22

346

Right ventricular outflow tract obstruction

187

0.90

0.10

3.9

2.1

7.95

12.71

iu/l

0.60

140

Hypertensive heart and/or renal disease

110

826

1.03

0.10

1.3

1.4

26.81

32.93

iu/l

1.20

689

L04AA Selective immunosuppressants

456

4499

1.01

0.10

1.5

1.4

29.69

29.81

iu/l

0.02

389

3864

Alcohol-induced chronic pancreatitis

437

1.05

0.10

1.3

1.4

21.40

26.51

iu/l

0.71

367

COPD, hospital admissions 3, with asthma pneumonia sepsis

107

882

1.03

0.10

1.3

1.4

27.55

30.45

iu/l

0.45

736

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.09

0.09

1.2

1.3

18.42

23.36

iu/l

—

Cardiomyopathies, Primary/intrinsic

762

1.04

0.09

1.5

1.4

28.37

27.42

iu/l

0.08

631

Dipeptidyl peptidase 4 (DPP-4) inhibitors

634

1.04

0.09

1.5

1.3

23.09

33.71

iu/l

2.88

531

Mesothelioma

1.06

0.09

1.0

1.6

28.72

22.40

iu/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach

1.15

0.09

1.1

1.3

50.07

24.33

iu/l

—

Cystic kidney disease

411

0.95

0.09

1.5

1.4

22.43

25.75

iu/l

0.23

347

Pure hypercholesterolaemia

856

5689

1.01

0.09

1.4

1.3

30.28

34.48

iu/l

2.84

706

4901

Tularaemia

126

1.11

0.09

1.4

1.3

33.22

24.15

iu/l

0.34

101

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

1.11

0.09

1.0

1.1

51.52

26.87

iu/l

—

Other pulmonary heart/vessel disease

237

0.93

0.09

1.3

1.5

37.12

24.20

iu/l

0.74

193

CR(E)ST syndrome

247

0.93

0.09

1.6

1.3

34.28

33.22

iu/l

0.04

214

Pedal cyclist injured in transport accident

436

4307

1.01

0.08

1.4

24.04

25.38

iu/l

0.39

368

3637

Central retinal artery occlusion

1.07

0.08

1.2

1.3

12.17

23.60

iu/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

461

0.95

0.08

1.4

33.20

30.22

iu/l

0.22

394

Disorders of plasma-protein metabolism, not elsewhere classified

0.80

0.08

2.2

1.3

30.28

24.56

iu/l

—

Carcinoma in situ of skin of trunk

0.81

0.08

1.0

1.3

20.98

28.49

iu/l

—

Gout, idiopatic and unspecified

943

1.03

0.08

1.4

25.83

27.29

iu/l

0.13

782

Alcohol withdrawal state with delirium

440

0.95

0.08

1.2

1.3

21.13

25.33

iu/l

0.51

367

Vitiligo

205

1.08

0.08

1.3

1.4

30.56

25.95

iu/l

0.25

175

Atrial fibrillation and flutter with reimbursement

206

1344

0.98

0.08

1.3

28.43

39.38

iu/l

4.48

170

1150

Exposure to excessive natural cold

0.84

0.07

1.5

1.3

24.67

19.40

iu/l

—

Hepatic failure, not elsewhere classified

313

1.06

0.07

1.6

1.4

21.14

27.50

iu/l

0.68

270

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

329

1.05

0.07

2.3

7.25

6.36

iu/l

0.15

211

Congenital malformations of aortic and mitral valves

520

1.04

0.07

1.8

1.7

28.33

18.86

iu/l

1.15

405

Complications of anaesthesia during pregnancy

1.07

0.07

1.4

13.70

19.08

iu/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

926

1.03

0.07

1.4

1.3

16.36

27.66

iu/l

4.10

791

Other juvenile arthritis

114

1166

0.98

0.07

1.4

1.5

24.05

19.09

iu/l

0.82

944

IgA nephropathy (IgA glomerulonephritis)

294

1.06

0.07

1.6

1.3

20.54

22.02

iu/l

0.11

243

Other congenital malformations of urinary system

1.06

0.07

1.0

1.8

16.07

15.52

iu/l

—

Unknown and unspecified causes of morbidity

119

1164

1.02

0.07

1.4

1.3

29.21

27.15

iu/l

0.27

104

1001

Autoimmune diseases excluding thyroid diseases, strict definition

2710

15038

1.00

0.07

1.3

27.55

25.95

iu/l

1.59

2335

12852

Parodontitis, under 40 years, or operation codes

306

3023

1.01

0.07

1.4

13.94

11.84

iu/l

0.73

243

2539

Contact with other hot metals

173

0.92

0.07

1.3

1.5

34.50

20.82

iu/l

—

147

Use of rasagiline

0.88

0.06

2.0

1.3

31.01

31.89

iu/l

—

Glomerulonephritis

131

1336

0.98

0.06

1.4

28.38

26.26

iu/l

0.27

114

1113

Bacterial meningitis

522

1.04

0.06

1.6

1.4

25.29

28.00

iu/l

0.25

450

Lesion of radial nerve

453

1.04

0.06

1.3

33.91

29.21

iu/l

0.43

390

L04AX Other immunosuppressants

1273

12792

0.99

0.06

1.5

1.4

27.98

28.44

iu/l

0.19

1092

11008

1067

9609

0.99

0.06

1.4

22.63

25.78

iu/l

2.78

831

8220

Other bacterial agents as the cause of diseases classified to other chapters

109

1.10

0.06

2.3

1.6

14.40

23.58

iu/l

—

Left ventricular outflow tract obstruction, narrow definition

671

1.03

0.06

2.0

1.7

25.86

18.26

iu/l

1.08

525

Glaucoma

534

4725

0.99

0.06

1.3

33.38

35.01

iu/l

0.53

465

4063

Primary open-angle glaucoma

134

1282

1.02

0.06

1.4

38.37

37.33

iu/l

0.12

117

1089

Ankylosing spondylitis, strict definition

959

1.02

0.06

1.4

1.3

23.61

25.76

iu/l

0.28

817

Second line medication for Crohn's disease

1332

13253

1.00

0.06

1.5

1.4

27.84

28.17

iu/l

0.13

1144

11391

Bullous disorders

527

0.97

0.06

1.4

28.65

29.44

iu/l

0.05

445

Tumor necrosis factor alpha inhibitors

357

3605

0.99

0.06

1.4

23.15

25.90

iu/l

0.97

317

3076

Corns and callosities

811

1.02

0.05

1.5

1.4

28.59

30.24

iu/l

0.14

695

Parodontitis, under 40 years

305

3019

1.01

0.05

1.4

13.82

11.81

iu/l

0.68

242

2536

Placenta praevia

216

2186

0.99

0.05

1.3

26.60

25.93

iu/l

0.11

188

1881

Pustulosis palmaris et plantaris

643

1.03

0.05

1.5

1.3

35.22

34.75

iu/l

0.04

547

Foreign body in ear

287

1.05

0.05

1.2

1.6

27.12

20.53

iu/l

0.31

238

Benign neoplasm: Descending colon

366

1.04

0.05

1.4

1.3

37.27

34.48

iu/l

0.16

307

Cleft hard palate NOS

110

0.90

0.05

1.4

1.5

11.55

17.19

iu/l

—

Motor- or nonmotor-vehicle accident in traffic area

110

0.91

0.05

1.4

1.5

9.18

17.69

iu/l

—

Multiple delivery

320

3171

1.01

0.05

1.3

31.51

29.94

iu/l

0.33

280

2685

Postprocedural musculoskeletal disorders, not elsewhere classified

614

1.03

0.05

1.6

1.3

31.03

35.45

iu/l

0.52

525

Acute tubulo-interstitial nephritis

1368

12084

1.00

0.04

1.4

1.3

26.03

26.60

iu/l

0.25

1147

10417

Combinations of oral blood glucose lowering drugs

220

2224

0.99

0.04

1.4

1.3

25.03

33.81

iu/l

5.08

193

1901

974

8902

1.00

0.04

1.4

21.76

25.58

iu/l

3.88

749

7608

Smoking dependency

125

1268

0.99

0.04

1.4

1.3

28.58

28.76

iu/l

0.02

1076

Etanercept

138

1398

0.99

0.04

1.3

1.4

21.19

26.81

iu/l

1.54

119

1179

Calcific tendinitis

131

1.07

0.03

1.9

1.3

25.58

32.60

iu/l

0.37

110

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

965

0.98

0.03

1.4

29.20

30.35

iu/l

0.12

813

Cardiac arrest

320

0.97

0.03

1.2

1.3

30.04

28.86

iu/l

0.08

267

Liveborn infants according to place of birth

231

1.04

0.03

1.8

2.1

7.59

8.19

iu/l

0.08

154

Normotensive glaucoma

280

1.04

0.03

1.2

1.3

55.00

39.86

iu/l

1.09

238

468

1.02

0.03

1.3

1.4

36.20

39.15

iu/l

0.24

395

Suppurative and necrotic conditions of lower respiratory tract

320

1.03

0.03

1.4

21.34

26.35

iu/l

0.48

262

Schizotypal disorder

511

0.98

0.03

1.4

19.44

24.35

iu/l

0.75

434

Nephrotic syndrome

380

1.03

0.03

1.5

1.6

13.36

21.97

iu/l

1.22

304

Other congenital malformations of face and neck

599

1.02

0.02

1.3

1.4

20.48

23.38

iu/l

0.33

502

COPD, hospital admission 2, with asthma infections

166

1403

1.01

0.02

1.3

1.4

27.18

31.22

iu/l

0.97

143

1188

Sulfasalazine

614

6117

1.00

0.02

1.3

28.08

28.97

iu/l

0.28

529

5300

Idiopathic gout

301

1.03

0.02

1.5

1.3

23.48

23.49

iu/l

0.00

253

Pneumonia derived septicemia

361

1.03

0.02

1.6

1.5

22.16

21.73

iu/l

0.03

293

Contact with machinery

780

0.99

0.02

1.2

1.4

15.55

20.04

iu/l

0.98

643

Burn and corrosion of shoulder and upper limb, except wrist and hand

262

1.03

0.02

1.4

1.6

20.41

21.64

iu/l

0.09

215

Endocarditis

193

1.04

0.01

1.5

1.4

27.27

21.15

iu/l

0.25

163

Assault by blunt object

223

1.03

0.01

1.6

1.4

21.61

23.84

iu/l

0.14

190

Benign neoplasm of other and unspecified female genital organs

718

0.99

0.01

1.4

1.3

28.50

32.13

iu/l

0.41

617

Open wound of head

757

7444

1.00

0.01

1.4

21.43

26.09

iu/l

4.34

604

6235

Other complications of labour and delivery, not elsewhere classified

566

5462

1.00

0.01

1.3

18.15

18.73

iu/l

0.20

498

4626

Dyspnoea

2043

15652

1.00

0.00

1.4

1.3

26.65

28.53

iu/l

1.77

1751

13516

Palatinal maxillary canine

166

0.96

0.00

1.6

1.9

45.74

6.77

iu/l

—

128

Adalimumab

210

2107

1.00

0.00

1.5

1.4

25.19

25.37

iu/l

0.03

192

1796

Burn and corrosion confined to eye and adnexa

404

1.02

0.00

1.2

1.4

32.04

25.75

iu/l

0.59

343

Other and unspecified vascular occlusions

344

1.02

0.00

1.4

1.3

32.10

iu/l

0.00

282

Chronic suppurative otitis media, including avohilmo

126

1254

1.00

0.00

1.5

19.00

22.09

iu/l

0.64

106

1028

Adenocarcinoma and papilloma adenocarcinoma of rectum

432

1.00

0.00

1.2

1.3

46.45

31.66

iu/l

1.65

363

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

443

0.99

0.00

1.2

1.3

45.65

31.98

iu/l

1.51

372

Mental and behavioural disorders due to tobacco

125

1255

1.00

0.00

1.4

1.3

28.58

28.94

iu/l

0.04

1066

Other abnormal findings in urine

124

0.97

0.00

1.8

1.5

25.74

21.84

iu/l

0.22

105

Injury of urinary and pelvic organs

225

0.98

0.00

1.3

1.5

23.35

21.95

iu/l

0.08

190

Atrial septal defect

745

1.00

0.00

1.8

1.7

23.03

20.99

iu/l

0.20

555

Pneumonitis due to solids and liquids

414

0.99

0.00

1.3

1.4

30.72

26.96

iu/l

0.24

346

Ulcer of lower limb, not elsewhere classified

792

1.00

0.00

1.2

1.4

26.97

29.90

iu/l

0.25

674

Open wound of shoulder and upper arm

238

1.01

0.00

1.4

1.5

16.41

20.93

iu/l

0.26

202

HSIL lesion of the vulva

322

0.99

0.00

1.2

1.3

34.30

30.76

iu/l

0.20

286

Polyarthrosis

172

1648

1.00

0.00

1.3

37.91

43.43

iu/l

1.45

158

1397

Retained placenta and membranes, without haemorrhage

378

3784

1.00

0.00

1.3

30.24

30.44

iu/l

0.04

339

3270

Abnormal findings on examination of urine, without diagnosis

562

1.00

0.00

1.4

1.5

22.18

24.08

iu/l

0.19

478

Pedal cyclist injured in noncollision transport accidents

202

2023

1.00

0.00

1.4

23.37

25.69

iu/l

0.50

171

1692

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

648

1.00

0.00

1.3

38.11

38.42

iu/l

0.02

568

Toxic effect of contact with venomous animals

619

1.00

0.00

1.5

1.4

16.38

26.00

iu/l

2.38

519

Isolated proteinuria

393

0.99

0.00

1.4

1.5

21.20

21.88

iu/l

0.05

332

Use of biperiden

696

1.01

0.00

1.4

23.88

31.53

iu/l

1.31

592

Bicuspidal aortic valve syndrome

385

0.99

0.00

1.7

1.5

38.00

21.40

iu/l

1.77

312

Pyothorax

235

1.02

0.00

1.5

1.4

16.16

25.58

iu/l

1.62

197

Leptospirosis

0.00

0.0

1.5

—

11.45

—

Traction detachment of retina

0.92

0.00

1.1

1.4

27.11

19.62

iu/l

—

Bacterial agents resistant to antibiotics

0.00

0.0

1.3

—

20.21

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.94

0.00

1.6

1.3

9.54

26.16

iu/l

—

Crushing injury of neck

0.00

0.0

1.7

—

16.63

—

Malignant neoplasm of trachea, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

11.44

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

1.2

—

29.40

—

Carcinoma in situ of lip, excluding all cancers

0.00

0.0

1.3

—

22.45

—

Carcinoma in situ of lip

0.00

0.0

1.3

—

22.45

—

Anhidrosis

0.00

0.0

1.6

—

23.77

—

Exposure to uncontrolled fire in building or structure

0.91

0.00

1.0

1.3

8.38

20.96

iu/l

—

Other and unspecified atrophic disorders of skin

1.00

0.00

1.8

1.3

15.46

29.15

iu/l

—

Exposure to high-pressure jet

0.00

0.0

1.6

—

15.92

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

47.92

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.88

0.00

1.2

42.38

27.61

iu/l

—

Hyperalimentation, other specified

0.00

0.0

1.0

—

9.68

—

Atrioventricular septal defect

1.00

0.00

3.0

2.5

13.08

19.72

iu/l

—

Unspecified contracted kidney

0.94

0.00

1.8

1.3

25.94

22.45

iu/l

—

Traumatic amputations involving multiple body regions

0.00

0.0

1.2

—

22.45

—

Lipid storage disorder, other/unspecified

0.00

0.0

1.2

—

35.18

—

Disorders of glycosaminoglycan metabolism

0.00

0.0

1.0

—

6.32

—

Fibrosis of liver

0.99

0.00

2.0

1.4

36.13

23.66

iu/l

—

Brain glioblastoma

0.99

0.00

1.4

1.3

18.34

22.79

iu/l

—

Total (external) ophthalmoplegia

0.00

0.0

1.2

—

39.76

—

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

0.0

1.7

—

34.41

—

Colitis due to radiation

0.86

0.00

1.0

1.3

14.66

19.84

iu/l

—

Acne tropica

0.00

0.0

1.2

—

39.35

—

Toxic effect of soaps and detergents

0.00

0.0

1.2

—

22.62

—

Amputation of ankle

0.00

0.0

1.2

—

17.42

—

Papulosquamous disorders in diseases classified elsewhere

0.00

0.0

1.2

—

35.72

—

Choroidal degeneration

0.00

0.0

1.6

—

21.98

—

Enophthalmos

0.00

0.0

1.6

—

11.45

—

Adenocarcinoma of small intestine

0.00

0.0

1.6

—

37.13

—

Blindness (ICD-9)

0.00

0.0

1.8

—

16.13

—

Pseudopelade

0.00

0.0

1.5

—

28.37

—

Carcinoma in situ of skin of eyelid, including canthus

0.00

0.0

1.8

—

15.90

—

Choroidal detachment

0.00

0.0

1.2

—

28.28

—

Disorders of peritoneum in infectious diseases classified elsewhere

0.00

0.0

1.3

—

16.44

—

Carcinoma in situ of skin of eyelid, including canthus

0.00

0.0

1.4

—

24.34

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

1.2

—

39.35

—

Birth asphyxia

120

1.00

0.00

2.3

2.5

18.09

8.86

iu/l

—

Malignant neoplasm of meninges

0.00

0.0

1.4

—

22.50

—

Intentional self-harm by hanging, strangulation and suffocation

0.98

0.00

2.0

1.2

5.28

16.44

iu/l

—

Benign neoplasm: Trachea

0.00

0.0

1.2

—

10.64

—

Scleritis and episcleritis in diseases classified elsewhere

0.00

0.0

1.5

—

36.20

—

Folate deficiency anaemia

0.89

0.00

1.2

1.4

36.88

28.23

iu/l

—

Palatinal maxillary operation

200

1.00

0.00

1.7

1.9

37.52

7.61

iu/l

0.47

154

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follitropin [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS